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Abstract 
 
Glycine receptors (GlyR) are anion-permeable channels that belong to the pentameric ligand-
gated ion channel family. Different GlyR subtypes are known. The main synaptic form is 
thought to be ʱ1β heteropentamers which mediate fast synaptic inhibition in the adult spinal 
cord and brainstem. Data on recombinant receptors suggest two possible stoichiometries for 
this subtype, 2ʱ1:3β and 3ʱ1:2β. Evidence for the first comes from experiments on oocytes, 
whereas  a  study  in  mammalian  cells  favours  the  latter,  raising  the  possibility  that 
stoichiometry depends on the expression system. Here, we assess the stoichiometry of ʱ1β 
GlyRs  in  Xenopus  oocytes  using  two  different  electrophysiological  approaches.  The  first 
involves the use of a reporter mutation at the conserved 9΄ position of the pore-lining domain. 
In  other  receptors,  this  mutation  shifts  agonist sensitivity  in  proportion  to  the  number  of 
mutated subunits. Recordings from mutant receptors failed to point towards one or the other 
stoichiometry. The second approach involved single-channel  recordings from  conductance 
mutants.  This  approach  was  also  inconclusive  for  stoichiometry.  However,  we  provide 
evidence  that  oocytes  are  not  a  suitable  expression  system  for  the  study  of  heteromeric 
glycine receptors as they are highly prone to contamination by homomers. 
 
ʱ2 homomeric GlyRs are predominant early in development and are replaced by ʱ1 subunits 
in the first postnatal days. We investigated the activation mechanism of these channels in 
HEK293  cells  by  maximum  likelihood  fitting  of  single-channel  data,  at  a  wide  range  of 
glycine concentrations. The mechanism we propose suggests that ʱ2 channels can open only 
when  all  binding  sites  are  occupied  by  glycine,  and  only  after  the  channel  undergoes  a 
conformational change („flip‟) that links binding to gating. Macroscopic data favour a two 
binding  site  model.  The  scheme  can  describe  adequately  macroscopic  currents  from  fast 
concentration jumps experiments when desensitization is included in the model.  
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1.1 Ion channels and the pLGIC family of receptors 
 
The ability of neurons to generate electrical signals and respond to each other relies on both the 
selective permeability of the cell membrane and on the electrochemical gradient of different 
ions across it. Ion channels maintain the selective permeability of the membrane by controlling 
ion fluxes. Some of these channels are able to respond to changes in the membrane potential 
(voltage-gated),  others  can  sense  mechanical  or  thermal  stimulation  of  the  cell  membrane 
(stretch and heat-activated channels), whereas others are gated by extracellular, or intracellular, 
signals (ligand-gated ion channels; LGICs).  
 
Neurotransmitter receptors belong to the latter group; a neurotransmitter binds to its specific 
receptor, an ion channel opens and the resulting ion fluxes change the membrane potential of 
the  cell.  Whether  the  neurotransmitter  is  excitatory  or  inhibitory  depends  on  the  type  of 
receptor activated and also by the permeant ion‟s concentration in and out of the cell. Fast 
synaptic transmission uses ionotropic receptors which give rise to fast events which typically 
last a few milliseconds (Purves et al., 3
rd edition). Ionotropic LGICs can be divided into four 
superfamilies: (1) the pentameric LGICs (pLGIC), (2) glutamate receptors, (3) the ATP-gated 
channels  and  (4)  the  TRP  channels  (Le  Novère  and  Changeux,  1999; 
http://www.ebi.ac.uk/compneur-srv/LGICdb/LGICdb.php).  The  pLGIC  superfamily  contains 
the  group  of  cation-permeable  channels  that  include  the  nicotinic  acetylcholine  receptor 
(nAChR),  the  serotonin  type  3  receptor  (5-HT3R)  and  the  zinc-activated  channels  (ZAC), 
cation  selective  GABA  channels,  the  group  of  anion-permeable  channels  which  are  the 
receptors for glycine (GlyRs) and GABA (GABAARs and GABACRs), the bacterial GLIC and 
ELIC channels and finally the glutamate and histamine receptors of invertebrates (Beg and 
Jorgensen, 2003; Bocquet et al., 2009; Davies et al., 2003; Gisselmann et al., 2002; Hilf and 
Dutzler, 2008; Lynch, 2004).  
 
The various subunits of pLGICs share a fairly high degree of similarity in their amino-acid 
sequence that points to a common evolutionary ancestor (Okamura et al., 2005; Ortells and 
Lunt, 1995; Xue, 1998). All pLGICs share some basic features: they are pentameric proteins 
with multiple agonist and antagonist binding sites that are distinct from the channel gate but 
can interact with it at a distance by changing the quaternary structure of the receptor. They can 
take at least three functional states i.e. closed at rest, open channel in the presence of agonist 15 
 
and closed channel in the presence of agonist (desensitized). When the agonist is absent, these 
receptors have a low probability of opening. Channel opening is initiated by the association of 
the agonist to the extracellular binding site of the receptor (binding). This leads to dramatic 
conformational changes of the receptor-agonist complex, causing the central ion pore to open 
(gating). Additional modulation of binding or gating can arise from the association of other 
molecules to distinct sites on the complex (e.g. antagonists, blockers). Also, the duration of the 
exposure to the agonist can determine the likelihood of access to open or desensitized states.  
 
1.2 Glycine receptors 
 
1.2.1 Background – glycine as a neurotransmitter 
Glycine was first proposed as a neurotransmitter after a detailed analysis of its distribution and 
concentration  in  different  spinal  cord  regions  by  Aprison  and  Werman  (1965).  Additional 
studies  thereafter  agreed  that  glycine  is  an  inhibitory  neurotransmitter:  in  the  spinal  cord, 
glycine  was  shown  to  be  associated  with  interneurons  (Davidoff  et  al.,  1967)  and 
electrophysiological studies by both Curtis et al. (1967) and Werman et al. (1967) showed that 
glycine  hyperpolarizes  adult  spinal  motoneurons  by  an  increase  in  the  neuronal  chloride 
conductance. Other studies showed that glycine can be synthesized in neurons, released after 
neuronal  stimulation  and  taken  up  by  spinal  motoneurons  and  synaptosomes  with  a  high-
affinity transport (see Bowery and Smart, 2006; Rajendra et al., 1997). The alkaloid strychnine 
is a potent blocker of spinal cord inhibitory neurotransmission (Curtis et al., 1968; Young and 
Snyder, 1973) and its high-affinity binding sites are colocalized with endogenous glycine and 
glycine-mediated actions (Rajendra et al., 1997).  
 
In the adult nervous system hyperpolarisation mediated by glycine reduces the excitability and 
firing of neurons (mainly in the spinal cord and the brainstem) and controls coordination of 
spinal reflexes, locomotion, pain transmission and respiration. Glycine and GABA produce 
hyperpolarisation only in adult neurons where the equilibrium potential for Cl
- is similar or 
more negative than the cell‟s resting potential. In embryonic neurons the situation is reversed: 
the intracellular Cl
- concentration is high and the opening of a chloride-conducting channel 
depolarizes the cell membrane (see Stein and Nicoll, 2003). Thus, GlyRs and GABARs are 
excitatory in embryonic neurons and their activation can ultimately result in calcium influx and 
this, in turn, is important for the proper development of the cell (Ye, 2008).  16 
 
1.2.2 Purification and cloning of GlyR subunits 
Betz and co-workers succeeded in purifying the glycine receptor from the rat spinal cord by 
affinity chromatography, taking advantage of the fact that the receptor could irreversibly bind 
to radiolabelled strychnine after exposure to UV light (Pfeiffer and Betz, 1981; Pfeiffer et al., 
1982; reviewed in Bowery and Smart, 2006; Lynch 2004). Three polypeptides were purified, 
with masses of 48 kDa, 58 kDa and 93 kDa (Pfeiffer et al., 1982). The 48 kDa peptide was 
shown  to  be  associated  with  strychnine  and  glycine;  the  entire  amino-acid  sequence  was 
resolved and cDNA clones obtained (Grenningloh et al., 1987; see also Baker et al., 1994). 
The high homology of this peptide with the amino-acid sequences of nicotinic AChR subunits 
let to the classification of the GlyR as a member of the pLGIC family (Langosch et al., 1988). 
The 48 kDa protein therefore, was named the ʱ subunit (now ʱ1), in accordance with the 
naming of ligand-binding subunits of this superfamily. The 58 kDa polypeptide, on the other 
hand, did not associate with strychnine or glycine (Graham et al., 1985). The amino-acid and 
the cDNA sequences corresponding to this peptide were analyzed and the protein was named 
the β subunit (Grenningloh et al., 1990a). The third isolated polypeptide of 93 kDa was found 
to be a peripheral cytoplasmic protein interacting with the receptor. Cloning of this protein, 
now known as gephyrin, was also performed by Betz and colleagues (Schmitt et al., 1987).   
 
Subsequent  molecular  cloning  studies  revealed  a  number  of  different  subunit  isoforms  in 
humans and rodents (Lynch 2004; Rajendra et al., 1997). Two additional ʱ subunit isoforms 
were identified in the rat, ʱ2 (Akagi et al., 1991; Kuhse et al., 1990a) and ʱ3 (Kuhse et al., 
1990b).  Sequences  corresponding  to  these  have  also  been  identified  in  humans  and  mice 
(Grenningloh  et  al.,  1990b;  Rajendra  et  al.,  1997;  see  also  Cummings  et  al.,  1998).  An 
additional ʱ4 isoform has been described in mice and chick (Harvey et al., 2000; Matzenbach 
et al., 1994). Further diversity of ʱ subtypes arises from alternative splicing of subunit pre-
mRNA or from gene polymorphisms. A variant of the ʱ1 subunit (ʱ1
ins), with eight additional 
amino-acids in the cytoplasmic region, was described in the rat (Malosio et al., 1991b). Two 
rat ʱ2 cDNA variants, products of alternative splicing, were also described (ʱ2Α, ʱ2Β; Kuhse 
et al., 1991). These variants, highly homologous to the human ʱ2 cDNA (Grenningloh et al., 
1990b),  differ  due  to  two  amino-acid  substitutions  in  the  N-terminal  domain.  Another  ʱ2 
variant (denoted as ʱ2
*) is a result of a polymorphism in the rat ʱ2 gene (Kuhse et al., 1990a). 
Alternative splicing of the human ʱ3 primary transcript generates two variants, denoted as ʱ3K 17 
 
and ʱ3L, of which the ʱ3L is identical to the rat ʱ3 subunit (Kuhse et al., 1990b; Nikolic et al., 
1998).  The  ʱ3K  variant  lacks  15  amino-acids  in  the  cytoplasmic  loop.  Adding  to  these, 
recently a new ʱ3 subunit variant has been identified in rats (Meier et al., 2005). This variant 
(ʱ3-Pro185Leu)  is  a  result  of  a  single  nucleotide  polymorphism  at  position  554,  due  to  a 
cytidine-to-uracil substitution during RNA editing (Meier et al., 2005).  
 
Non-mammalian GlyR subunits have been studied in detail in the zebrafish CNS. An ʱ subunit 
variant  (ʱZ1)  is  highly  homologous  to  the  mammalian  ʱ1  subunit  but  also  shares  some 
similarities,  in  the  transmembrane  and  cytoplasmic  domains,  with  the  ʱ2  subunit  (David-
Watine et al., 1999). More recently a second variant of this subunit has been identified, with 15 
additional amino-acids in the N-terminal domain (named ʱZ1L), likely to arise from alternative 
splicing of the zebrafish primary transcript (Devignot et al., 2003). Imboden and colleagues 
cloned three other ʱ subunits, which they named ʱZ2, ʱZ3 and ʱZ4; phylogenetic analysis and 
molecular characteristics of the ʱZ2 variant classify it as an ʱ2-like subunit whereas ʱZ3 is 
more similar to the mammalian ʱ3 (Imboden et al., 2001a and b). 
 
Despite  the  big  diversity  of  ʱ  subunits,  only  one  β  subunit  (the  one  originally  cloned  by 
Grenningloh  et  al.,  1990a;  Handford  et  al.,  1996)  is  known  today.  The  equivalent  non-
mammalian βZ subunit was found in zebrafish (Imboden et al., 2001c). All the ʱ subunits share 
a high sequence identity to each other (~80-90% homology; Rajendra et al., 1997) whereas the 
β subunit only shares a similarity of ~47% with the ʱ1 subunit (Grenningloh et al., 1990a and 
b).     
 
1.2.3 Distribution of GlyR subunits in the CNS 
Soon after their cloning, in situ hybridization studies in the rat showed that ʱ1 transcripts are 
found at high density in the spinal cord and the brainstem of adults and at lower levels in the 
superior  and  inferior  colliculi,  the  cerebellar  deep  nuclei  and  the  hypothalamus  (García-
Alcocer et al., 2008; Malosio et al., 1991a; Sato et al., 1992) but are absent from cortical 
regions. Developmentally, ʱ1 transcripts become detectable at approximately E15, reaching a 
peak at P15 (Malosio et al., 1991a).  Expression of the ʱ1
ins mRNA represents ~30% of the 
total  ʱ1  mRNA  and  follows  a  similar  pattern  throughout  development  (Legendre,  2001; 
Malosio et al., 1991b).           
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Transcripts  for  ʱ2  are  found  mainly  in  the  embryonic  spinal  cord  and  the  brainstem;  by 
contrast to ʱ1, mRNA is also found in the cortex, hippocampus and the thalamus (Malosio et 
al.,  1991a;  Sato  et  al.,  1992)  and  at  high  densities  in  the  developing  cerebellum  (García-
Alcocer et al., 2008). In the adult, transcripts of ʱ2 are still detectable at low levels, mainly in 
the auditory brainstem  nuclei, the retina and  certain  regions  of the  cortex (Malosio  et  al., 
1991a; Piechotta et al., 2001; Racca et al., 1998). The ʱ2Α and ʱ2Β variants described in the 
rat have similar patterns of distribution during development. Both isoform mRNA levels are 
high  early  during  development  (higher  for  ʱ2Α)  but  drop  quickly  after  maturation;  the 
transcripts for ʱ2Α become undetectable whereas ʱ2Β is still present in the adult brain (Kuhse 
et al., 1991; Legendre, 2001).  
 
The decrease of ʱ2 mRNA levels from embryogenesis to adulthood  (by P20 in the rat) is 
accompanied by a postnatal increase in ʱ1 and ʱ3 transcripts (Malosio et al., 1991a). The 
levels of ʱ3 transcripts are generally lower than those of  ʱ1 throughout development. The 
mRNA for ʱ3 has been mostly detected in the olfactory bulb, hippocampus and the cerebellar 
granule layer with lower signals present in the spinal cord (Malosio et al., 1991a; see also 
Harvey et al., 2004).  
 
Transcripts of the ʱ4 subunit are detected at very low levels in the adult rat spinal cord and 
retina and in the mouse adrenal glands (Matzenbach et al., 1994). More recently, an in situ 
hybridization  study  performed  in  chick  embryos  localized  ʱ4  mRNA  molecules  in  high 
densities in the spinal cord, dorsal root and sympathetic ganglia, suggesting that this subunit is 
an embryonic GlyR subunit isoform, similar to ʱ2 (Harvey et al., 2000; Legendre, 2001).  
 
The distribution of the β subunit mRNA is much wider than that of any ʱ, with transcripts in 
most regions of the embryonic and adult brain. These have low levels before birth, increase 
postnatally and remain like that throughout adulthood and are present also in areas that lack ʱ 
subunits (Fujita et al., 1991; Malosio et al., 1991a). This is a puzzling finding as β subunits 
cannot form functional GlyRs without the presence of an ʱ subtype in recombinant expression 
systems and it is reasonable to assume that the same occurs in vivo (Grenningloh et al., 1990a).  
 
Consistent with mammalian studies, mRNA for the ʱΖ1, ʱΖ2 and also the βΖ subunits are 
detected in the zebrafish retina, spinal motoneurons and in posterior brain regions (Imboden et 19 
 
al., 2001c). These results are in agreement with immunocytochemical studies performed on the 
goldfish Mauthner neuron using antibodies against the mammalian ʱ1 subunit (Seitanidou et 
al., 1988; Triller et al., 1993).  
 
1.2.4 Functional GlyRs in the nervous system 
The distribution of functional glycine receptors has been studied by approaches that include in 
vitro  autoradiography  of  [
3H]-strychnine  or  [
3H]-glycine  (Zarbin  et  al.,  1981;  Young  and 
Snyder, 1973) to identify the localization of strychnine or glycine binding sites respectively, 
immunocytochemistry  studies  with  monoclonal  antibodies  in  combination  with  electron  or 
light microscopy (Racca et al., 1997; Triller et al., 1985) and also studies on animals with 
targeted deletions of GlyR subunits or of glycine transporters (Betz et al., 2006; Harvey et al., 
2004; McDearmid et al., 2006; Young and Cepko, 2004; Young-Pearse et al., 2006). This 
work broadly agrees with the results of the in situ hybridization: receptors for glycine are 
present at high levels in the spinal cord and the brainstem (pons and medulla) and at lower 
levels in the midbrain, thalamus, hypothalamus, the cerebellum, the hippocampus and in retinal 
ganglia  (Legendre,  2001;  Lynch,  2004;  Rajendra  et  al.,  1997).  In  many  of  these  regions, 
glycine-mediated neurotransmission has also been described, suggesting that these GlyRs are 
synaptic. Detailed studies have also been performed for the Mauthner neuron in the zebrafish 
hindbrain, characterizing the inhibitory glycinergic synapses present there (Triller et al., 1997).   
 
GlyRs  are  also  involved  in  non-synaptic  function.  Early  in  development,  the  activation  of 
glycine (and GABA) leads to cell depolarisation, resulting in the activation of voltage-gated 
Ca
2+  channels,  in  a  transient  increase  in  intracellular  Ca
2+  and  finally  in  the  activation  of 
cytoplasmic  mechanisms  that  underlie  development  (Gao  et  al.,  1998;  Flint  et  al.,  1998).  
GlyRs are also thought to facilitate transmitter release by a presynaptic depolarizing action 
(Jeong et al., 2003; Turecek and Trussell, 2001, 2002).  
 
GlyRs are often colocalised with receptors for GABA. Mixed presynaptic boutons containing 
both transmitters were shown to exist in the spinal cord (Schneider and Fyffe, 1992; Todd, 
1990; Todd et al., 1996), in the brainstem (Dumba et al., 1998), in cerebellar Golgi cells 
(Dugué et al., 2005; Ottersen et al., 1988) and in the cerebellar cortex (Crook et al., 2006). 
Mixed inhibitory interneurons in the spinal cord co-release GABA and glycine from individual 
vesicles that contain both transmitters (Chéry and de Koninck, 1999; Jonas et al., 1998). The 20 
 
presence  of  mixed  synaptic  terminals  is  usually  correlated  with  the  expression  of  both 
GABAAR and GlyRs in the postsynaptic membrane, as shown by immunocytochemistry (Todd 
et  al.,  1996;  Triller  et  al.,  1987)  and  electrophysiological  studies  (Hamill  et  al.,  1983), 
supporting  the  idea  that  some  neurons  can  mediate  both  GABAergic  and  glycinergic 
transmission (Figure 1.1). 
 
 
Figure 1.1  Features of glycine-mediated synaptic transmission 
In the presynaptic cell the vesicular inhibitory amino-acid transporter (VIAAT) packs glycine 
into synaptic vesicles, often together with GABA. Excitation of the cell causes the fusion of 
synaptic vesicles with the presynaptic membrane and the release of glycine (and GABA) into 
the  synaptic  cleft.  The  neurotransmitters  are  then  diffused  in  the  cleft  and  bind  to  their 
receptors in  the postsynaptic membrane, increasing the cell‟s  Cl
-  conductance. Glycinergic 
transmission is terminated by the uptake of glycine into adjacent nerve terminals or glial cells, 
mediated by glycine transporters (GlyTs).     
 
 
It was recently shown that GABA, co-released with glycine, can act directly on GlyRs and 
modulate the decay of glycinergic transmission (Lu et al., 2008; see also Singer, 2008). A 
GABAergic component in glycinergic transmission (distinguishable due to the slower time 
course  of  GABAergic  currents)  is  important  early  in  development,  when  both 
neurotransmitters depolarize neurons. Afterwards, transmission changes to glycine-dominant 
in  most  spinal  and  brainstem  synapses  (Baccei  and  Fitzgerald,  2004;  Gao  et  al.,  2001; 
González-Forero  and  Alvarez,  2005).  GABARs  produce  longer  currents  and  the  more 
sustained depolarizations may be needed by the embryonic neurons to increase the levels of 
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cytoplasmic Ca
2+ (Gao and Ziskind-Conhaim, 1995, 1998; Gao et al., 1998; see also Tapia et 
al., 2001). 
 
1.2.5 Structure 
i. General features – models of structure 
The ACh receptor at the neuromuscular junction is the most studied receptor in the pLGIC 
family. This receptor was the first ligand-gated channel to be characterized in detail. Most of 
the available information, therefore, concerning the structure of other members of the family, 
such as GlyRs which concern this study, is deduced from the knowledge concerning the ACh 
receptor.  
 
Despite  the  fact  that  none  of  the  pLGIC  family  members  has  been  crystallized  to  date,  a 
detailed  knowledge  of  the  structure  of  AChRs  comes  from  very  well  defined  models:  the 
crystal structure of a soluble ACh binding protein from the Lymnea stagnalis snail (AChBP; 
Brejc et al., 2001; Smit et al., 2001), the cryo-electron microscopy structure of the Torpedo 
AChR (Miyazawa et al., 2003; Unwin, 2005) and the recently resolved X-ray structures from 
two prokaryotic pLGICs, from Gloeobacter violaceus (GLIC; Bocquet et al., 2009) and from 
Erwinia chrysanthemi (ELIC; Hilf and Dutzler, 2008). The AChBP is a homolog of the N-
terminal  domain  of  the  AChR,  providing  high  resolution  information  on  the  extracellular 
domain (Karlin, 2002), whereas the other three models provide detailed information on the 
pore of the channel.  The 4Å resolution  image  from  Unwin‟s  group  has  been essential for 
understanding the relations between the structure and the function of pore residues and for 
locating the position of the gate.  
 
ii. Subunit topology 
Characteristic sequence motifs in the secondary structure of pLGIC subunits include (Figure 
1.2):  (1)  an  extracellular  N-terminal  domain  where  agonists  bind,  (2)  four  ʱ-helical 
transmembrane domains (TM1-TM4), (3) a large intracellular loop between TM3 and TM4 and 
(4) the extracellular C-terminal region (Karlin, 2002). All subunits have a conserved cysteine 
loop in the N-terminal domain. For the ʱ1 GlyR subunit, this loop is between Cys138 and 
Cys152 (Rajendra et al., 1997). In the case of GlyR subunits, there is a second Cys-loop, 
formed by a disulfide bond between residues Cys198 and Cys209 for the ʱ1 subunit (Rajendra 
et al., 1997). All pLGICs assemble as pentamers: as homomers of five identical subunits or as 22 
 
heteromers of different subunits (Karlin, 2002; Langosch et al., 1988). The wide variety of 
subtypes of the pLGICs found in the CNS arises from the big number of possible different 
combinations of subunits to compose heteromers (Sivilotti and Colquhoun, 1995).  
 
 
 
Figure 1.2  Membrane topology of a GlyR subunit 
Representation of the human ʱ1 subunit showing the extracellular N- and C-terminals and the 
four transmembrane domains, with the pore-lining TM2 highlighted in dark grey. Also shown 
are  functionally  important  regions  or  residues  involved  in:  assembly  (grey  boxes),  zinc 
modulation (black circles), ligand binding (grey circles), ionic selectivity (white diamond), 
gating (black diamonds) and single-channel conductance (black squares). The dashed-lined box 
indicates the gephyrin binding domain (human β subunit numbering).  
 
 
iii. N-terminal domain   
The sequence of the snail‟s AChBP subunits shares ~20-24% similarity with the N-terminal 
region of muscle nAChR subunits and a ~15-18% homology with subunit sequences of the 5-
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HT3, GABAA, GABAC and glycine receptors (Sixma, 2007; Sixma and Smit, 2003). It lacks the 
intracellular and transmembrane domains of a pLGIC but it can bind to agonists, toxins and 
competitive antagonists that are known to bind to the nACh receptor, making it an important 
model for the ligand binding region (Karlin, 2002; Sixma and Smit, 2003; Ulens et al., 2006), 
even though it remains unclear whether the AChBP is in a resting, activated or desensitized 
state. The 2.7Å crystal structure of the AChBP (Brejc et al., 2001) showed that each subunit 
has a sandwich-like structure of 10 β-sheets, following a short ʱ-helix at the most distant part 
from  the  membrane,  and  forms  a  modified  immunoglobulin  structure.  The  pentamer  is  a 
cylinder with an external diameter of 80Å, an inner diameter of ~18Å and a height of 60Å 
(Sixma and Smit, 2003). A similar structure has also been described for the bacterial GLIC and 
ELIC, although the ʱ-helix appears to be missing from the prokaryotic channels (Bocquet et 
al., 2009; Hilf and Dutzler, 2008).  
 
The  agonist  binding  sites  are  located  in  pockets  between  the  interfaces  of  neighbouring 
subunits, each pocket being formed by loops of residues from both subunits involved (Figure 
1.3). Residues from ʱ subunits contribute to loops A, B and C, whereas the neighbouring γ, δ 
or ε subunit forms loops D, E, F and G (reviewed in Arias, 2000; Corringer et al., 2000; Sine, 
2002; Sixma and Smit, 2003). By analogy with the muscle AChR, the principal binding subunit 
is termed ʱ; the secondary binding subunit is a non-ʱ peptide (Karlin, 2002; Sine, 2002; Sine 
and Engel, 2006).  
 
A  combination  of  studies  (reviewed  in  Karlin,  2002;  Sine,  2002;  Sixma  and  Smit,  2003) 
resulted in the generation of several models of pLGICs (cfr. Figure 1.3 from Laube et al., 
2002). Modelling and mutagenesis studies on GlyRs were able to identify different amino-
acids that are essential for glycine and/or strychnine binding (Breitinger and Becker, 2002; 
Laube et al., 2002; Lynch , 2004). According to the terminology given for ACh receptors four 
equivalent loops (A, B, C, D) on the N-terminal part of GlyRs, immediately preceding the 
TM1,  have  been  implicated  in  agonist/antagonist  binding.  Loops  B  and  C  are  the  most 
essential. Mutational studies surrounding the Phe159–Gly160–Tyr161 triplet in Loop B (ʱ1 
numbering; Schmieden et al., 1993; Vandenberg et al., 1992b) and the equivalent Gly167 on 
ʱ2 (or Glu167 on ʱ2*; Kuhse et al., 1990a) suggest that the region containing the triplet forms 
a binding domain for strychnine and is probably involved in agonist binding (Figure 1.2). A 
similar triplet motif was found in GABAA (Amin and Weiss, 1993) and 5-HT3 receptors (Spier 24 
 
and Lummis, 2000), showing a conservation of this domain in pLGICs (Lynch, 2004). These 
are residues that constitute the “aromatic box” which is involved in cation- interaction in the 
whole superfamily (Grudzinska et al., 2005; Pless et al., 2008). Loop C includes the second 
cysteine  loop  formed  between  residues  Cys198  and  Cys209  (ʱ1  numbering)  which  is 
characteristic of GlyRs (Figure 1.2; Rajendra et al., 1997). Disruption of the loop by point 
substitutions of either the Cys198 or the Cys209 abolishes the binding of glycine or strychnine 
(Rajendra  et  al.,  1995b).  Other  residues  of  the  loop  also  affect  glycine  and/or  strychnine 
binding (Rajendra et al., 1995b; Vandenberg et al., 1992a and b). Adding to these two regions, 
other residues found in loop A (Han et al., 2001; Vafa et al., 1999) and loop D (Schmieden et 
al., 1992) have also been studied, but, as mutations of such residues have little effect in the 
sensitivity of GlyRs to ligands, it is questionable whether they are part of a ligand binding 
domain (Lynch, 2004).  
 
 
 
Figure 1.3  The N-terminal region of the ʱ1 GlyR  
This model, by Laube and colleagues (2002), is created by homology modelling based on the 
crystal structure of the AChBP from Lymnea stagnalis (Brejc et al., 2001). The N-terminal 
regions of the five subunits, viewed from the top, are coloured separately. The model shows 
the five possible binding sites for glycine (ball and stick structure) located at the interfaces of 
adjacent subunits.  
 
 
As most studies were performed on homomeric GlyRs, the role of the β subunit in binding has 
not been investigated thoroughly. A study on heteromeric ʱ1β GlyRs however, concluded that 25 
 
residues Arg86 (Loop D) and Glu180 (Loop B) of the β subunit are in direct interactions with 
glycine  (Grudzinska  et  al.,  2005;  see  also  Betz  and  Laube,  2006).  Interestingly,  a 
hyperekplexia  mutation  at  residue  Gly229  (Loop  C)  of  the  β  subunit  affects  the  glycine 
sensitivity of heteromeric receptors (Rees et al., 2002). 
A recent study investigated the role of the signature Cys-loop, formed between Cys138 and 
Cys152 (ʱ1 subunit; Figure 1.2) and concluded that, although it is essential for modulation by 
anesthetics, it is unlikely to serve as a binding site for glycine (Schofield et al., 2004; see also 
Vandenberg  et  al.,  1993). The loop  appears to be important  for receptor activation during 
gating (Schofield et al., 2003).     
 
Besides its contribution in ligand binding, the N-terminal domain of GlyR subunits contains 
residues that are important for the assembly of pentamers and also residues that are involved in 
the modulation of GlyR function by zinc (Figure 1.2). Both processes are discussed below.  
 
iv. Transmembrane domains (TM) 
Direct information on the structure of the membrane-spanning part of pLGICs comes from the 
bacterial GLIC and ELIC X-ray structures and also from Unwin‟s work on the Torpedo AChR. 
Note that the three models are in excellent agreement (Bocquet et al., 2009; Hilf and Dutzler, 
2008).  The  resolution  for  Unwin‟s  model  has  been  progressively  increased  from  the  first 
description in 1995 to the latest 4Å model (Miyazawa et al., 1999 and 2003; Unwin, 1995, 
2005). The model shows the four TM domains of each subunit arranged symmetrically around 
the central ion pore. All TM domains are ʱ-helical: the channel is lined mostly by the five TM2 
helixes, whereas the other TM domains (arranged in a clockwise orientation) shield the channel 
from the membrane lipids (Miyazawa et al., 1999). A number of mutagenesis and chemical 
labeling  studies  agree  that  the  TM2  domains  form  the  ion  pore.  In  agreement,  peptide 
fragments  of  M2  segments  of  ʱ1  GlyR  subunits  can  spontaneously  adopt  an  ʱ-helical 
secondary structure and assemble together to form chloride channels in lipid bilayers (Mitchell 
et al., 2000).  
 
Other  indirect  methods  have  been  used  to  probe  the  structure  of  the  membrane-spanning 
regions  (reviewed in  Cascio,  2004;  Karlin,  2002;  Lummis,  2004;  Lynch, 2004). The most 
extensively used one is the substituted cysteine accessibility method (SCAM) described by 
Karlin and Akabas (1998) and recently used by Lynch and co-workers to identify residues on 26 
 
the M2-M3 loop related to glycine binding and GlyR activation (Lynch et al., 2001). SCAM 
studies agree with Unwin‟s data that most (at least 75%) of the segment of TM2 domains is an 
ʱ-helix (Akabas et al., 1994). Unwin‟s model predicts that each TM domain extents ~10Å over 
the membrane surface. In agreement with the hydrophobicity of these regions, charged amino-
acids are present only at the beginning and end of each TM domain (Miyazawa et al., 2003). 
The charged residues that frame each TM domain of the GlyR ʱ1 subunit are: Arg218 and 
Asp247 (TM1), Arg252 (0΄) and Arg271 (19΄; TM2), Asp284 and Arg309 (TM3) and Lys389 
and Lys411 for TM4.  
 
 
Figure 1.4  The ion channel pore of GlyRs 
Schematic representation of two ʱ1 subunit TM2 domains tilting inwards towards the pore 
axis, according to Unwin‟s model for the AChR. The highly conserved Leu (9΄) in the middle 
of  the  domain  and  the  adjacent  10΄,  13΄  and  14΄  residues  (shown  in  black)  form  the 
hydrophobic interactions that keep the pore closed. Other residues shown are the ones related 
to picrotoxin inhibition (red), ionic selectivity (white) and the charged residues that mark the 
limits of the TM2 (in orange). Numbering is as in Miller (1989).  
 
 
When the pore is viewed from the synaptic cleft the five TM2 domains appear to tilt inwards 
towards the central  axis.  The highest density  on the electron  microscope appears near  the 
middle of the ion pore, suggesting this is the gate of the channel (Miyazawa et al., 1999, 2003; 
9΄
10΄
13΄
14΄
2΄
9΄
10΄
13΄
14΄
2΄
6΄ 6΄
0΄ 0΄
19΄ 19΄
-1΄
Pore axis
9΄
10΄
13΄
14΄
2΄
9΄
10΄
13΄
14΄
2΄
6΄ 6΄
0΄ 0΄
19΄ 19΄
-1΄
Pore axis27 
 
Unwin, 2005). This area coincides with a highly conserved leucine at position 9΄ of the TM2 
(Figure 1.4). According to this model, the pore is highly symmetrical due to equal side-by-side 
hydrophobic interactions between the residues at 9΄, 10΄, 13΄ and 14΄, forming two levels of 
contacts: one between the side-chains of a 9΄ leucine and the 10΄ residue on its adjacent TM2 
and the second between the side-chains of residues at positions 13΄ and 14΄ of neighbouring 
subunits. These interactions create a hydrophobic girdle that causes the TM2 domains to bend 
inwards, keeping the channel closed (Miyazawa et al., 2003). The residues that line the pore of 
GlyRs (ʱ1 subunit numbering) are Leu261 (9΄), Thr262 (10΄), Thr265 (13΄) and Gln266 (14΄). 
The  location  of  the  gate  in  the  middle  of  the  TM2  regions  has  also  been  suggested  by 
molecular dynamics simulations on the AChR (Amiri et al., 2005; Corry, 2006) and more 
recently by picrotoxin trapping experiments on the GABAR (Bali and Akabas, 2007). Earlier 
studies with SCAM suggested a different location deeper in the pore, between positions -2΄ and 
2΄ (Wilson and Karlin, 1998; Xu and Akabas, 1996), but this may have been an artefact due to 
undetected spontaneous openings of the Cys-mutants (Bali and Akabas, 2007).  
 
v. The loops between TM domains 
The charged residue at position 247 (Asp247, ʱ1 numbering) indicates the beginning of the 
TM1-TM2 loop, which is formed by only five amino-acids (TM1-Asp-Ala-Ala-Pro-Ala-TM2). 
It was suggested early on that this loop links the binding signals with the gate of the channel 
(Lynch et al., 1997; see also Czajkowski, 2005). There is also evidence that the five residues 
lie in the ion-conducting pathway (Filippova et al., 2004) suggesting a role of the loop in ionic 
selectivity (see also Galzi et al., 1992; Imoto et al., 1988; Keramidas et al., 2000). This domain 
can influence the desensitization properties of GlyRs (Saul et al., 1999) and might play a role 
in zinc potentiation (Lynch et al., 1998).  
 
The TM2-TM3 loop extents from Arg271 to Asp284 and according to Unwin‟s model it is 
formed by the helical parts of the domains that extend outside the membrane (Ma et al., 2005; 
Miyazawa et al., 2003). The best characterized residue is the charged Arg271 (Figure 1.2): 
mutations of this residue to Gln or Leu cause hyperekplexia (Shiang et al., 1993) by reducing 
the channel sensitivity to glycine (by ~400–fold; Rajendra et al., 1994). Other effects include 
transforming partial agonists to competitive antagonists (Rajendra et al., 1995a) and converting 
picrotoxin  from  a  competitive  antagonist  to  an  allosteric  potentiator  (Lynch  et  al.,  1995). 
Finally,  these  mutations  also  reduce  single-channel  conductance  by  abolishing  the  high 28 
 
conductance state of the wild-type receptor (Langosch et al., 1994). Together these effects 
suggest that the TM2-TM3 loop may mediate the transduction of binding into gating (Lynch et 
al., 1997). Other mutations in this area cause hyperekplexia (Kwok et al., 2001) and a single-
channel study on one of these mutations, at position 276 (Lys276Glu; Figure 1.2), showed that 
indeed the mutation affects gating (Lewis et al., 1998). Residues in the TM2-TM3 loop are 
also involved in the modulation of glycine and GABA receptors by alcohols and anesthetics 
(Dupre et al., 2007; Mihic et al., 1997), by zinc (Lynch et al., 1998) and by protons (Li et al., 
2003; Wilkins et al., 2005).  
 
This large cytoplasmic loop (TM3-TM4) is the least conserved region, in length and sequence, 
across the pLGIC family members (Le Novère and Changeux, 1999). What information there 
is on the loop‟s structure comes from Unwin‟s study, which managed to resolve an ʱ-helical 
segment  (called  the  membrane-associated  helix,  MA)  before  the  beginning  of  the  TM4 
(Unwin, 2005). In ʱ1 the loop extends from Arg309 to Lys389 and is even longer in the β 
subunit  (Asn333  to  Leu463).  Naturally  the  role  of  the  cytoplasmic  loop  as  a  target  for 
modulation by internal molecules has been intensively studied and has shown interactions with 
kinases and phosphatases and sites that undergo ubiquitination (Lynch, 2004). Residues in the 
MA stretch contribute to regulating  the single-channel conductance of cationic channels (Gee 
et al., 2007; Hales et al., 2006; Kelley et al., 2003; Peters et al., 2004) and more recently the 
same has been shown for GlyRs (Carland et al., 2009; see section 3.2.1). The TM3-TM4 loop 
of the β subunit contains the gephyrin binding domain (Figure 1.2), an 18 amino-acid motif 
required  for  interaction  with  gephyrin,  and  therefore  receptor  clustering  and  anchoring  to 
synapses (Kneussel and Betz, 2000; Kneussel and Loebrich, 2007; Meyer et al., 1995).  
 
1.2.6 Function  
i. Ionic selectivity  
Permeability experiments on glycine and GABA receptors indicate pore diameters of 5.2 Å and 
5.6 Å, respectively (Bormann et al., 1987; Rundström et al., 1994) and identical permeability 
sequences for both receptor types (SCN
- > I
- > Br
- > Cl
- > F
-; Bormann et al., 1987). The 
conductance sequence for GlyRs is Cl
- > Br
- > I
- > SCN
- > F
- and there are likely two binding 
sites for anions in the pore region (Bormann et al., 1987).   
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Early work on AChRs has shown that rings of charged residues in the pore determine ionic 
selectivity and conductance (Imoto et al., 1988; Imoto, 1993; Konno et al., 1991). Mutation of 
the appropriate residues can convert a cation-selective receptor, like the ʱ7 neuronal nAChR, 
into  an  anion-selective  channel  (Galzi  et  al.,  1992)  and  vice-versa.  The  ionic  selectivity 
conversion was assessed for most members of the nicotinic superfamily (reviewed in Jensen et 
al., 2005; Keramidas et al., 2004). For anion-selective channels like GABAA-Rs and GlyRs, 
conversion of selectivity can be achieved by reversing Galzi‟s mutations. Both a deletion of the 
proline at -2΄ position and the Ala-1΄Glu substitution are needed to create cationic ˁ1 GABAA 
receptors (Wotring et al., 2003; see also Jensen et al., 2002) whereas the Ala-1΄Glu mutation 
(Ala251) is sufficient by itself in the ʱ1 GlyR homomer (Keramidas et al., 2002; Figure 1.4).   
 
In addition to that, uncharged residues within the TM2 domain (such as those at positions 2΄, 6΄ 
and 9΄) also affect the ionic selectivity and conductance (Cohen et al., 1992a, b; Imoto et al., 
1991; Villarroel et al., 1991).   
 
ii. Assembly and trafficking to the cell membrane  
The first evidence that GlyRs are pentamers came from  chemical cross-linking of purified 
spinal cord GlyR subunits. This gave rise to products of up to 260 kDa that contained the 48 
kDa (ʱ1 subunit) and 58 kDa subunits (β subunit) in varying ratios. Given that 260 kDa is 
approximately 5 times the mean subunit mass, it was concluded that the native GlyRs are 
pentamers (Langosch et al., 1988, 1990).  
 
Channel assembly takes place in the endoplasmic reticulum (ER) and involves many control 
points and the interference of various chaperone proteins (Millar and Harkness, 2008; Sarto-
Jackson and Sieghart, 2008). The N-terminal region of GlyRs contains „assembly boxes‟, i.e. 
determinants for heteromeric or homomeric assembly (Kuhse et al., 1993). Mutations of β 
subunit residues in these boxes to the equivalent ʱ1 residues makes β subunits behave like 
alphas and assemble as homomers. The minimum β-to-ʱ1 mutations necessary for homomeric 
assembly were mutations in box1 and box3 or in box1, box2 and box8 (Griffon et al., 1999; 
Kuhse et al., 1993; Figure 1.2).  
 
Exit  from  the  ER  occurs  after  the  individual  subunits  have  received  the  appropriate  post-
translational  modifications  and  have  been  assembled  into  pentamers  with  the  correct 30 
 
composition (Connolly, 2008; Millar and Harkness, 2008; Sarto-Jackson and Sieghart 2008). 
Little  is  known  about  the  subsequent  steps  and  how  receptors  are  trafficked  to  the  cell-
membrane, which chaperone proteins are involved or how the targeting at somatic, dendritic or 
axonal membrane occurs. There is evidence to suggest that after exiting the ER and trans-
Golgi  network,  newly-formed  GlyR  pentamers  are  inserted  into  the  plasma  membrane  via 
exocytosis (Meier et al., 2000; Rosenberg et al., 2001). The insertion is localized mainly in the 
soma, where the receptors form clusters of low density (microclusters) and is followed by 
lateral diffusion towards postsynaptic regions where GlyRs interact with gephyrin (Groc and 
Choquet, 2008; Meier et al., 2000; Rosenberg et al., 2001).  
 
iii. Retention to synapses – Interaction with gephyrin 
Gephyrin is essential for long-term, stable anchoring of the receptors to the cytoskeleton of 
postsynaptic  regions  (Kneussel  and  Loebrich,  2007).  In  situ  hybridization  studies  revealed 
different gephyrin isoforms throughout the nervous system and peripheral tissues, where they 
interact with polymerized tubulin (Kirsch et al., 1991, 1993b; Prior et al., 1992; Racca et al., 
1997) and immunocytochemistry studies detected gephyrin in CNS neurons containing high 
densities of GlyRs (Kirch and Betz, 1993; Triller et al., 1985 and 1987; van den Pol and Gorcs, 
1988). Betz and colleagues characterized the gephyrin binding motif on the cytoplasmic loop 
of β subunits (Meyer et al., 1995; Figure 1.2). Until recently therefore the consensus has been 
that only β subunit-containing receptors can be localized in synapses and hence can have a role 
in synaptic transmission (but see Legendre, 2001). Treatment of cultured spinal neurons with 
antisense oligonucleotides against gephyrin is sufficient to block the postsynaptic clustering of 
GlyRs and similar results are obtained with drugs that disrupt the cytoskeleton or with targeted 
mutations of the gephyrin gene (Feng et al., 1998; Kirsch et al., 1993a; Kirsch and Betz, 1995).  
 
Even after stabilization by gephyrin, GlyRs still can diffuse freely between subcompartments 
of the cell membrane (Dahan et al., 2003; Kneussel and Loebrich, 2007; Meier et al., 2001). 
Lateral diffusion of GlyRs is Ca
2+-dependent and can be driven by the activation of NMDARs, 
suggesting that the recruitment of GlyRs in synapses acts as a compensation for increased 
excitatory neurotransmission (Lévi et al., 2008).  
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iv. Release and uptake of glycine – Characteristics of glycinergic transmission 
In the neuron, glycine can either be newly synthesised or recycled by re-uptake after its release 
from synaptic terminals. The packaging of glycine in synaptic vesicles and their accumulation 
near  the  release  site  requires  its  active  transport  from  the  cytosol  into  the  vesicles:  the 
procedure requires an H
+/ATPase on the vesicular membrane (which provides the necessary 
energy for the transport) and also the  vesicular inhibitory amino-acid transporter (VIAAT; 
Figure 1.1), which can also pack GABA into vesicles, in exchange for protons (Gasnier, 2000; 
McIntire et al., 1997; Sagné et al., 1997). The stoichiometry of this exchange is one proton per 
glycine molecule (Gasnier, 2000) and in mixed glycine/GABA neurons the two transmitters 
compete for their uptake into vesicles (Chaudhry et al., 1998; Dumoulin et al., 1999; Wojcik et 
al., 2006).  
 
The basic concept of classic neurotransmission is that the arrival of an action potential in a 
presynaptic  terminal  is  followed  by  the  simultaneous  fusion  and  release  of  many  synaptic 
vesicles carrying the transmitter (Katz and Miledi, 1965b). Like other transmitters, the release 
of glycine can be either evoked or spontaneous and is highly dependent on the extracellular 
calcium  concentration  and  its  entry  through  voltage-gated  calcium  channels  (Borst  and 
Sakmann, 1996; Clements, 1996; Katz and Miledi, 1965a; Reid et al., 2003). Likewise, the 
release of glycine can be modulated by mGluRs that inhibit the actions of voltage-gated Ca
2+ 
channels  or  activate  presynaptic  K
+  channels,  interfering  with  the  release  machinery 
(Katsurabayashi  et  al.,  2004;  Shoudai  et  al.,  2007).  Other  factors  indirectly  affecting  the 
release  of  glycine  and/or  the  frequency  of  glycinergic  IPSCs  are  volative  anaesthetics, 
neurotrophins and cell-stressing conditions (Bardoni et al., 2007; Saransaari and Oja, 2009; 
Yamashita et al., 2001). Presynaptic ligand-gated channels (nAChRs, GABAARs, P2X ATP 
receptors and glycine receptors themselves) can also modulate the release of glycine (Jang et 
al., 2002; Jeong et al., 2003; Kiyosawa et al., 2001; Takeda et al., 2003; Wang et al., 2001). 
 
After its release in the cleft, glycine is cleared away by re-uptake into adjacent nerve terminals 
or glial cells (Figure 1.1). The process is mediated by a family of membrane proteins, named 
glycine transporters (GlyTs; Eulenburg et al., 2005). Two different GlyTs have been identified, 
GlyT1 and GlyT2, which mediate glycine uptake in glial cells and neurons respectively (Gadea 
and Lopez-Cólomé, 2001; Jursky and Nelson, 1995; Zafra et al., 1995a, b). The presence of 
GlyT2  on  glycinergic  neurons  ensures  the  enrichment  of  synaptic  terminals  with  glycine 32 
 
needed for vesicular loading. The distinct localization and pharmacology of the two GlyTs 
(Mezler et al., 2008; Supplisson and Roux, 2002) and the generation of GlyT knockout mice 
have been important tools for the identification of glycinergic synaptic transmission sites and 
neurotransmission deficiencies (Betz et al., 2006; Eulenburg et al., 2006).      
 
v. Modulation of GlyR function 
GlyR subunits carry a number of motifs on which modulatory molecules can act, including 
motifs for phosphorylation, ubiquitination and glycosylation and also binding sites for ions, 
cytoplasmic proteins and pharmaceutical compounds. 
  Zinc: The most extensively studied modulation of GlyR function is the one mediated by 
zinc ions (Zn
2+). The modulation by zinc is biphasic: at low concentrations (<10 μM) zinc 
potentiates glycine-mediated currents whereas at higher concentrations it acts as an inhibitor 
(Bloomenthal et al., 1994; Laube et al., 1995; Miller et al., 2005a, b; Smart et al., 2004). These 
effects are mediated by two distinct binding sites for Zn
2+ in the N-terminal domain of GlyRs 
(Figure 1.2): mutagenesis studies have highlighted residues Asp80 and Glu192 (ʱ1 subunit) for 
the potentiating effect (Laube et al., 2000; Lynch et al., 1998; Miller et al., 2005a) and His107, 
His109, Thr112 and Thr133 for inhibition (Harvey et al., 1999; Laube et al., 2000; Miller et 
al., 2005b, 2008; Nevin et al., 2003). Other divalent cations such as copper and nickel can also 
inhibit GlyRs (Chen et al., 2006; Schumann et al., 2009; Trombley and Shepherd, 1996; Wang 
et al., 2002).  
  Ca
2+: Changes in the levels of cytoplasmic Ca
2+, either by entry via Ca
2+-gated channels or 
via ionotropic  glutamate channels,  appear to  modulate GlyR-mediated  currents  (Diana  and 
Bregestovski, 2005; Fucile et al., 2000; Mukhtarov et al., 2005; Ragozzino and Eusebi, 1993; 
Xu  et  al.,  1999,  2000).  The  results  of  these  studies  are  conflicting,  arguing  in  favour  of 
potentiation or inhibition depending on the preparation. In cultured spinal cord neurons, in 
brainstem  motoneurons  and in  recombinant  systems  internal  Ca
2+  was  shown to  potentiate 
glycinergic  responses  (Fucile  et  al.,  2000;  Mukhtarov  et  al.,  2005).  This  enhancement  is 
associated  with  an  increase  in  the  apparent  affinity  of  GlyRs  for  glycine  and  has  been 
hypothesized to be mediated by the Ca
2+-dependent dissociation of a cytoplasmic factor from 
the GlyR (Diana and Bregestovski, 2005; Fucile et al., 2000).  
  Phosphorylation: Consensus sites for phosphorylation (by PKC, PKA, CaMKII and PTK) 
are present in the TM3-TM4 cytoplasmic loop; in addition to that kinases can modulate GlyR 33 
 
function  through  other  proteins  such  as  gephyrin  (Zita  et  al.,  2007).  Modulation  by 
phosphorylation appears to be tissue-dependent (Legendre, 2001; Lynch, 2004). For example, 
phosphorylation by PTK or PKC enhances glycine-induced currents in hippocampal neurons 
(Caraiscos et al., 2002; Schönrock and Bormann, 1995) but PKC-mediated phosphorylation 
depresses glycinergic IPSCs in the spinal cord (Albarran et al., 2001; Tapia et al., 1997; Vaello 
et al., 1994). Activation of PKA instead had opposite effects on the same preparation (Tapia et 
al., 1997; Vaello et al., 1994). Phosphorylation also appears to increase the rate of receptor 
desensitization and slow the recovery from desensitization and the deactivation of glycinergic 
currents (Gentet and Clements, 2002).  
  G-proteins: βγ subunits enhance glycinergic currents in spinal neurons and recombinant 
systems via an increase in the apparent affinity of the receptors for glycine and an increase in 
the probability of channel opening. The interaction is mediated by two basic amino-acid motifs 
in the TM3-TM4 loop of the ʱ1 subunit (Yevenes et al., 2003, 2006). 
  Protons: There is evidence that protons antagonize the binding of zinc to its inhibitory site: 
lowering the external pH inhibits glycine currents and also results in a reduced inhibition by 
zinc  of  recombinant  GlyR  (Harvey  et  al.,  1999).  In  the  spinal  cord  reduction  of  the 
extracellular pH causes a reversible inhibition of both evoked and spontaneous GlyR-mediated 
currents, whereas the opposite occurs at high pH (Li et al., 2003). Proton sensitive sites have 
been identified in the N-terminal domain of both the ʱ1 and the β subunit and mutations on 
these residues cause a reduction in proton sensitivity to variable extents (Chen et al., 2004; 
Chen and Huang, 2007).  
 
Other substances  are known to modulate GlyRs, but less is known of their mechanism of 
action: neurosteroids (Laube et al., 2002; Maksay et al., 2001), substance P (Wang et al., 
1999), melatonin (Wu et al., 2000), tropeines (Maksay et al., 2004), alcohol and anaesthetics 
(for reviews see Cascio, 2006; Laube et al., 2002).  
 
1.2.7 Pharmacology  
i. Glycine and partial agonists 
Irrespective of the expression system or the receptor subtype, glycine is a highly potent, full 
agonist for GlyRs (Legendre, 2001; Lynch, 2004). Other amino-acids acting on GlyRs are β-
alanine, taurine and GABA, with the rank order of potency being: glycine > β-alanine > taurine 34 
 
> GABA (Figure 1.5; de Saint Jan et al., 2001; Fucile et al., 1999; Horikoshi et al., 1988; 
Lewis et al., 1991).  
 
The concentration of taurine in the developing CNS is approximately 5-fold higher than in the 
adult, reaching the millimolar range, making it a good candidate for the activation of GlyRs 
during development (Flint et al., 1998; Mori et al., 2002). The actions of taurine on GlyRs (and 
on GABARs) have been well documented in  most brain regions including the spinal cord 
(Baev et al., 1992), the retina (Balse et al., 2006; Pan and Slaughter, 1995; Young and Cepko, 
2004) and the brainstem (Kontro and Oja, 1987; Ren and Greer, 2006). Similarly to taurine, β-
alanine can also act on GABAA receptors (Horikoshi et al., 1988; Tokutomi et al., 1989). Both 
taurine and β-alanine have high-affinity transporters in the mammalian brain (Liu et al., 1992; 
Smith et al., 1992). GlyRs can also be activated by GABA (David-Watine et al., 1999; de Saint 
Jan et al., 2001; Fucile et al., 1999). Despite the wide distribution of taurine or β-alanine 
however, there is no evidence yet to show that either of them can mediate synaptic currents at 
GlyRs. On the other hand, a direct action on synaptic GlyRs of the rat auditory nucleus was 
recently shown for GABA (Lu et al., 2008; Singer, 2008).  
 
 
Figure 1.5  Glycine and partial agonists of GlyRs 
The chemical structure of endogenous amino-acids acting on GlyRs. 
 
 
The efficacy of GlyR agonists can vary depending on the expression system or the level of 
expression (see for example Taleb and Betz, 1994). Therefore, taurine behaves as a full agonist 
on ʱ1 GlyRs in mammalian cells (Rajendra et al., 1995a) but as a partial agonist in oocytes 
(Schmieden et al. 1989, 1992). A recent study on the partial agonism of glycine receptors 
glycine β-alanine
taurine GABA
glycine β-alanine
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showed that taurine is a partial agonist due to of its reduced ability to induce a conformational 
change in the channel that will lead to opening, compared with glycine (Lape et al., 2008). 
Variations due to different expression systems have also been reported for the less studied ʱ2 
and ʱ2β subtypes (Farroni and McCool, 2004).  
 
ii. Picrotoxin 
Picrotoxin (PTX) is a plant alkaloid that exerts its convulsant action by inhibiting GABAARs, 
GlyRs  and the  invertebrate  glutamate  receptor  chloride channel  (Lynch,  2004). PTX is  an 
equimolar  mixture  of  picrotin  and  picrotoxinin,  both  of  which  can  inhibit  glycine-evoked 
currents in a manner that depends on receptor subtype (Lynch et al., 1995; Yang et al., 2007). 
Homomeric  GlyRs  are  very  sensitive  to  PTX  (IC50  values  of  5-10  μΜ)  in  difference  to 
heteromeric channels which are less sensitive (Pribilla et al., 1992). A series of side-directed 
mutations  identified  amino-acids  within  the  TM2  region  of  the  β  subunit  which  confer 
resistance to PTX to heteromeric GlyRs (Pribilla et al., 1992). Thereafter, a series of studies 
investigating the effects of PTX inhibition have tried to elucidate the location of the binding 
site and characterise the mechanism of action of this compound (Hawthorne and Lynch, 2005; 
Shan et al., 2001; Wang et al., 2006; Yang et al., 2007). PTX inhibition is highly sensitive to 
point mutations at residues 2΄ and 6΄ of the TM2 (Figure 1.4; Shan et al., 2001; Wang et al., 
1995; Xu et al., 1995) and the initial hypothesis was that PTX binds in the channel pore and 
acts  as  an  open-channel  blocker  (Cascio,  2006  Lynch,  2004).  However,  recent  evidence 
suggests that the mechanism of action on GlyRs is more complicated and may differ across 
different anionic channels, ranging from channel block to an allosteric mechanism of inhibition 
(see Hawthorne and Lynch, 2005; Lynch et al., 1995; Wang et al., 2006; Yang et al., 2007).    
 
iii. Strychnine 
Strychnine is a plant alkaloid acting as a high-affinity competitive antagonist of GlyRs. It can 
selectively antagonise both glycine and partial agonists with a dissociation constant of 2-15 nM 
(Lewis et al., 1998; Legendre, 2001; Lynch, 2004). Due to its selective action on GlyRs, it is 
the  only  known  tool,  to  date,  to  distinguish  between  Gly-  and  GABA-mediated  inhibitory 
neurotransmission in the CNS. Based on this, it has been used extensively for the purification 
and localisation of GlyRs in the brain and spinal cord (see sections 1.2.2-1.2.4). Different 
strychnine analogs have also been developed and their actions tested (reviewed in Rajendra et 
al., 1997). 36 
 
1.2.8 Glycine receptor-related diseases  
Defects  in  GlyR  function  in  humans,  mice  and  cattle  can  lead  to  startle  diseases.  Human 
hyperekplexia is a neurological disorder characterised by excessive responsiveness to startle, 
usually accompanied by muscle rigidity and in severe cases by stiffness in the neonatal period. 
Many mutations in either the ʱ1 or the β subunit of GlyR are known to cause hyperekplexia 
(Kwok et al., 2001; Lynch, 2004), usually by reducing the expression of GlyRs or by impairing 
gating. This reduces the effectiveness of inhibitory neurotransmission during a reflex, which 
increases the frequency of excitation of motoneurons (Bakker et al., 2006; Lynch, 2004). In 
humans these mutations can either be hereditary (major and minor phenotype), or sporadic 
(Bakker et al., 2006). The most common cause of hereditary hyperekplexia is a point mutation 
at Arg271 (Figure 1.2) in ʱ1 (Kwok et al., 2001; Langosch et al., 1994; Rajendra et al., 1994; 
Shiang et al., 1993). Most of the identified autosomal dominant mutations have been localized 
either in the TM1-TM2 or the TM2-TM3 loop (reviewed in Lynch, 2004; Zhou et al., 2002) 
suggesting that hyperekplexia can be related with a distortion in the allosteric mechanism of 
gating (Lewis et al., 1998; Lynch et al., 1997). Sporadic cases of hyperekplexia, with similar 
symptoms as the hereditary forms, have also been identified, resulting from mutations in GlyR 
genes or from mutations in GlyR-related proteins such as  glycine transporters or gephyrin 
(Bakker et al., 2006; Eulenburg et al., 2006; Rees et al., 2003).  
 
In mice, three naturally-occurring mutations result in startle syndromes with symptoms similar 
to those of human hyperekplexia. The spastic mutation is an insertion of a ~7 kb repeating 
element in the GlyR β gene, leading to inappropriate splicing and to reductions in the levels of 
the β subunit (Kingsmore et al., 1994; Mülhardt et al., 1994). This subsequently affects the 
ability of receptors to cluster in synapses. The spasmodic mouse results from a point mutation 
(Ala52Ser) in ʱ1, which leads to a 6-fold reduction in glycine sensitivity (Graham et al., 2006; 
Ryan et al., 1994; Saul et al., 1994). A detailed kinetic analysis showed that the mutation 
decreases the ability of the receptor to acquire a pre-opening conformation that enables the 
channel to open after glycine binding (Plested et al., 2007; see also Steinbach, 2007). The third 
startle case is that of oscillator mice, caused by a frameshift mutation in the TM3-TM4 loop of 
the ʱ1 subunit, resulting in a drastic reduction in the surface expression of GlyRs (Kling et al., 
1997; Buckwalter et al., 1994). This is the only GlyR mutation with a lethal phenotype. Mutant 
mice differ from human hyperekplexia cases in that they have a normal phenotype for up to 3 37 
 
weeks after birth, until the developmental switch from ʱ2 to ʱ1 subunit is complete at ~P20 
(Malosio et al., 1991a). 
 
1.3 Kinetics of GlyRs  
 
1.3.1 Activation mechanism of GlyRs 
Studies on cationic pLGICs suggest that the structural link between the binding sites and the 
transmembrane regions is formed by the interactions between three domains (Figure 1.6): the 
pre-TM1 region (β-sheet 10), the loop 2 (which connects the first and second β-sheets) and the 
TM2-TM3 loop (Lee and Sine, 2005; Lummis et al., 2005; Sine and Engel, 2006; Unwin et al., 
2002). Similar conclusions have been drawn for glycine and GABAA channels (Kash et al., 
2003 and 2004; Keramidas et al., 2006; Crawford et al., 2008).According to these studies the 
binding  of  the  neurotransmitter  triggers  a  wave  of  conformational  changes  through  the 
membrane, which begins from the binding site and leads to the opening of the channel pore 
(Chakrapani et al., 2004; Czajkowski, 2005).  
 
 
Figure 1.6  From agonist binding to channel gating 
On the left is a structural model of two adjacent subunits of the muscle nicotinic receptor built 
from the AChBP (extracellular domain) and Unwin‟s model for the transmembrane regions 
(from Czajkowski, 2005). The TM2 domains are in red. The area in the box is enhanced on the 
right. In yellow are the three loops involved in the transitions from binding to gating.   
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Events such as binding, gating and channel activation are not easily discriminated by mere 
mutagenesis  studies  if  these  rely  only  on  macroscopic  measurements  and  the  wild-type 
activation mechanism is poorly characterised (Colquhoun, 1998). Detailed studies have been 
performed for nicotinic receptors using linear-free energy relationships in combination with 
single point mutations and single-channel recording, to provide information about the sequence 
with which the activation wave spreads through the receptor (for examples see Cymes et al., 
2002; Grosman et al., 2000).  
 
Alternatively, the role of a residue can be studied by characterizing the channel activation 
mechanism by single-channel recording from wild-type and mutant receptors. The simplest 
mechanism of LGIC activation, shown in Figure 1.7, was introduced by del Castillo and Katz 
in 1957 (Colquhoun, 2006a). With kinetic models the events of binding and gating can be 
distinguished: binding is determined by the microscopic dissociation rate constant KA (where 
KA  =  koff/kon)  and  channel  opening  by  the  equilibrium  constant  for  gating  E  (E  =  β/ʱ; 
Colquhoun, 1998).  
 
   
Figure 1.7  A simple mechanism of channel activation 
This mechanism was introduced by del Castillo and Katz to describe the activation of muscle 
nicotinic receptors. It describes how the binding of an agonist (A) to the resting receptor (R) 
results in a complex (AR) that can undergo the conformational changes that lead to the open 
state (AR*). Both the equilibrium dissociation constant for binding (KR = koff/kon) and the 
equilibrium  constant  for  gating  (E  =  β/ʱ)  determine  the  sensitivity  of  the  receptor  for  the 
agonist (Colquhoun, 1998).  
 
 
The scheme in Figure 1.7 is an over-simplification of the real activation mechanism of any 
pLGIC, as it assumes a single binding step, a single bound shut state and a single open state 
and no desensitization.  
 
At present, the most appealing mechanism for describing the activation of GlyRs in a single-
channel level is the „flip‟ model of Burzomato et al. (2004), shown in Figure 1.8. Channel 
openings can occur from any of three liganded shut states with the efficacy for gating (E) 
increasing as more glycine molecules bind. Binding of the ligand increases the probability that 
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the channel is in a higher-affinity shut form (flipped states). A plausible physical interpretation 
for the flipped states is that they represent the receptor at a point at which the extracellular 
domain  has  closed  onto  the  agonist,  but  the  wave  of  conformational  change  has  not  yet 
reached the channel gate. The „flip‟ model describes well all the characteristics of the channel 
including the EC50 and Hill slope values obtained from macroscopic data for both the ʱ1 and 
ʱ1β channel subtypes (Beato et al., 2004; Burzomato et al., 2004). The model can describe 
well the behaviour of native GlyRs from spinal cord motoneurons (Beato and Sivilotti, 2007), 
is equally successful for describing data from mutant GlyRs bearing the spasmodic mouse 
mutation (Plested et al., 2007) and can be used for describing the action of partial agonists for 
both glycine and muscle nicotinic receptors (Lape et al., 2008).  
 
The most recent activation mechanism for ʱ2 homomeric GlyRs has been described by Mangin 
and colleagues (Mangin et al., 2003). This is described more thoroughly in Chapter 3.3.  
 
 
Figure 1.8  The „flip‟ mechanism and the reaction rates for ʱ1β GlyRs 
This mechanism was suggested by Burzomato et al., (2004) to describe the activation kinetics 
of  ʱ1β  GlyRs.  It  describes  the conformational  changes  that occur in  the channel  after the 
binding of up to three glycine molecules, that shift the receptor from the resting states (R) to 
higher  affinity  shut  states  (Flipped),  hence  enabling  the  channel  to  open  (R*).  For  these 
reaction rates: KR = 520 μΜ; KF = 8 μM; E1 = 1.3; E2 = 13; E3 = 20. All reaction rates are in 
s
-1 except the association rate constants for the R and F states, which are in M
-1s
-1 (Burzomato 
et al., 2004). 
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1.3.2 Characteristics of glycinergic synaptic currents 
The switch from ʱ2 to the expression of ʱ1 subunits at ~P20 in rats (Malosio et al., 1991a) 
underlies the developmental changes in the time course of the IPSCs. Thus, glycinergic IPSCs 
progressively become faster (with faster decay rates) as the expression of ʱ1 subunits increases 
(Ali et al., 2000; Legendre and Korn, 1994; Singer et al., 1998; Singer and Berger, 1999 and 
2000).  The  time  course  of  glycinergic  IPSCs  is  usually  characterised  by  a  fast  mono-
exponential  rising  phase  and  a  mono-  or  bi-exponential  deactivation  phase  (Beato,  2008; 
Burzomato et al., 2004; Legendre, 2001; Singer et al., 1998; Singer and Berger, 1999). The 
deactivation time constant for spontaneous IPSCs are in the range of 6-10 ms (Burzomato et 
al., 2004; Singer et al., 1998). The time course of deactivation is now known to be affected by 
the intracellular chloride concentration (Pitt et al., 2008). Glycine is removed from the synaptic 
cleft with a time constant of 0.3-0.9 ms (Beato, 2008; Clements, 1996; Legendre, 2001; Suwa 
et al., 2001). 
 
A  number  of  different  studies  have  shown  that  the  amplitude  distribution  of  glycinergic 
mIPSCs is highly variable and skewed towards big currents but the deactivation kinetics of 
these currents do not differ, irrespective of amplitude (Legendre and Korn, 1994, 1995; Singer 
et al., 1998). On the other hand, when responses to concentration jumps are considered, the 
current amplitude is correlated with differences in the desensitization properties of receptors, 
with at least two desensitization components being observed when the receptor density is high 
(Legendre et al., 2002). Information concerning the kinetics of desensitization of GlyRs is still 
limited (but see Beato et al., 2007; Pitt et al., 2008; see also Mangin et al., 2003).  
 
1.4 Aim 
 
As mentioned previously, adult synaptic GlyRs are ʱ1β heteromers and their stoichiometry is 
still somewhat uncertain: data on recombinant receptors suggest two possible stoichiometries, 
2ʱ1:3β and 3ʱ1:2β. Evidence for the first comes from experiments on oocytes (Grudzinska et 
al., 2005), whereas a study in mammalian cells favors the latter (Burzomato et al., 2003), 
raising the possibility that stoichiometry depends on the expression system. The primary aim of 
my work was to identify the stoichiometry of ʱ1β heteromeric GlyRs in Xenopus oocytes. For 
this purpose I used two independent approaches. The first one involves recording from oocytes 
expressing  heteromers  with  a  reporter  mutation  in  the  TM2  domain,  which  shifts  glycine 41 
 
sensitivity in proportion to the number of mutated subunits in the pentamer. This approach was 
used for identifying the stoichiometry of many members of the pLGIC family, including ʱ1β 
GlyRs  in  HEK293  cells  (Burzomato  et  al.,  2003).  The  second  approach  involves  single-
channel recordings from conductance mutants, in a manner similar to that described by Béhé et 
al.  (1995)  and  Cooper  et  al.  (1991)  for  NMDA  receptors  and  ʱ4β2  nicotinic  receptors, 
respectively.  
 
The second objective of my project was to characterize the kinetics of ʱ2 GlyRs in the same 
way as done for other GlyR subtypes (Beato et al., 2004; Burzomato et al., 2004; Lape et al., 
2008). The interest in the ʱ2 subtype arises from the fact that it is likely to be the embryonic 
subtype in the spinal cord. The kinetic analysis of ʱ2 homomers involved maximum likelihood 
fitting of a mechanism to single-channels from HEK293 cells. Macroscopic data from glycine 
concentration jumps were also considered. The model describes the transitions between open, 
shut and desensitized states of the channel, taking into account the conformational changes that 
lead from binding to channel opening and the number of functional agonist binding sites in the 
channel.  
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2.1 Stoichiometry of α1β GlyRs in Xenopus oocytes – 9΄ mutations 
 
2.1.1 cRNA constructs for oocyte expression 
cDNA constructs, containing the coding sequences for the rat GlyR ʱ1 (GenBank accession 
number  AJ310834)  and  β  subunits  (accession  number  AJ310839)  and  an  added  Kozak 
consensus sequence (GCCACC) upstream of the start codon (Groot-Kormelink and Luyten, 
1997), were amplified and cloned as described previously (Beato et al., 2002; Burzomato et al., 
2003).  To  facilitate  their  expression  in  oocytes  the  constructs  were  subcloned  into  the 
pSP64T.GL  vector,  the  features  of  which  are  shown  in  Figure  2.1.  The  constructs  were 
designed  using  the  Vector  NTI  programme  (Suite  5.5,  Invitrogen,  UK).  The  9΄  mutations 
(ʱ1
L289T, ʱ1
L289S, β
L307T and β
L307S; mutants shall be referred to as ʱ1
LT, ʱ1
LS, β
LT and β
LS) were 
introduced using the QuickChange
TM Site-Directed Mutagenesis Kit (Stratagene, UK) and the 
full-length sequence of each subunit was verified.  
 
In order to proceed to synthesis of capped RNA (cRNA) for expression of the subunits in 
oocytes, it was first necessary to produce large amounts of stock plasmid DNA. This was done 
by transforming competent bacterial cells (DH5ʱ E.coli cells, Invitrogen, UK) and thereafter 
purifying the produced plasmids (HiSpeed plasmid Maxi Kit, QIAGEN GmbH). Details of 
these procedures can be found in Appendix A.  
 
The [insert]/pSP64T.GL constructs were linearized downstream of 3΄ UTR (Figure 2.1) and 
cRNA was transcribed using the SP6 mMessage mMachine Kit (Ambion, UK; see Appendix 
A). The quality and quantity of each subunit cRNA were checked by RNA gel electrophoresis 
using the appropriate RNA markers. 
 
2.1.2 Xenopus laevis oocyte preparation and cRNA injection 
Mature female Xenopus laevis frogs (Figure 2.2A) were anaesthetized by immersion in ethyl 
m-aminobenzoate  solution  (tricaine,  methanesulphonate  salt,  Sigma-Aldrich,  UK;  0.2% 
solution w/v, brought to pH 7.2 by the addition of NaOH) for 30-40 min and were killed by 
decapitation and destruction of the brain and spinal cord (in accordance with Home Office 
regulations) before removal of the ovarian lobes. The ovarian lobes were washed thoroughly 
and  clumps  of  stage  V-VI  oocytes  (Figure  2.2B)  were  dissected  in  sterile,  double-filtered 
modified Barth's solution consisting of (in mM): NaCl 88; KCl 1; MgCl2 0.82; CaCl2 0.77; 44 
 
NaHCO3  2.4;  Tris-HCl  15;  with  50  units/ml  of  penicillin  and  50  mg/ml  of  streptomycin 
(Invitrogen, UK) in HPLC water; pH 7.4 was adjusted with NaOH. During the dissection, 
immature,  dead  or  dying  cells  were  discarded.  The  remaining  oocytes  were  treated  with 
collagenase (type IA, Sigma-Aldrich; 245 collagen digestion units/ml in 5 ml Barth's solution; 
10-12 oocytes/ml; this is a rather mild treatment that does not produce defolliculation on its 
own) for 50-65 min on an orbital shaker at 18 
oC and 100 rpm, then rinsed several times with 
fresh Barth‟s solution and stored at 4 
ʿC overnight. Prior to cRNA injection, the follicle layer 
(Figure  2.2C)  was  removed  manually  from  collagenase-treated  cells  with  watchmaker‟s 
forceps (Fine science tools, Interfocus).  
 
   
Figure 2.1  The rat ʱ1/pSP64T.GL construct 
Features of the pSP64T.GL vector used for oocyte expression of GlyRs. The vector contains 5΄ 
and 3΄ untranslated regions (UTRs; blue arrows) for the Xenopus β-globin gene (Akopian et 
al., 1996). The coding sequence for the rat ʱ1 subunit (red arrow) is inserted between the two 
UTRs. The plasmid also contains a prokaryotic promoter (SP6; black arrow), recognized by a 
RNA polymerase during the in vitro transcription reaction and the coding sequence of a gene 
that provides resistance to ampicillin (green arrow). The linearisation of the construct for the in 
vitro transcription was performed using XbaI (the unique restriction site for the enzyme is 
indicated by the black line).    
 
 
Oocytes chosen for injection were placed on a nylon mesh (24 x 15 mm with each square of 
the grid measuring 1 x 1 mm), glued to a 35 mm Petri dish (Figure 2.2D). Injection needles 
were produced from glass capillaries (3.5" Drummond #3-000-203-G/X, 88.9 x 1.14 x 0.053 
mm, Drummond Scientific Co). These were pulled, broken to form a staggered tip of 12-16 μm 
rat GlyR ʱ1/pSP64T.GL
4622 bp
TCTAGA
rat GlyR ʱ1/pSP64T.GL
4622 bp
TCTAGA45 
 
and finally forged into the shape of a hypodermic needle, to minimize damage to the oocyte 
membrane. The needles were backfilled with RNase-free mineral oil (Sigma-Aldrich, UK) and 
loaded from the tip with the appropriate cRNA combination (Table 2.1). The cRNA mixtures 
were injected into the cytoplasm (vegetal pole, Figure 2.2D) with a Nanoject automatic oocyte 
Injector (Drummond Scientific, Broomall, PA). The success of the injection was confirmed 
visually by a real-time increase in the cell diameter. All cRNA aliquots were freshly defrosted 
from -80 ºC and kept on ice during the procedure. The injections were done under sterile 
conditions in order to avoid cRNA degradation and/or infection of the injected cells.  
 
Table 2.1  Wild-type and/or 9΄ mutant cRNA combinations use for injections. 
 
cRNA combination 
 
α1:β concentration for injection (ng/μl) 
 
Oocyte batches (N) 
 
ʱ1 
 
0.5 
 
2 
ʱ1+β  0.5:20  5 
ʱ1
LT  0.5, 2, 5, or 8  2 
ʱ1
LT+β    0.5:20, 1:40 or 2:80  2 
ʱ1+β
 LT  0.5:20 or 2:80  6 
ʱ1
LT+β
LT  0.5:20 or 1:40  2 
ʱ1
LS  0.5, 5 or 8  2 
ʱ1
LS+β  0.5:20  2 
ʱ1+β
 LS  0.5:20  2 
ʱ1
LS+β
LS  0.5:20 or 1:40  2 
 
 
After injection the oocytes were incubated (in individual wells of a multiwell plate) for ~48-60 
hrs at 18 
oC in Barth's solution containing 5% heat-inactivated horse serum to improve oocyte 
health (Gibco BRL; Boorman et al., 2000) and then stored at 4 
oC. Experiments were carried 
out at 18 
oC between 2.5 and 5 days from injection. The total amount of cRNA injected per 
oocyte (in 46 nl of RNase-free water) was determined empirically, with the aim of achieving a 
maximum glycine-evoked current that would not exceed 1 µA (to contain the series resistance 
error to an acceptable size). For all ʱ1+β combinations, the ʱ1:β ratio of cRNA in a mixture 46 
 
was kept constant at 1:40, in order to avoid contamination by ʱ1 homomeric receptors, in the 
hope of forcing oocytes to express a predominantly heteromeric receptor population (this is 
successful in HEK293 cells, see Burzomato et al., 2003). 
 
 
Figure 2.2  The Xenopus laevis oocyte as an expression system 
A, The South African clawed frog, Xenopus laevis. B, Mature, stage V-VI oocytes with well-
defined animal (dark green) and vegetal hemispheres (yellow). C, Representation of an oocyte 
with its surrounding layers: the vitelline layer surrounds the cell membrane and is removed 
prior to patching whereas the outer layer of follicle cells is removed manually after enzymatic 
treatment. D, Cytoplasmic injection of oocytes with cRNA: the cells are placed on a nylon 
mesh glued on a Petri dish. The arrow indicates the injection needle (from Sigel and Minier, 
2005).  
 
 
2.1.3 Electrophysiological recordings – TEVC 
The collagenase treatment is performed for stripping off the follicle cells that surround the 
oocyte and are coupled with it via gap junctions (Figure 2.2C). This ensures that the electrical 
coupling does not interfere with the signal recorded from oocytes; also, the removal of the 
follicular layer allows an easier impalement with the electrodes. The large size of the oocyte 
(diameter ~1.2 mm) makes it ideal for two-electrode voltage clamp recording (TEVC). Each 
A  B 
Cell membrane 
Vitelline 
membrane 
Follicle 
cell layer 
C  D 47 
 
cell used for recording was held in a circle of insect pins, positioned in a thick Sylgard
® layer 
coating the floor of a 0.2 ml bath. Cells were continuously superfused (4.5-5 ml/min) with 
modified Ringer solution composed of (in mM): NaCl 150; KCl 2.8; MgCl2 2; CaCl2 1; HEPES 
10;  pH  7.2  adjusted  with  NaOH.  All  recordings  were  done  at  18 
oC.  Cells  were  voltage-
clamped at -70 mV with the TEVC mode of an Axoclamp 2B amplifier (Molecular Devices, 
CA).  Electrodes  were  pulled  from  filamented,  thin-walled  borosilicate  glass  (GC150TF, 
Warner Instrument Corp.) and backfilled with 2 M potassium acetate. Their resistance did not 
exceed 1 MΩ on the current-passing side. Recordings were not started if the holding current 
exceeded -200 nA (in the absence of agonist). Such cells were discarded.  
 
Concentration-response  curves  were  obtained  by  decreasing  the  concentrations  of  glycine, 
freshly prepared from frozen stock aliquots with Ringer solution, and applied at 5 min intervals 
via  the  bath  perfusion.  These  intervals  were  sufficient  to  ensure  reproducible  responses. 
Glycine (Fluka) was applied for a period sufficient to obtain a stable plateau response or the 
beginning of a sag after a peak (at low or high concentrations respectively). Currents were 
recorded on a flat bed chart recorder (Kipp & Zonen) and on a computer (Clampex 9 software, 
Molecular Devices, CA). To compensate for rundown throughout each experiment, a standard 
glycine concentration (~EC30 for each combination) was applied every third response. The 
experiment was started only after checking that this standard gave reproducible responses and 
was compensated for rundown only if this did not exceed ~30% from the first to the second 
standard; otherwise the experiment was stopped. For rundown corrections see Appendix B.   
 
Picrotoxin (Sigma-Aldrich, UK) concentration-inhibition curves for cells injected with ʱ1 or 
ʱ1+β were obtained as follows: a standard glycine concentration (100 μM; ~EC50 of ʱ1 GlyRs) 
was applied at the beginning of each experiment and then increasing concentrations of PTX 
were co-applied with the standard (PTX/Gly). Each PTX application started 5 minutes before 
each PTX/Gly application, to ensure PTX equilibration. The standard glycine (in the absence 
of PTX) was repeated every third response; this was done after 5 min perfusion with control 
Ringer solution, to wash out any remaining PTX. Experiments with more than a 30% (ʱ1) and 
40% (ʱ1β) decrease in the current from the first to the second standard were discarded: in the 
experiments chosen for fitting, there was an average of 22.6% (for ʱ1, n = 3) and 38.5% (for 
ʱ1+β, n = 4) decrease from the initial control current. For all combinations data were obtained 
from more than one oocyte batch in order to ensure reproducibility of results.  48 
 
2.1.4 Data Analysis – Curve fitting 
Concentration-response  curves  were  plotted  using  the  responses  to  different  glycine 
concentrations (after corrections for rundown). Each curve was then fitted to the Hill equation: 
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where I is the measured current, Imax is the maximum current, [A] is the agonist concentration, 
nH  is  the  Hill  coefficient  and  EC50  is  the  agonist  concentration  for  50%  of  the  maximum 
response. Each experiment was fitted separately by equally weighted least squares, using the 
program CVFIT (Colquhoun and Vais; http://www.uc.ac.uk/pharmacology/dc.html). The curve 
parameters calculated by the program are Imax, nH and EC50. Numbers in the text are means ± 
standard deviation of the mean (SEM) from the individual fits of each experiment. For each 
experiment, responses were normalized to the fitted Imax of the same experiment; normalized 
responses from all experiments were then pooled, giving an average concentration-response 
curve. These were fitted again to the Hill equation, for the purpose of display in figures.  
 
Concentration-inhibition  curves  to  PTX  were  fitted  to  the  Hill  equation  (eq.3).  The  curve 
parameters  calculated  by  CVFIT  in  this  case  are  Imax,  nH  and  IC50  (the  concentration  of 
picrotoxin at 50% of inhibition). The average parameters for each combination (Table 3.1, 
Chapter 3) and the plots of the pooled normalized values (Figure 3.2, Chapter 3) were obtained 
as above. PTX experiments from ʱ1+β injected cells were also fitted with a two-component 
Hill equation: 
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where  I  is  the  normalized  glycine  current  measured  at  its  peak;  [B]  is  the  picrotoxin 
concentration; 
1 50 IC  and 
2 50 IC  are the antagonist concentrations (for 50% inhibition) for the 
first and second component, respectively; nH1 and nH2 are the Hill coefficients for the two 
components and r is the ratio between the amplitudes of two components. The two-component 
fits were done in order to check for contamination by ʱ1 homomers. Two-component free fits 
gave poorly defined parameters. Each experiment was therefore re-fitted, by constraining the 
first component‟s parameters to be equal to those obtained from the free fits of the ʱ1 receptor 
experiments. Even so, these fits were also poorly defined.  49 
 
 
Significance tests were performed using Students‟ t test and a one-way nonparametric ANOVA 
followed by Bonferroni‟s post hoc multiple comparison test (GraphPad Prism 4, GraphPad 
Software).   
 
2.2 Stoichiometry of α1β GlyRs - conductance mutations 
 
2.2.1 Chimeric GlyR subunit constructs  
Two chimeric subunits (Figure 2.3A) were chosen for the conductance experiments in oocytes: 
(i) the rat GlyR β subunit with the TM2 domain of the rat GlyR ʱ1 (named β
Ch) and (ii) the rat 
GlyR ʱ1 subunit containing the TM2 domain of the rat GlyR β subunit (ʱ1
Ch). Figure 2.3B 
shows the exact amino-acid residues that have been exchanged between the two subunits. The 
chimeric constructs were created by Dr. Fe Abogadie. Subcloning in the pSP64T.GL vector 
and cRNA production followed the procedure described in sections 2.1.1 and Appendix A.  
 
 
 
Figure 2.3  Chimeric GlyR subunit constructs 
A, Structure of the chimeric constructs: the β
Ch is identical to the rat wild-type subunit but 
contains the TM2 domain of ʱ1. Similarly, the ʱ1
Ch contains the TM2 domain of β. B, The 
amino-acid sequence of the TM2 domain for the rat ʱ1 and β subunits (top two lines). The 
bottom two lines show the amino-acids that were exchanged between the two subunits for the 
creation of the TM2 chimeras. Note that the last amino-acid (position 21΄) was also exchanged, 
in agreement with Bormann et al. (1993).  
ʱ1
β
ΤΜ1 ΤΜ2 ΤΜ3 ΤΜ4
ʱ1Ch
βCh
0' 9' 20'
ʱ1 279 R V G L G I T T V L T M T T Q S S G S R A S
β 297 R V P L G I F S V L S L A S E C T T L A A E
ʱ1Ch 279 P F S S L A S E C T T L A E
βCh 297 G T T T M T T Q S S G S R S
A
B50 
 
For transient expression in human embryonic kidney cells (HEK293) the coding sequences for 
the rat GlyR ʱ1, β, ʱ1
Ch and β
Ch subunits, with the Kozak consensus sequence (GCCACC) 
added upstream  of each codon, were cloned into the pcDNA3.1 vector. The features  of a 
[insert]/pcDNA3.1  construct  are  described  in  Figure  2.4.  The  full-length  sequence  of  each 
cDNA was verified by sequencing.  
 
    
 
 
Figure 2.4  The rat ʱ1/pcDNA3.1 construct 
The  pcDNA3.1  vector  contains  a  viral  promoter  (cytomegalovirus  promoter,  CMV;  blue 
arrow) which can drive the expression of the inserted ʱ1 gene in HEK293 cells. The coding 
sequence for the rat ʱ1 subunit (red arrow) is inserted immediately after the promoter. The 
plasmid  also  contains  two  prokaryotic  promoters  (T7  and  SP6;  black  and  grey  arrows 
respectively), a polyA signal for the bovine growth hormone (orange line) and the coding 
sequences for genes that provide resistance to ampicillin (dark-green arrow) and neomycin 
(light-green arrow).  
 
 
2.2.2 Oocyte injections with cRNA 
Oocytes  were  prepared  and  injected  as  previously  described  in  section  2.1.2.  Table  2.2 
summarizes the injected cRNA combinations. As mentioned previously I wanted to avoid the 
contamination of the experiments by homomeric receptors. The cRNA mixtures (in 46 nl of 
RNase-free water per oocyte) were therefore prepared by maintaining a ratio of 1:40 for ʱ1+β 
combinations and 1:40:40 for ʱ1+β+β
Ch. For the latter combination I also tested a ratio of 
1:10:10 and 1:20:20.   
 
 
rat GlyR ʱ1/pcDNA3.1
6782 bp
rat GlyR ʱ1/pcDNA3.1
6782 bp51 
 
Table 2.2  Wild-type and/or TM2 chimeric cRNA combinations used for injections.  
 
cRNA combination 
 
α:β or α:β:β concentration (ng/μl) 
 
Oocyte batches (N)   
 
ʱ1 
 
2 or 3 
          
              4 
ʱ1+β  1:40 or 2:80                5 
ʱ1+β
Ch  1:40, 2:80 or 3:120                8 
ʱ1
Ch  2 or 10                2 
ʱ1
Ch+β  2:80                2 
β
Ch  2                1 
             
 
ʱ1+β+β
Ch 
 
1:40:40, 2:80:80, 3:30:30 or 2:40:40 
           
              7 
 
 
2.2.3 Culture and transfection of HEK293 cells  
Flasks  of  HEK293  cells  (American  Type  Culture  Collection-CRL-1573;  LGC  Promochen, 
Teddington, UK) were maintained in a humified incubator at 37 °C (95% air and 5% CO2). 
Cells  were  cultured  in  Dulbecco‟s  modified  Eagle‟s  medium  (DMEM)  supplemented  with 
sodium pyruvate (0.11 g/l), heat-inactivated fetal bovine serum (10% v/v) and penicillin G 
(100  units/ml)/streptomycin  sulphate  (100  μg/ml),  all  purchased  from  Invitrogen,  UK. 
Passaging of cells was performed every 2-3 days and up to 30 times (see Appendix A for a 
standard passaging protocol). Cells were plated on sterile glass coverslips (13 mm diameter, 
sterilized over flame) which were placed in 35 mm sterile Petri dishes containing 1.5-2 ml of 
DMEM.  Plating  was  performed  4-6  hours  before  transfection  to  allow  cells  to  attach. 
Transfection was by calcium phosphate-DNA co-precipitation (Groot-Kormelink et al., 2002). 
Briefly: the cDNA mixture for each combination was added to CaCl2 solution (340 mM in 
sterile water) at a volume ratio of 1:5 respectively. The DNA/CaCl2 mixture was added drop-
by-drop in an equal volume of 2x Hank‟s buffered saline (HBSS containing: 280 mM NaCl, 
2.8 mM Na2HPO4, 50 mM HEPES, pH 7.2 with NaOH) to form the precipitate. The final 
mixture was then added dropwise over the plated cells.  
 
The total amount of the cDNA mixture per plate was kept constant at 3 μg. The composition is 
shown in Table 2.3. For the transfection of the ʱ1+β+β
Ch cDNA combination I used an overall 52 
 
subunit  cDNA  ratio  of  1:40  (ʱ1:  total  β)  to  minimize  the  contamination  by  homomers 
(Burzomato  et  al.,  2003).  The  cDNA  mixture  also  included  a  plasmid  (pEGFP-c1;  BD 
Biosciences,  UK)  which  contains  the  coding  sequence  for  the  enhanced  green  fluorescent 
protein (e-GFP) with the added Kozak sequence immediately upstream of the start codon and 
the  mammalian  cytomegalovirus  promoter  (CMV).  Expression  of  the  fluorescent  marker 
allowed the detection of transfected cells. After transfection the cells were incubated for at 
least 10 hours (37 
oC, 95% air and 5% CO2), then washed repetitively with HBSS (to remove 
the remaining precipitate) and finally were left to rest in 2 ml of DMEM. Recordings were 
performed 2-3 hours after washing and for not more than 3 days after transfection.     
 
Table 2.3  Composition of the ʱ1+β+β
Ch cDNA mixture for HEK293 cell transfection. 
   Plasmid DNA  α1 + β + β
Ch 
 
[ʱ1]/pcDNA3.1 
 
2% 
[β]/pcDNA3.1  40% 
[β
Ch]/pcDNA3.1  40% 
pEGFP-c1  18% 
 
 
2.2.4 Test of expression – TEVC recordings from oocytes 
Before  proceeding  to  single-channel  recording  I  checked  whether  the  chimera-containing 
combinations  produced  sufficient  current.  I tested this  by  bath-applying 1 mM  glycine (in 
Ringer solution) and measuring the macroscopic current using TEVC. Cells were held at -70 
mV. The four combinations tested were: ʱ1+β
Ch, β
Ch, ʱ1
Ch
 and ʱ1
Ch+β. The concentrations of 
the cRNA mixtures for each combination are the lowest ones shown in Table 2.2, except in the 
case of ʱ1
Ch where both concentrations were tested. In order to make sure that the very low or 
absent responses to glycine in the case of the ʱ1
Ch
 and ʱ1
Ch+β combinations really mean that 
these receptors are not functional and are not a chance finding due to bad oocyte health or low 
expression efficiency for the given batch, these experiments were done in two different oocyte 
batches. In every batch I also injected a highly expressing combination (ʱ1+β, 1:40 ng/μl, 46 nl 
per oocyte) to compare the expression levels with those from the four combinations.  
 53 
 
2.2.5 Single-channel recordings from oocytes 
Recordings were obtained in the cell-attached and in the outside-out configuration. For both 
cases, oocytes were stripped of their vitelline membrane (Figure 2.2C) immediately before 
patching to ensure a clean cell membrane and the formation of a gigaohm seal (Hamill et al., 
1981).  Devitellinization  was  achieved  by  incubating  the  oocyte  for  5-10  minutes  in 
hyperosmotic Barth‟s solution (3-5 ml of Barth‟s solution and 1 ml of sucrose, 1 M), followed 
by manual removal of the vitelline membrane with sharp-tipped watchmaker‟s forceps. All 
recordings were performed at 18 
oC.  
 
i. Cell-attached single-channel recordings – current/voltage plots 
Oocytes  were  bathed  in  a  high  potassium  solution  to  drive  the  oocyte  resting  membrane 
potential to a consistent value, close to 0 mV. The solution contained (in mM): KCl 150; 
HEPES 10; EGTA 10; pH 7.2 adjusted with KOH.  
 
Because I was interested in measuring single-channel conductances, I did not want to depend 
on the oocytes‟ internal concentration of chloride, which may vary between cells (or batches) 
and could be limiting the measured conductance of the channels. I therefore set up conditions 
that would allow the measurement of chloride currents without any limitations from the oocyte: 
1. patches were held at a positive holding potential (i.e. negative pipette potential), which 
forces chloride ions to flow from the pipette to the cell. This current is not influenced by 
differences  in  internal  chloride  concentrations  between  different  cells.  2.  To  increase  the 
driving  force  for  chloride,  the  pipette  solution  contained  a  high  concentration  of  chloride. 
Bormann et al. (1987) reported a half-saturating chloride concentration of 108 mM for GlyRs 
in outside-out patches. Hence, electrodes were back-filled with (in mM): KCl 200; HEPES 10; 
EGTA 10; pH 7.2 adjusted with KOH. The pipette solution also contained 1 mM glycine; at 
this concentration channel openings occur in clusters. The pipette solution was freshly thawed 
from frozen aliquots. For the ʱ1+β+β
Ch combination I also tested a glycine concentration of 50 
μM (see results). 
 
Patch pipettes were pulled from thick-walled, filamented borosilicate glass (GC150F, Harvard 
Apparatus)  and  coated  near  the  tip  with  Sylgard
TM  (Dow  Corning)  for  improving  their 
dielectric properties. Prior to use each electrode was fire-polished to maintain a clean tip for 
the formation of a giga-ohm seal. The final resistance of the electrodes was 4-10 MΩ.  54 
 
For each current/voltage (I/V) plot single-channel currents were obtained at holding potentials 
ranging from 0 to +70 mV (ie. pipette potentials of 0 to -70 mV). As I increased the holding 
potential, in some patches I observed a high frequency of channel openings, attributable not to 
GlyRs but to endogenous stretch channels. These channels, well characterized by Yang and 
Sachs, (1990) and Methfessel et al. (1986) are easily distinguishable from GlyRs. Despite this, 
all patches in which these channels were detected were discarded.  
 
ii. Outside-out single-channel recordings – chord conductance measurements 
Oocytes were bathed in a modified Ringer‟s solution containing (in mM): NaCl 150; KCl 2.8; 
MgCl2 1; CaCl2 2; HEPES 10; pH 7.4 adjusted with NaOH; ~305 mOsm osmolarity. Glycine 
(1 mM in extracellular solution) was applied  in the superfusant with exchange time of ~2 
minutes.  All  outside-out  experiments  were  performed  at  a  holding  potential  of  -100  mV. 
Electrodes were prepared as described for the cell-attached experiments. They had a resistance 
of 10-15 MΩ and were backfilled with (in mM): CsCl 120; TEA-Cl 20; CaCl2 1; MgCl2 2; 
HEPES 10; EGTA 11; pH 7.2 with CsOH; osmolarity was adjusted with sucrose to be equal or 
higher than the bath solution‟s (~310-315 mOsm) to increase the stability of the excised patch. 
Glycine was applied only after ensuring that no single-channel activity was detected when the 
patch was kept in bath solution for at least 1 minute. Due to the bigger membrane surface 
compared  with  cell-attached  patches,  often  many  channels  were  simultaneously  open  in 
outside-out patches. I did not record unless well separated clusters were detected.  
 
All solutions used for single-channel recording (in both configurations) were prepared using 
HPLC-grade  water  (VWR,  UK)  to  minimize  contamination  by  glycine  and  were  filtered 
through a 0.2 μm cyclopore
TM track-etched membrane (Whatman International Ltd, Maidstone, 
UK) to remove impurities that can block electrodes or affect the quality of the seal. To ensure a 
high signal-to-noise ratio, the level of the bathing solution was kept as low as possible. In the 
case of outside-out recording the excised membrane patch was lifted to just under the surface 
of the solution, to minimize the pipette capacitance and to reduce noise. The quality of every 
patch was checked immediately after sealing, by observing the noise meter on the amplifier 
(IRMS); patches were discarded if the noise on the meter exceeded 0.27 pA after the holding 
potential  was  applied.  Single-channel  currents  were  recorded  with  an  Axopatch  200B 
amplifier, pre-filtered at 10 kHz using the amplifier‟s 4-pole Bessel filter (Molecular Devices, 
CA)  and  saved  on  a  digital  audio  tape  with  a  DRA-200  digital  tape  recorder  (Bio-Logic 55 
 
Science Instruments, Claix, France). For off-line analysis each record was replayed from the 
tape, filtered at 3 kHz with an 8-pole Bessel filter and digitized at 33 kHz with a Digidata 
1322A using Clampex software (both from Molecular Devices, CA).  
 
All single-channel data were analyzed by cursor measurement of amplitudes using the event 
detection mode of Clampfit 9.2 software (Molecular Devices, CA).  
 
iii. Analysis of cell-attached recordings 
Each  cluster  in  a  patch  was  analyzed  individually.  Events  shorter  than  10  ms  (for  1  mM 
patches, both configurations) were ignored. During the scan dubious events (double openings, 
baseline  breakdowns  etc.)  were  rejected.  At  the  end  of  the  scan  a  list  of  all  events  per 
amplitude level is created. For all cell-attached experiments (1 mM Gly) there was always only 
one main level of opening for each cluster. Any other levels, attributed to „subconductances‟, 
appeared rarely (<1% of events) and hence were excluded from the analysis (rejected during 
the  scan).  From  the  list  of  amplitudes  measured  by  the  software  I  calculated  the  average 
amplitude for each cluster. For each holding potential, clusters were separated into groups of 
similar mean amplitude. The average amplitude of each group represents a data point on the 
I/V plot. Data points were fitted to equation 5 (straight line):  
                                              [eq.5] 
 
where A is the slope of the line, corresponding to the slope conductance of a channel, and B is 
the Y axis intercept (current at 0 mV).   
 
In addition to the 1 mM patches obtained in the cell-attached configuration, I also had one 
patch  with  50  μM  glycine  in  the  pipette  solution.  At  this  concentration  I  did  not  observe 
clusters of channel openings but only shorter groups of fewer openings, e.g. bursts. All bursts 
obtained  at  each  holding  potential  were  analysed  together,  with  a  continuous  scan  of  the 
software.  
 
iv. Analysis of outside-out recordings 
The analysis of outside-out patches was also performed by cursor measurement. In this case I 
recorded only at one holding potential (-100 mV). Similar to before, each cluster was scanned 
individually, ignoring events shorter than 10 ms. By contrast to what is observed for cell-
attached experiments, GlyRs open to several conductance levels in outside-out patches (Beato 
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et al., 2002; Beato and Sivilotti, 2007; Bormann et al., 1993). For each level I calculated the 
average amplitude for the entire patch. In the average values I only included openings at the 
main conductance level of each cluster. These average current amplitudes were then converted 
into chord conductances, assuming a reversal potential of 0 mV and with no correction for 
junction potential. The junction potential formed between the bath and pipette solution was 3.8 
mV (calculated in Clampex). This would mean a corrected membrane potential of -103.8 mV. 
The equilibrium potential for chloride, calculated from the Nernst equation is ~2 mV. The 
errors in the chord conductance estimations, therefore, are minimal: for example, what was 
reported as amplitude of 4 pA at -100 mV is truly 4.1 pA at -101.8 mV, when the corrections 
for junction potential and the equilibrium potential of 2 mV are considered. 
 
2.2.6 Single-channel recordings from HEK293 cells 
Recordings were obtained in the cell-attached configuration. The transfected cells were bathed 
in extracellular solution that contained (in mM): Na-gluconate 20; NaCl 102.7; KCl 2; CaCl2 2; 
MgCl2 1.2; HEPES 10; TEA-Cl 20; sucrose 15; glucose 14; pH 7.4 with NaOH). Solutions and 
electrodes  were  prepared  as  described  for  oocytes.  Electrodes  were  back-filled  with 
extracellular solution containing glycine at the required concentration (1 mM or 200 μM). 
Their resistance was 5-12 MΩ. The pipette solution was freshly thawed from frozen aliquots. 
For  I/V  plots  all  patches  were held  at  a  range  of  holding potentials  (0 mV to  -100  mV). 
Recordings, pre-filtered at 10 kHz, were obtained with an Axopatch 200B amplifier. For off-
line analysis they were filtered at 3 kHz and digitized at 33 kHz. 
 
Analysis was performed similarly to what was described for the oocyte cell-attached data. For 
1 mM and 200 μM patches, at which clustered channel openings were observed, events that 
had a duration of less than 10 ms were excluded. Each cluster was analyzed individually. 
Unwanted events such as double openings or baseline breakdowns were rejected. After the 
scan, the average amplitude at each holding potential was plotted on an I/V plot and data were 
fitted to equation 5, in order to estimate the slope conductance for each patch.  
 
Additional to Clampfit analysis, one recording from each concentration was also idealized by 
time course fitting, using the program SCAN, courtesy of David Colquhoun. The software 
converts the trace to a list of openings and shuttings, where the duration of each event and also 
the  fitted  amplitude  values  of  each  opening  are  listed.  After  choosing  and  imposing  the 57 
 
appropriate resolution (20 μs), stability plots and fitted amplitude diagrams for each holding 
potential were created using EKDIST. Only openings longer than twice the risetime of the 
filter (and equal to ~221 μs for 3 kHz) were used for the fitted amplitudes histograms in order 
to avoid the uncertainty of assigning amplitudes to short events. Each histogram was fitted by a 
single  Gaussian  component.  The  mean  current  amplitude  at  each  holding  voltage, 
corresponding  to  the  peak  of  the  Gaussian  curve,  was  then  plotted  on  the  I/V  plot,  for 
estimating the slope conductance for that patch. All the programs used for analysis can be 
downloaded from http://www.ucl.ac.uk/Pharmacology/dc.html. 
 
2.3 Kinetics of α2 GlyRs in HEK293 cells 
 
2.3.1 GlyR α2 subunit cDNA construct, HEK293 cell culture and transfection 
HEK293 cells were transiently transfected with the pcDNA3.1 vector containing the coding 
sequence for the rat GlyR ʱ2 subunit (Isoform A; GenBank accession number AJ310837). The 
ʱ2/pcDNA3.1 construct has a total size of 6815 bp and contains all the features shown in 
Figure 2.4. The full-length sequence of the cDNA was verified by sequencing PCR. HEK293 
cells  were  cultured  and  transfected  as  described  previously.  The  DNA  mixture  used  for 
transfection  contained  3-20%  of  ʱ2/pcDNA3.1  and  18%  pEGFP-c1;  the  mixtures  were 
supplemented with the appropriate amount of pcDNA3.1 vector cDNA lacking the ʱ2 coding 
sequence. Adding the empty vector ensured that the level of ʱ2 GlyR homomer expression is 
kept optimal and the single-channel patches did not contain too many simultaneous channel 
openings.  Cells  used  for  concentration  jumps  (outside-out  recordings)  were  plated  onto 
coverslips  coated  with  poly-L-lysine  prior  to  transfection.  Coating  was  performed  by 
incubating the coverslips for ~40 minutes with poly-L-lysine (Sigma-Aldrich, UK), followed 
by thorough washing with autoclaved water and oven-drying at 60 °C.  
 
2.3.2 Single-channel recordings – experimental procedure and data analysis 
Recordings, performed at 19-21 °C, were obtained in the cell-attached configuration and at a 
holding potential of -100 mV (pipette potential of +100 mV) for all patches. Solutions and 
electrodes  were prepared as described before  in sections 2.2.5 and 2.2.6. The extracellular 
solution contained (in mM): Na-gluconate 20; NaCl 102.7; KCl 2; CaCl2 2; MgCl2 1.2; HEPES 
10; TEA-Cl 20; sucrose 15; glucose 14; pH 7.4 with NaOH) and the electrodes (5-12 MΩ) 
were back-filled with extracellular solution containing glycine (at concentrations ranging from 58 
 
20 μM to 10 mM). All recordings were filtered at 10 kHz and stored on a PC hard drive 
(sampling rate 100 kHz).  
 
For off-line analysis the recordings were filtered at 5 or 7 kHz and sampled at 50 kHz or 71.43 
kHz respectively, according to the signal-to-noise ratio of each recording. Amplitudes, open 
times and shut times were idealized with SCAN. More than 10000 transitions were used from 
each patch. Parts of records that included baseline changes or breakdowns, dubious channel 
openings etc. were excluded from the scan. After choosing and imposing the resolution (20 μs 
for both shut and open times), dwell-time distributions of shut times and open periods and also 
histograms of fitted amplitudes were created with EKDIST. For all patches the fitted amplitude 
histograms were fitted with a single Gaussian curve. Only fitted amplitudes longer than two 
filter risetimes (equal to twice the 10-90% risetime of the filter that is calculated as 0.3321/fc 
were fc is the cutoff frequency; risetime is 66 μs for 5 kHz or 47μs for 7 kHz) were used for 
the histograms.  
 
The distributions of shut times and open periods were fitted with a mixture of exponential 
density functions. Each open period was defined as the duration of time at which the channel 
remained continuously open, regardless of amplitude; that is the time between two adjacent 
shut times longer than the imposed resolution. The true number of the channels in one patch is 
unknown but for kinetic analysis it is essential to isolate, within the idealised record, stretches 
of openings that are likely to arise from one individual channel. The reason for the initial fitting 
of shut-time distributions with EKDIST was to determine a critical shut time (tcrit) that would 
enable  me  to  divide  the  record  into  true  one  channel  stretches  of  openings.  Fits  to  the 
distributions obtained at EKDIST are only descriptive and not mechanism dependent; hence 
parameters  estimated  by  EKDIST  were  not  used  further  in  the  analysis.  The  process  of 
determining tcrit can be ambiguous but the conclusions do not depend critically on this choice.  
 
For  ʱ2  receptors  it  was  impossible  to  distinguish  between  clusters  and  bursts  at  different 
glycine concentrations (see Results). Hence, the Popen for each idealized record was calculated 
after considering all openings as clusters. The definition of a cluster is a group of openings that 
is separated by a gap that is longer than tcrit. Popen for each cluster was the ratio between the 
cluster‟s total open time and cluster length. Dubious openings and clusters with a low number 
of open periods (<10) were excluded. The tcrit value I chose (7-10 ms) was different and higher 59 
 
than the various tcrit values chosen for model fitting. This was done in order to have more 
accurate measurements of Popen since a low tcrit might result in breaking a cluster into several 
others. Two traces were idealised for each concentration and the Popen values for all clusters 
were pooled and averaged for the Popen-concentration curve. Fits of the Popen curve with the Hill 
equation were poorly defined. 
 
For kinetic modeling the postulated mechanisms were evaluated using maximum likelihood 
fitting  and  the  program  HJCFIT  (http://www.ucl.ac.uk/Pharmacology/dc.html).  For  this 
purpose the idealized data from all concentrations were grouped into sets, each set containing 2 
or 3 patches at low, intermediate and high agonist concentrations. When only two patches were 
used, these were always of low and high concentration. A total of 12 patches were used, two of 
each of 20 μM, 30 μM, 50 μM, 100 μM, 1 mM and 10 mM glycine. All recordings from one 
set were input into the program together with a resolution of 20 μs (set as the duration of the 
fastest event that can be detected), a tcrit value for each patch and a mechanism and the data 
were fitted simultaneously with HJCFIT. The program calculates a likelihood value for the 
initial guesses for the rate constant values, taking into account the imposed resolution and by 
implementing a correction for missed events (Colquhoun et al., 2003; Hawkes et al. 1992). The 
rate constant values are then adjusted in order to maximize the likelihood, until a maximum is 
reached. 
 
The openings are separated into groups according to the tcrit so that all openings in a group are 
likely to derive from the same channel. Ideally, the groups would correspond to individual 
bursts at low agonist concentrations (20-100 μM) and to clusters (groups of bursts) at higher 
agonist concentrations (1 mM, 10 mM). In the case of low concentrations HJCFIT calculates 
the likelihood of each group using the initial and final vectors (CHS vectors) as described by 
Colquhoun et al., (2003). These take into account that shut times longer than tcrit are excluded 
and the recording is divided into bursts that are separated by shut times longer than tcrit. The 
true length of a shut time (deriving from one channel) has to be at least as long as the observed 
one. Similarly, for high agonist concentrations the likelihood is calculated with steady-state 
vectors. CHS vectors cannot be used in this case because the true duration of shut times is 
likely to be distorted by desensitization (Colquhoun et al., 2003). For fitting I tested different 
values of tcrit combined with the use, or not, of CHS vectors for low concentrations (20-100 60 
 
μM). This  was  done because  I  could  not  discriminate between  clusters and bursts: at  low 
concentrations openings were clustered, similar to high concentrations.  
 
To test the quality of a fit, as a first step I refitted data using different initial guesses for the rate 
constant  values.  If  the  fit  is  good  and  the  likelihood  surface  has  only  one  well-defined 
maximum, changing the initial guesses should still converge to the same estimates for the rate 
constants. Additionally, fits that gave association rate constant values greater than 10
9 M
-1s
-1 
were rejected since such values are physically impossible. As a second step, I compare the 
predictions of the mechanism and the rate constants obtained by HJCFIT with the experimental 
data.  This  is  done  using  different  data  display:  shut-time  distributions,  open-period 
distributions and the predicted Popen curve. All data are expressed as mean ± SEM.  
 
2.3.3 Recordings of macroscopic currents and analysis 
Concentration  response  curves  for  glycine  (courtesy  of  L.Sivilotti;  unpublished  data)  were 
performed  in  the  whole-cell  configuration  at  a  holding  potential  of  -60  mV.  Glycine 
(concentrations ranging from 50 μΜ to 10 mM) was applied by means of a U-tube system, 
with exchange times lower than 6 ms. Experiments were carried out as in Burzomato et al. 
(2003). Current responses were compensated for rundown as described in Appendix B and the 
corrected responses for each experiment were fitted to the Hill equation (equation 3) using 
CVFIT. Individual experiments were normalized to their fitted maxima, then pooled and fitted 
again to give the plot in Figure 3.31C.  
 
Fast concentration jumps were performed in outside-out patches with a theta tube (Hilgenberg, 
Malsfeld, Germany) cut to the tip to a final diameter of ~150 μm. The tube was driven by a 
piezo stepper (Burleigh Instruments, NY, USA). Glycine (0.1, 0.5, 1 and 10 mM), prepared in 
bath  solution,  was  washed  in  and  out  through  the  double-barreled  perfusion  system.  The 
exchange  time  was  measured  between  normal  and  30%  diluted  bath  solution  before  each 
experiment (to optimize the position of the electrode) and after the end of the experiment and 
rupture of the patch.  
 
The bath solution contained (in mM): Na-gluconate 20; NaCl 102.7; KCl 2; CaCl2 2; MgCl2 
1.2; HEPES 10; TEA-Cl 20; sucrose 15; glucose 14; pH 7.4 adjusted with NaOH. For studying 
the effect of different Cl
- concentrations the pipettes (with a resistance of 8-15 MΩ) were 61 
 
backfilled either with a „high [Cl
-]‟ solution containing (mM) 107.1 KCl, 1 CaCl2, 1 MgCl2, 10 
Hepes, 11 EGTA, 20 TEA-Cl and 2 MgATP or with a „low [Cl
-]‟ solution that contained (in 
mM) 121.1 K-gluconate, 1 CaCl2, 1 MgCl2, 10 HEPES, 11 EGTA, 6 TEA-Cl and 2 MgATP 
(both  with  pH  7.2,  adjusted  with  KOH).  The  osmolarity  of  the  intracellular  solution  was 
adjusted with 20-40 mM sucrose so that it was equal or higher than of the bath solution. When 
the „low [Cl
-]‟ solution was used, the silver chloride wire of the pipette holder was chlorinated 
prior to each experiment, to compensate for the increased flow of Cl
- ions from the wire to the 
solution.  All  outside-out  recordings  were  performed  at  a  holding  potential  of  -100  mV. 
Correction  for  junction  potential  was  not  applied.  During  the  3-5  min  intervals  between 
different glycine concentrations the patch was held at -60 mV, to prolong the stability of the 
seal. Recordings were filtered at 5 kHz and digitized with a sampling rate of 20-50 kHz.  
 
For each glycine concentration ~10-50 responses to individual sweeps were recorded. Sweeps 
were  separated  by  at  least  20  s  to  allow  full  recovery  from  desensitization  (Gentet  and 
Clements, 2002). All sweeps from each concentration were averaged for analysis, excluding 
failures or responses that contained patch breakdowns. Only experiments in which the rundown 
between the average current from the first and last three sweeps in a series was less than 5% 
were  included  in  the  analysis.  The  risetime  for  average  currents  and  tip  potentials  was 
measured from 10-90% of the peak using Clampfit 9.2 software and  experiments in which the 
open tip response had a 10-90% exchange time slower than 300 μs were rejected. Both the time 
course of desensitization at prolonged glycine applications and the time course of deactivation 
at long (1 s) and short applications (2 ms) were fitted with a sum of one or two exponentials. 
Data are expressed as averages ± SEM.  
 
Simulations of the deactivation of macroscopic currents using single-channel kinetic models 
were performed in SCALCS software (http://www.ucl.ac.uk/Pharmacology/dc.html).  
 
Average currents from 1 s concentration jumps to three different glycine concentrations (100 
μΜ, 500 μΜ and 10 mM at high [Cl
-] pipette solution, equimolar to the bath) were used for 
obtaining a rough estimation of concentration-response curve parameters. For these patches the 
average responses were normalized to the fitted maximum (response at 10 mM glycine) and 
fitted to the Hill equation with CVFIT.  
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Rate constants corresponding to the desensitized states in scheme 7A were determined using 
ChanneLab  software  (Synaptosoft  Inc.),  which  optimizes  the  rate  constant  values  of  a 
mechanism  by  a  simplex  algorithm.  The  open  tip  potential,  measured  at  the  end  of  each 
experiment, was used as input for the agonist concentration profile. Currents were usually 
fitted in steps. The average response to a long glycine application (200 ms) was fitted to the 
model leaving all desensitization entry and exit rates free. Initially, I fitted the first 100 ms of 
each current in order to get estimates for the slow desensitization and these were later on fixed 
for obtaining also the rates for the fast desensitization component (in patches where this was 
present). All other rate constants in the model were fixed to the values obtained from HJCFIT 
for model 7A. The same procedure was followed for all three glycine concentrations (500 μΜ, 
1 mM, 10 mM) applied in each patch. As a last step I only fitted the rising phase of the glycine 
current by leaving the binding rate constant (k+) free and fixing all other rates. These fits were 
performed for individual currents and also simultaneously for all three concentrations of each 
patch. When referred to rate constants, data are expressed as the average of all fits ± the % of 
coefficient of variation (CV). 
 
2.4 Appendix A (protocols) 
 
2.4.1 Transformation of chemically competent E.coli cells 
  LB medium: For 1 liter of medium 20 g of LB Broth base (Invitrogen, UK) was diluted in 
water to a final volume of 1 liter; the solution was autoclaved for 2 hours and then stored at 4 
°C for a maximum of a month to avoid contamination. 
  Ampicillin-containing LB medium plates: 20 g of LB Broth base medium and 12 g of 
select agar (Gibco BRL, UK) were mixed in water at a final volume of 1 liter; the bottle was 
autoclaved  for  2  hours.  Ampicillin  was  added  to  a  final  concentration  of  100  μg/ml  (LB: 
antibiotic 1:1000). The final medium was poured in Petri plates (~25 ml per plate); the plates 
were stored at 4 °C for not more than one month. 
  Transformation  of  DH5a  E.coli  cells:  The  Invitrogen  Kit  (#18258-012)  contains  DH5ʱ 
competent E.coli cells for routine transformation of large plasmids (up to 30 kb). Before the 
reaction assembly, DH5ʱ cells were removed from -80 
ʿC and thawed on ice for 30 min. For 
the transformation reaction 2 μl of plasmid DNA were used for transfecting 100 μl of cells 
followed by incubation on ice for 30 min. The cells were then heat-shocked for exactly 45 s in 63 
 
water bath at 37 
ʿC and placed on ice for at least 2 min. 900 μl of SOC medium (at 37 
 ʿC) was 
added to a final volume of 1 ml and the mixture was placed in a thermomixer (at 37 
 ʿC) for 1 
hour, mixing at the lowest speed. A volume of the transformation reaction was finally spread 
on  separate,  dry  LB  agar  plates  containing  ampicillin  and  the  plates  were  inverted  and 
incubated overnight at 37 
ʿC.  
 
2.4.2 Plasmid purification – Maxiprep (QIAGEN Maxi Kit) 
The  HiSpeed  QIAGEN  Maxi  Kit  is  used  for  the  isolation  and  purification  of  high-yield 
plasmid DNA. A single, isolated colony from a selective plate was picked and inoculated in 5 
ml LB medium containing 5 μl of ampicillin. The culture was then incubated in a shaking 
incubator at 37 
ʿC and at maximum speed for 8 hours. The starter culture was later diluted into 
a flask containing 100 ml LB medium and 100 μl ampicillin and incubated overnight in a 
shaking  incubator  at  37 
ʿC  and  at  maximum  speed.  The  following  day  the  mixture  was 
centrifuged at a maximum speed for 20 min at 4 
ʿC, the supernatant was removed and the 
pellet was treated, following the manufacturer‟s protocol, so as to destroy the cells (lysis) and 
isolate and purify the plasmid DNA.  
 
2.4.3 In vitro synthesis of capped RNA (AMBION – mMESSAGE mMACHINE Kit) 
The kit is designed for the in vitro synthesis of large amounts of capped RNA, to be used for 
oocyte injection. The cap analog at the 5΄ end of the RNA sequence (7-methyl guanosine) 
provides  protection  from  ribonucleases  (RNases)  and  gives  stability  to  the  molecule  by 
mimicking most eukaryotic mRNAs in vivo. 
  Linearization of the [insert]/pSP64T.GL construct: the enzyme used for linearization must 
have a unique restriction site in the construct and this should not be in the insert. For the 
pSP64T.GL vector a good candidate is XbaI (Figure 2.1), which cuts the construct downstream 
of the 3΄ UTR. While assembling the reaction the enzyme was kept at -20 
ʿC. Approximately 
10 ng for each DNA sample was added in 4 μl of 10x Buffer (corresponding to the enzyme 
used) and 2 μl of the restriction enzyme. MilliQ water was added to a final volume of 40 μl. 
The samples were incubated for 2-3 hours at the optimal temperature for each enzyme (37 
ʿC 
for XbaI). To check the success of the digestion 2 μl of each digest (diluted in 8 μl of MilliQ 
water and 1 μl of loading dye) were loaded on a 1% agarose gel containing 2 μl of ethidium 
bromide (in 1x TAE buffer, National Diagnostics, UK). The samples were separated at 110 
V/cm for 1 hour. Additional confirmation of a single band with the correct size was given by 64 
 
loading DNA molecular weight markers on the gel. The DNA bands were visualized by UV 
transillumination. 
  Proteinase K treatment: this was done in order to destroy any contaminating RNases or 
other enzymes that may inhibit the transcription reaction. Hence, the linear DNA (38 μl ) was 
mixed with 5 μl of 10x proteinase K buffer, 2.5 μl of 10% SDS, 4 μl of RNAse-free water and 
0.5 μl of proteinase K (total 50 μl) and incubated for 1 hour at 37 
ʿC. 
  Phenol/Chloroform extraction: for purifying the linear DNA, 200 μl of equilibrated RNase-
free phenol was added to the mixture and centrifuged for 10 min at 14000 rpm at ambient 
temperature. 200 μl of phenol-chloroform was then added to the aqueous phase and the mixture 
was centrifuged for 10 min at 14000 rpm at ambient temperature. The aqueous phase was again 
separated, RNase-free chloroform was added (200  μl) and centrifuged as before. The final 
aqueous phase contained the purified linear plasmid DNA. 
  DNA precipitation: 15 μl of 3 M NaOAc and 3 volumes of ice-cold ethanol 100% (both 
RNase-free)  were  added  to  the  aqueous  solution  and  the  mixture  was  placed  at  -20 
ʿC 
overnight. The precipitate was centrifuged for 30 min at 4 
ʿC and 14000 rpm, the supernatant 
was  removed  and  the  pellet  was  washed  using  100  μl  of  70%  ethanol.  The  mixture  was 
centrifuged (10 min at 14000 rpm), the supernatant was removed and the pellet was left to dry. 
Later it was dissolved in 10 μl RNase-free water, placed for 2 min in a heating block at 70 
ʿC 
and afterwards for 2 min on ice. 
  In  vitro  transcription  reaction:  The  mMESSAGE  mMACHINE  Kit  (Ambion)  must 
correspond  to  the  specific  type  of  RNA  polymerase  (SP6;  Figure  2.1)  according  to  the 
promoter  site  upstream  of  the  sequence  to  be  transcribed.  The  procedure  was  done  in  an 
RNase-free environment and the enzymes were kept at -20 
ʿC or in a cooler while assembling 
the reaction: the reagents (10x reaction buffer, 2x NTP/CAP ribonucleotides and RNase-free 
water) were thawed and centrifuged until being completely in solution; the ribonucleotides 
were  kept  on  ice  and  the  10x  reaction  buffer  at  room  temperature  while  assembling  the 
reaction. All the reagents were added in the following order, in RNase-free tubes: 2 μl of 10x 
reaction buffer, 10 μl of 2x NTP/CAP, linearized DNA template corresponding to 1 μg, 2 μl of 
10x enzyme mix and RNase-free water for a total volume of 20 μl; the sample was centrifuged 
and  incubated  for  2-3  hours  at  37 
ʿC.  For  removal  of  the  DNA  template  the  sample  was 
centrifuged for 10 s and 1 μl of RNase-free DNase 1 (2 U/μl) was added; the mixture was 
incubated for 15 min at 37 
ʿC and then left on ice. 65 
 
  Recovery of the RNA: The MEGAclear Kit (Ambion) is developed for purification of RNA 
from high yield transcription reactions by removing nucleotides, oligonucleotides, proteins and 
salts from the RNA samples. An RNase-free environment is again essential for preserving the 
quality of the RNA. The procedure was done by following the protocol provided with the kit. 
The cRNA samples were stored at -80 
ʿC. 
  RNA  electrophoresis:  The  cRNA  samples,  including  also  a  0.24–9.5  kb  RNA  ladder 
(Invitrogen, UK), were diluted in a 1:1 ratio with Glyoxal sample loading dye (Ambion) and 
incubated for ~30 min at 50 °C. The sample was loaded on a 1% agarose gel made from 1x Gel 
Prep/Running buffer (NorthernMax-Gly, Ambion), separated at 110 V for ~1 hour and the 
RNA band was visualized by UV transillumination. The lack of degradation is a sign of good 
cRNA quality.  
 
2.4.4 Mammalian cell culture (HEK293 cells) 
The old medium was removed from the flask and cells were washed with Hanks‟ balanced salt 
solution (HBSS; Invitrogen, UK) and were detached from the bottom of the flask after brief 
exposure  (40-50  s)  to  trypsin  (1  ml  for  a  25  cm
2  flask  of  ~70%  confluence).  Cells  were 
collected  in  supplemented  DMEM  (4  ml),  centrifuged  at  1000  rpm  for  2-4  min  and 
resuspended in 5 ml of DMEM. This step was performed in order to remove any remaining 
trypsin from the culturing medium. A small quantity of the cell suspension was then transferred 
into  a  new  flask  containing  DMEM,  in  the  required  dilution.  The  procedure  was  always 
performed under sterile conditions to avoid contamination; cells were passaged every 2-3 days 
and up to ~30 times.  
 
2.5 Appendix B (calculations-data analysis) 
 
2.5.1 Response rundown calculation  
As previously mentioned, the concentration-response curves obtained from oocytes or HEK293 
cells were corrected for response rundown. A standard concentration of glycine (~EC20-EC30) 
was applied at the start of each experiment and then after every third response (1
st, 4
th, 7
th, 10
th 
application etc). The responses to be used in the concentration-response curve (2
nd and 3
rd, 5
th 
and 6
th, 8
th and 9
th application etc) were therefore bracketed by two applications of standard. 
For the rundown calculation the response to each standard concentration was recorded and 66 
 
expressed  as  a  percentage  (correction  factor,  X)  of  the  response  to  the  first  standard.  For 
example: 
Current from 1
st standard = 165 nA which is considered as a 100% response 
Current from 3
rd standard = 155 nA which represents 93.9% of the initial response. 
 
The correction factor for all standard applications was calculated and used in the following 
equations in order to correct for rundown for the concentrations applied between standards: 
IC = IR x 100 / [X1 – (X1–X2)/3]   (eq.1)  for the first data point following a standard and 
IC = IR x 100 / [X1 – 2(X1–X2)/3]  (eq.2)  for the second data point following a standard.  
IR represents the recorded current response to a given concentration and IC the current after the 
correction of the same response for rundown; X1 and X2 are the correction factors for the 
standards  before  and  after  the  application  of  two  data  point  concentrations  of  glycine, 
respectively.  These  equations  assume  that  the  degree  of  rundown  is  linear  between  two 
standard applications.  
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3.1 Stoichiometry of α1β GlyRs in Xenopus oocytes – 9΄ mutations 
 
3.1.1 Knowledge concerning the stoichiometry of heteromeric GlyRs 
As mentioned previously, in the pLGIC family the functional agonist binding sites are located 
in the interfaces between ʱ and non-ʱ subunits (Brejc et al., 2001; Unwin, 2005). Because of 
that, knowing how many copies of the ʱ subunit are in the heteromer pentamer is useful, as it 
sets the upper limit for the number of binding sites. 
 
Several  biochemical  and  electrophysiological  studies  have  addressed  the  question  of 
stoichiometry for many subtypes of LGICs, either in native tissues or in recombinant systems 
(Anand et al., 1991; Boorman et al., 2000; Chang et al., 1996; Cooper et al., 1991; Plazas et 
al., 2005a, b; for reviews see Gotti and Clementi, 2004; Karlin, 2002; Sieghart et al., 1999). 
The stoichiometry of heteromeric GlyRs remains a puzzle. Other channels in this superfamily, 
such as the muscle nicotinic and GABA receptors contain two copies of the main binding 
subunit (ʱ-like) and therefore are thought to contain two ligand binding sites. In contrast to 
that, the long-held view for GlyRs is that they have a stoichiometry of 3ʱ:2β. Evidence for this 
first came from the cross-linking experiments of Langosch and colleagues, performed on the 
purified native receptor from the spinal cord (Langosch et al., 1988). Chemical cross-linking 
with reagents of different lengths and specificities revealed products of up to 260 kDa that 
contained the 48 kDa (ʱ1) and 58 kDa subunits (β) in varying ratios. The 260 kDa product (5 
times the mean subunit size) corresponds to a subunit pentamer. The 48 kDa/58 kDa ratio 
(determined by densitometry of silver-stained NaDodSO /polyacrylamide gels) was compatible 
with a stoichiometry of either 3ʱ:2β or 4ʱ:1β. The first was considered to be more plausible 
since one intermediate of lower molecular weight was identified as a β-β dimer, indicating the 
presence of at least two copies of the β subunit (Langosch et al., 1988).  
 
An indirect confirmation of the 3ʱ:2β stoichiometry was also given by Kuhse and coworkers 
while studying the “assembly boxes” that determine the formation of heteromers (Kuhse et al., 
1993; see section 1.2.7ii). As one of their tools, the authors use chimeric ʱ/β subunits that can 
only  assemble  into  heteromeric  receptors,  hence  behaving  like  wild-type  β  subunits.  Co-
expression in oocytes of the ʱ1/β chimeric subunit with the ʱ2 subunit that contains a reporter 
mutation (ʱ2
G167L + ʱ1/β chimera combination) showed that the effects of the mutation were 
stronger  than  those  of  a  ʱ2
G167L/β  +  ʱ1  combination,  indicating  that  more  copies  of  the 69 
 
mutation are present in the receptor in the first case (Kuhse et al., 1993). This is consistent with 
a  stoichiometry  of  3ʱ:2β  for  the  heteromers,  in  agreement  with  Langosch  and  coworkers 
(1988). The argument however is dependent on the linear behavior of the reporter mutation 
(the effect of the mutation being proportional to the number of subunits that carry it in the 
receptor) and also on the lack of homomeric ʱ2
G167L contamination. Equally, the method relies 
on the appropriate behaviour of the chimeric subunit (i.e. that the transferred assembly cassette 
does not decrease the effects of the mutation). 
 
An alternative approach to determine the stoichiometry of heteromeric GlyRs was used in my 
laboratory in human embryonic kidney cells (HEK293, Burzomato et al., 2003). This used a 
reporter mutation (a hydrophilic substitution of the 9΄ leucine residue in the TM2; Figure 3.1A) 
that is known to produce a leftward shift in the agonist concentration-response curve for all 
pLGICs tested so far (for examples see Boorman et al., 2000; Chang et al., 1996; Filatov and 
White, 1995; Groot-Kormelink et al., 1998; Labarca et al., 1995). Co-expression of a mutated 
ʱ1 or β subunit with wild-type β or ʱ1 subunit, respectively, resulted in a greater shift of the 
glycine  concentration-response  curve  when  the  ʱ1  subunit  was  mutated.  The  simplest 
explanation of this is that more copies of the ʱ1 subunit are incorporated into the pentamer, 
being in favour of the previously suggested stoichiometry of 3ʱ:2β (Burzomato et al., 2003).  
 
Despite  of  the  evidence  presented  so  far,  there  still  remains  some  uncertainty  concerning 
stoichiometry. A more recent paper (Grudzinska et al., 2005) favors a subunit ratio of 2ʱ:3β on 
the basis of results from tandem ʱ1_β constructs in Xenopus oocytes and of metabolic labeling 
of oocyte ʱ1β GlyRs with [
35S]-methionine (Grudzinska et al., 2005). Two explanations can be 
given for the inconsistency between this study and those arguing a 3ʱ:2β stoichiometry. Firstly, 
it is possible that tandem subunits do not incorporate efficiently into the receptor product. A 
similar problem was seen with tandem constructs for neuronal nicotinic receptors indicating 
that concatemeric dimers or trimers should not be considered as reliable tools for studying the 
stoichiometry of a recombinant receptor (Groot-Kormelink et al., 2004; see also Nicke et al., 
2003).  Secondly,  even  if  tandems  assemble  correctly,  it  is  very  likely  that  the  oocyte 
expression system differs from HEK293 cells in the way heteromeric glycine receptors are 
formed. This argument could reconcile the results of Grudzinska et al. (2005) from the [
35S]-
methionine labeling experiments, that argue for a 2ʱ:3β stoichiometry, with the results from 
HEK293 cells that are in favor of a 3ʱ:2β assembly (Burzomato et al., 2003).  70 
 
3.1.2 Aim 
For clarifying the above argument I tested in Xenopus oocytes the same experimental approach 
that Burzomato et al., (2003) followed in HEK293 cells. I therefore expressed 9΄ mutant ʱ1β 
GlyRs  in  oocytes,  with  the mutation being present  either on the  ʱ1 or the  β subunit,  and 
compared their glycine sensitivity with that of wild-type channels. Simply, if the GlyR channel 
has a stoichiometry of 3ʱ1:2β then a 9΄ mutation on the ʱ1 subunit will cause a greater effect 
compared  with  inserting  the  mutation  on  the  β  subunit.  The  opposite  should  occur  if  the 
stoichiometry is 2ʱ1:3β. The idea of this approach is driven from the fact that, according to 
Unwin‟s model for the channel pore, the 9΄ leucine residue takes part in the hydrophobic girdle 
that keeps the channel closed. In agreement with this model, substitution of the conserved 
hydrophobic 9΄ leucine (Figure 3.1A) with a hydrophilic residue (serine, S or threonine, T; 
Figure  3.1B)  causes  an  increase  in  agonist  sensitivity  and  a  decrease  in  the  agonist  EC50. 
Apparently, the disruption of the hydrophobic girdle by a polar residue makes the channel 
easier to open. This has been well demonstrated for the muscle AChR (Filatov and White, 
1995; Labarca et al., 1995), for neuronal nicotinic receptors (Boorman et al., 2000; Groot-
Kormelink et al., 1998; Revah et al., 1991), for GABA receptors (Chang and Weiss, 1998) and 
more recently for GlyRs (Burzomato et al., 2003). In all the above studies, each substitution of 
a 9΄ leucine caused an equivalent leftward shift in EC50. The magnitude of this decrease is 
independent of which subunit carries the mutation and the total shift is proportional to the 
number of mutated subunits that form the receptor (Figure 3.1C). For the muscle nicotinic 
receptor (Labarca et al., 1995) each mutation caused a ~10 fold increase in agonist sensitivity. 
As well as an increase in agonist sensitivity, 9΄ mutations have also been related to a decrease 
in the rate of desensitization (Revah et al., 1991; Yakel et al., 1993) and an increase in the 
number of spontaneous openings (Chang and Weiss, 1998). The magnitude of these effects is, 
in most cases examined, proportional to the number of mutations, though saturation might 
occur if 3 or more copies of the mutation are present (Chang and Weiss, 1998, 1999; Plazas et 
al., 2005a).  
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Figure 3.1  The reporter mutation approach at position 9΄ 
A, Sequence alignment of the pore-lining TM2 domain for the different LGIC subunits. Note 
the  conservation  of  the  9΄  Leu  (shown  in  the  box)  throughout  the  superfamily.  Charged 
residues are highlighted in yellow (negative charge) and blue (positive charge). B, Structure of 
the amino-acid side-chains of threonine and serine used for the hydrophobic-to-hydrophilic 
mutation of 9΄ leucine. C, Schematic representation of the effects of the reporter 9΄LT mutation 
in a pLGIC (only three subunits are shown here). According to Unwin‟s model for the closed 
pore, hydrophobic interactions between the five leucines and surrounding residues (not shown) 
keep the channel closed. The introduction of a hydrophilic threonine disturbs the hydrophobic 
girdle, causing an increase in agonist sensitivity. This effect is proportional to the number of 
mutations inserted in the pentamer and is independent of subunit subtype.  
 
 
The  progressive  effect  of  9΄  mutations  in  the  agonist  EC50  has  proven  very  useful  for 
stoichiometry studies of the nicotinic superfamily. Besides the Burzomato et al. (2003) study 
on GlyRs, which will be repeated here in oocytes, Boorman and co-workers used 9΄ mutations 
on  ʱ3β4β3  neuronal  nAChRs  in  Xenopus  oocytes  and  came  up  with  a  stoichiometry  of 
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2ʱ3:2β4:1β3  for  the  triplet  (Boorman  et  al.,  2000),  Chang  and  colleagues  deciphered  the 
stoichiometry of ʱ1β2γ2 GABAA receptors to being 2:2:1 (Chang et al., 1996) and finally 
Plazas  used  9΄,  13΄  and  17΄  mutations  in  ʱ9ʱ10  receptors  in  oocytes  and  suggested  a 
stoichiometry of 2ʱ9:3ʱ10 (Plazas et al., 2005a, b). 
 
3.1.3 Expression of heteromeric GlyRs in Xenopus laevis oocytes – Picrotoxin test 
The first aim was to confirm that, in oocytes, most of the GlyRs expressed after co-injection of 
ʱ1 and β cRNA are ʱ1β heteromers. In order to do this, I tested the sensitivity of the receptors 
to the channel blocker picrotoxin (PTX). As mentioned previously (section 1.2.7), this alkaloid 
is a standard pharmacological tool for the discrimination between homomeric and heteromeric 
GlyRs,  with  homomers  being  much  more  sensitive  to  PTX  inhibition  than  ʱβ  heteromers 
(Pribilla et al., 1992). Oocytes were therefore injected with ʱ1+β GlyR subunit cRNA (1:40 
ratio) and I compared concentration-inhibition curves to PTX with those obtained in oocytes 
expressing ʱ1 homomeric receptors alone.  
 
An example of the effect of PTX on homomeric and heteromeric receptors is shown in Figure 
3.2. Homomeric receptors are clearly more sensitive to the blocker as shown by the traces in A: 
the current elicited by the application of 100 μM glycine (approximately EC50 for ʱ1 and for 
ʱ1β) on the homomer (top row) was clearly reduced by PTX concentrations greater than 0.5 
μM and almost completely abolished by 100 μM PTX (from 335 nA to 3 nA). The same PTX 
concentrations caused a smaller reduction in glycine currents elicited in oocytes injected with 
ʱ1+β  (bottom  row).  Concentration-response  curves  from all experiments,  fitted to  the Hill 
equation, are shown in Figure 3.2B. As expected, the IC50 for homomeric receptors was very 
low, indicating their high sensitivity to picrotoxin, in agreement with Pribilla et al., (1992); the 
average IC50 from four cells injected with ʱ1+β was ~18-fold higher, suggesting the expression 
of ʱ1β heteromers. The Hill slope coefficient was similar for both combinations and close to 
unity (Table 3.1).  
 
Figure 3.2 and Table 3.1 summarise results from four oocytes that, when injected with ʱ1+β 
cRNA, expressed heteromeric channels. Unexpectedly, two other oocytes (from a total of 6 
cells) injected with the 1:40 subunit ratio (ʱ1:β) gave a low picrotoxin IC50 (1.8 μΜ and 6.3 
μM)  when  fitted  with  a  single-component  Hill  equation,  as  if  they  were  not  expressing 
heteromeric receptors at all. In order to estimate the extent of homomeric contamination in 73 
 
oocytes  injected  with  ʱ1+β,  each  of  the  remaining  4  experiments  was  refitted  to  a  two-
component Hill equation. I first fitted the data leaving all parameters free. In every experiment 
these fits were poorly defined. As a second step, I refitted the data by constraining the IC50 of 
the first component to be that of homomers and the two nH to be equal 1. These fits were also 
poorly  defined.  The  above  would  suggest  that  the  ʱ1  homomeric  component  is  not  large 
enough to be detected during a macroscopic experiment; for this reason I continued using the 
1:40 ratio, for the expression of a predominant heteromeric receptor population that contributes 
to most of the agonist current.   
 
Table  3.1    Mean  concentration-inhibition  curve  parameters  ±  SEM  obtained  from  one 
component Hill equation fits from oocytes injected with ʱ1 or ʱ1+β subunit cRNA. 
 
Student‟s two-tailed t test: 
  p < 0.001 
 
 
3.1.4 Expression of L9΄T mutant α1β GlyRs in oocytes  
In  order  to  test  the  effects  of  the  9΄  LT  mutation  on  the  sensitivity  of  oocyte-expressed 
receptors, cells were injected with different subunit combinations (ʱ1+β
LT, ʱ1
LT+β, ʱ1
LT+β
LT 
or ʱ1
LT alone; 1:40 subunit ratio of ʱ1 to β; see Methods) to obtain concentration-response 
curves  to  glycine.  It  was  not  possible  to  measure  currents  from  the  ʱ1
LT  and  ʱ1
LT+β
LT 
combinations, as  these  oocytes  appeared unhealthy, with an increased  holding current  that 
made voltage clamp difficult when the electrodes were inserted (this current is likely to arise 
from spontaneous openings of the all-mutant channels, see Chang and Weiss, 1998).  
 
Representative responses to a range of glycine concentrations for the mutant and wild-type 
combinations are shown in Figure 3.3A. From the traces it is clear that the glycine sensitivity of 
either mutant is similar and does not differ much from the wild-type channels. This is more 
evident when all data are fitted to the Hill equation and the curve parameters are obtained from 
the fits (Figure 3.3B, Table 3.2). 
 
  IC50 (µM) 
*  nH
  Imax (nA)  N 
α1  5.3 ± 2.7  1.4 ± 0.4  340.2 ± 33.5  3 
α1+β (1:40)  90.6 ± 17.4  0.9 ± 0.1  322.3 ± 69.6  4 74 
 
 
 
Figure 3.2  Picrotoxin sensitivity of oocyte-expressed receptors 
A, Inward currents elicited by the co-application of a standard glycine concentration (100 µM; 
EC50 concentration of ʱ1 GlyRs) with increasing concentrations of PTX to oocytes held at -70 
mV.  PTX  concentrations  are  indicated  above  the  traces;  bars  show  the  duration  of  each 
application.  B,  Pooled  concentration-inhibition  curves  for  homomeric  and  heteromeric 
receptors,  taken  from  fitting  the  mean  normalized  responses  with  a  one-component  Hill 
equation. Note the higher sensitivity of homomeric receptors for PTX. 
 
 
The average EC50 for ʱ1β receptors was 81.5 ± 3.6 μΜ and only a very small reduction in EC50 
was observed for the mutant receptors (61.7 ± 13.1 μΜ for ʱ1β
LT and 50.1 ± 9.1 μΜ for ʱ1
LTβ). 
This reduction was too small and inconsistent to reach statistical significance (p > 0.05 for both 
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mutant combinations compared with wild-type). This result is completely different from that of 
Burzomato et al. (2003) in HEK293 cells. 
 
Given this lack of effect of co-expression of mutant subunits, it is reasonable to ask whether 
the mutant subunits incorporate into the receptor at all, particularly in the case of the β subunit 
(glycine receptors need ʱ subunits to be functional). In other words, could the concentration-
response curve of ʱ1+β
LT be so similar to that of ʱ1+β because both are mainly due to the 
activity of the homomer ʱ1? As seen from the plots in Figure 3.3B, mutant receptors have an 
obvious reduction in the Hill slope (Table 3.2) and this is statistically significant. Also, if β 
incorporates  poorly,  ʱ1
LT+β  receptors  would  also  be  mainly  homomers,  and  they  would 
contain  5  copies  of  the  mutation,  so  this  does  not  explain  the  small  change  seen  for  the 
mutation. It is also to be noted that the maximum current elicited by glycine was somewhat 
lower for the mutant combinations (p < 0.001). These were indications that the mutant subunits 
take part in the receptors and that the presence of the mutation does cause some effect in 
receptor properties. Despite this however, no obvious differences exist between receptors with 
the ʱ1 subunit mutated and those with the β mutated (p > 0.05). Hence these results cannot be 
interpreted in terms of stoichiometry, as done previously for HEK293 cells. 
 
An explanation for these findings is that oocyte-expressed heteromeric receptors are a mixture 
of  pentamers  containing  two  and  three  alpha  subunits.  This  would  explain  why  the 
concentration-response  curves  for  the  mutants  are  so  similar,  irrespective  of  whether  the 
mutation is in ʱ1 or β, as effectively the receptor has on average 2.5 mutations in both cases. 
 
Table 3.2  Mean concentration-response curve parameters ± SEM from separate fits of wild-
type and L9΄T mutation data, fitted with the Hill equation. 
 
 Bonferroni‟s multiple comparison tests:  
*    p > 0.05 for ʱ1β-ʱ1β
LT, ʱ1β-ʱ1
LTβ and ʱ1β
LT-ʱ1
LTβ 
**  p < 0.01 for ʱ1β-ʱ1β
LT; p < 0.001 for ʱ1β-ʱ1
LTβ; p > 0.05 for ʱ1β
LT-ʱ1
LTβ  
***   p < 0.001 for ʱ1β-ʱ1β
LT and ʱ1β-ʱ1
LTβ; p > 0.05 for ʱ1β
LT-ʱ1
LTβ  
 
  EC50 (µM) 
*  nH 
**  Imax (nA) 
***  N 
α1+β  81.5 ± 3.6  2.7 ± 0.3  717.0 ± 73.6  5 
α1+β
LT  61.7 ± 13.1  1.6 ± 0.1  346.5 ± 49.7  7 
α1
LT+β  50.1 ± 9.1  1.1 ± 0.1  203.9 ± 41.0  5 76 
 
 
Figure 3.3  Effects of the L9΄T mutation on oocyte-expressed receptors  
A, Glycine responses from oocytes expressing wild-type and mutant receptors (-70 mV). The 
mutation causes a decrease in the current produced by different glycine concentrations (shown 
above  the  traces,  in  μM).  The  bars  show  the  duration  of  each  application.  B,  Average 
concentration-response  curves,  pooled  to  their  fitted  maxima  for  each  combination.  The 
mutation causes little decrease in the agonist EC50 (p = 0.18). The mutated receptors have a 
lower Hill slope compared with wild-type ʱ1β but the difference between the two mutants is 
insignificant (p > 0.05).   
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3.1.5 Expression of L9΄S mutant α1β GlyRs in oocytes 
Due to the L9΄T results being inconclusive, I made a further attempt and chose a different 
mutation (leucine, L to serine, S) at the same position. It has previously been shown that the L 
to S substitution has a greater effect in this position, compared with L to T (Chang and Weiss, 
1998). The same approach of co-expressing L9΄S mutant with wild-type subunits (1:40 ratio of 
ʱ1:β) in oocytes was therefore used in order to compare mutant and wild-type concentration-
response  curves  (Table  2.1,  Methods).  Again,  it  was  impossible  to  record  from  oocytes 
expressing ʱ1
LSβ
LS receptors (the total holding current was more than 1 µA in all the cells 
tested). However, as seen from the traces in Figure 3.4A, I was able to record glycine responses 
from ʱ1
LS receptors, though in this case the size of the responses was very much smaller (note 
the different scale for ʱ1
LS traces). The sensitivity of this combination for glycine was ~30-fold 
higher than that of wild-type homomeric receptors with an EC50 value of 2.9 ± 0.7 μΜ (Table 
3.3A). I was only able to record from 3 cells due to the increased vulnerability and low glycine-
evoked current of this combination, indicative of high spontaneous activity of the all-mutant 
pentamers. The pooled data from the 3 cells, normalized to the maxima, are shown in Figure 
3.4B, alongside data from wild-type ʱ1 GlyRs for comparison.  
 
As in the case of the L9΄T, the glycine sensitivity of the two mutant heteromeric combinations 
was similar to wild-type ʱ1β receptors with glycine EC50 of 81.2 ± 3.3 μΜ and 112.7 ± 10.0 
μΜ for ʱ1β
LS and ʱ1
LSβ respectively (Figure 3.5A). Similarly, the effect of the mutation was 
apparent only as a Hill slope decrease, at least in the case of the ʱ1
LSβ combination (Figure 
3.5B; Table 3.3B).    
 
The  data  from  the  ʱ1+β
LS  combination  question  whether  the  mutant  subunits  actually 
incorporate  to  form  heteromers.  Receptors  from  these  cells  have  EC50  and  nH  values  very 
similar to those of wild-type ʱ1 GlyRs (Table 3.3). Similarly, application of PTX to ʱ1+β
LS 
oocytes gave an IC50 of 7.42 ± 3.39 (n = 3) indicating a high sensitivity, as in the case of 
homomers (data not shown). Even if we assume, however, that β
LS fails to incorporate, this 
does not explain why ʱ1
LSβ receptors do not have an EC50 intermediate between that of ʱ1β 
and ʱ1
LS receptors. 
 
 
 78 
 
 
 
Figure 3.4  Effects of the L9΄S mutation on homomeric GlyRs 
A, The traces are inward currents elicited by the application of glycine (in μΜ) to oocytes (held 
at -70 mV) expressing wild-type and ʱ1
LS receptors. Note the different scale for currents from 
ʱ1
LS-expressing oocytes. B, Average, normalized glycine responses, fitted to the Hill equation 
and pooled to their fitted maxima for the two receptor combinations.  
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Figure 3.5  Effects of the L9΄S mutation on heteromeric GlyRs 
A, Glycine responses recorded from wild-type and mutant heteromeric receptors. The glycine 
concentrations above the traces are in μΜ. All cells were held at -70 mV. Note the reduction in 
the current from ʱ1
LSβ receptors. B, Average, normalized glycine responses, fitted to the Hill 
equation and pooled to their fitted maxima for each receptor combination. The β
LS mutation did 
not cause any obvious effect on the expressed receptors.  
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Table 3.3  Mean concentration-response curve parameters ± SEM from oocytes expressing 
wild-type and L9΄S mutant receptors, fitted with a single-component Hill equation 
 
A: Students‟ t test:  B: Bonferroni‟s multiple comparison tests:  
*  p < 0.0001  p > 0.05 for ʱ1β-ʱ1β
LS; p < 0.01 for ʱ1β-ʱ1
LSβ and ʱ1β
LS-ʱ1
LSβ 
**  p = 0.0004  p> 0.05 for ʱ1β-ʱ1β
LS; p < 0.05 for ʱ1β-ʱ1
LSβ; p < 0.01 for ʱ1β
LS-ʱ1
LSβ 
***  p = 0.001  p < 0.01 for ʱ1β-ʱ1β
LS; p < 0.001 for ʱ1β-ʱ1
LSβ; p > 0.05 for ʱ1β
LS-ʱ1
LSβ 
 
 
To summarize, both the 9΄LT and the 9΄LS mutation did not produce the expected results in 
oocytes: in both cases the agonist sensitivity of heteromeric mutant receptors does not differ 
much  from  the  wild-type  heteromer  despite  the  fact  that  the  incorporation  into  functional 
channels is evident (as a reduction in the Hill coefficient values for all mutant combinations, 
except the ʱ1β
LS). This is different to what has seen in HEK293 cells for the GlyR (Burzomato 
et  al.,  2003)  and  also  for  other  pLGICs.  As  a  result  I  could  not  come  to  any  conclusion 
concerning the stoichiometry of ʱ1β channels in oocytes with this approach and hence had to 
resort to an alternative method.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  EC50 (μM)
 *  nH
 **  Imax (nA)
 *** 
 
N 
A  α1  101.1 ± 3.8  3.31 ± 0.24  704.58 ± 86.11  5 
 
α1
LS  2.9 ± 0.7  0.79 ± 0.17  23.88 ± 6.76 
 
3 
B  α1+β
  81.5 ± 3.6  2.7 ± 0.29  717.03 ± 73.60 
 
5 
 
α1+β
LS  81.2 ± 3.3  3.07 ± 0.23  408.64 ± 52.73 
 
7 
 
α1
LS+β   112.7 ± 10.0  1.56 ± 0.23  274.08 ± 22.02 
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3.2 Stoichiometry of α1β GlyRs – conductance mutations 
 
3.2.1 Single-channel conductance of GlyRs 
Two  different  domains  have  been  shown  to  determine  the  single-channel  conductance  of 
nicotinic and 5-HT3 channels (Peters et al., 2006). One is the TM2 domain: this is known to be 
the  main  determinant  of  both  conductance  and  ion  selectivity  in  this  receptor  superfamily 
(Cohen et al., 1992a, b; Imoto et al., 1991; Labarca et al., 1995; Villarroel et al., 1991; see 
section 1.2.7.i). The second domain was originally identified in the cytoplasmic loop of 5-HT3 
channels, in a region that contains three conserved arginine residues in the 5-HT3A subunit 
(R432,  R436  and  R440).  These  are  partly  responsible  for  the  difference  in  conductance 
between homomeric 5-HT3A and heteromeric 5-HT3AB channels: mutations at these residues 
lead to a ~28 fold increase in single-channel conductance for the triple mutant (Davies et al., 
1999; Kelley et al., 2003; Peters et al., 2004 and 2005). This latter region, within the MA 
stretch,  was  recently  shown  to  control  the  ionic  conductance  of  ʱ1  homomeric  glycine 
receptors, suggesting that the portals for ions accessing the channel from the cytoplasm are 
similar in cationic and anionic pLGICs (Carland et al., 2009; Hales et al., 2006).  
 
Extensive single-channel work on GlyRs has shown that the incorporation of the β subunit into 
heteromers  leads  to  channels  with  approximately  half  the  single-channel  conductance  of 
homomers. The residues that determine this difference in conductance were localized to the 
TM2 domain: expression of subunits with mutations in this domain was shown to alter the 
single-channel  conductance  of  both  homomeric  and  heteromeric  glycine  channels,  in 
agreement  with  this  region  being the major determinant  of single-channel  conductance  for 
glycine receptors (Bormann et al., 1993; Carland et al., 2009). Surprisingly, in the case of 
GlyRs, the number of different conductance levels that can be observed in a patch depends on 
the recording configuration. Cell-attached studies report the presence of only one conductance 
level, irrespective of receptor subtype (for examples see Beato et al., 2004; Beato and Sivilotti, 
2007;  Burzomato  et  al.,  2004).  The  situation  gets  more  complicated  when  recordings  are 
performed  in  a  cell-free  configuration  (i.e.  excised  patch)  where  GlyR  channels  open  at 
different conductance levels. This was shown both for native (Bormann et al., 1987; Takahashi 
and Momiyama, 1991; Twyman and MacDonald, 1991) and for recombinant GlyRs (Beato et 
al., 2002; Bormann et al., 1993). A detailed outside-out study on HEK293 cells reported five 
different conductance states for ʱ1 GlyRs (ranging from 20-90 pS), six states for ʱ2 and ʱ3 82 
 
GlyRs and 2-3 states for heteromeric channels (Bormann et al., 1993). The reasons underlying 
the discrepancy between cell-attached and excised GlyRs are unclear though it is reasonable to 
assume that disruptions in the microenvironment of the channel, caused by the excision, may 
be relevant (see Fucile et al., 2000).    
 
3.2.2 Aim 
Given that the work with the 9΄ mutation did not allow coming to a conclusion on channel 
stoichiometry, I wanted to pursue the question of stoichiometry of ʱ1β GlyRs in oocytes using 
a  different  approach  which  involves  single-channel  recordings  from  conductance  mutants. 
Such  an  approach  has  been  used  by  Cooper  et  al.  (1991)  for  the  investigation  of  the 
stoichiometry of chick ʱ4β2 neuronal nicotinic receptors and by Béhé et al. (1995) for the 
determination of NR1 subunit copies in NMDA receptors expressed in Xenopus oocytes. The 
idea of the approach is simple: co-injection of the wild-type and the conductance mutant form 
of a given subunit leads to the expression of receptors with a mixture of wild-type, all-mutant 
and hybrid (intermediate) single-channel conductances. Based on the number of intermediate 
conductances one can determine the number of copies of the subunit in question in the receptor 
(i.e. its stoichiometry).  
 
The selection of the appropriate conductance mutation is important and as mentioned above 
both the TM2 domain and the cytoplasmic loop are good candidate regions. Bormann and co-
workers have already shown that substitution of β GlyR subunit residues within the TM2 with 
their corresponding residues in ʱ1 and transfection of this chimeric subunit (β
Ch) together with 
ʱ1 leads to the expression of ʱ1β
Ch heteromeric channels with a homomer-like conductance 
(Bormann  et  al.,  1993).  This  TM2-chimeric  subunit  is  therefore  a  good  candidate  as  a 
conductance mutant for my experiments.  
 
The steps followed are, in brief:  
i.  Construction of the rat β
Ch (β subunit containing the ʱ1 TM2, see Figure 2.3, Methods).  
ii.  Measure of the slope conductance of ʱ1 and ʱ1β GlyRs in oocytes. This was done in the 
  cell-attached configuration in order to avoid the presence of multiple conductance levels 
  for each receptor subtype. The subunit ratio of ʱ1 to β was kept to 1:40.  
iii. As a control I also injected oocytes with ʱ1+β
Ch (to confirm a homomer-like conductance 
  as Bormann et al., 1993). The subunit ratio was 1:40. 83 
 
iv. Finally, in order to determine the stoichiometry of the ʱ1β GlyR, mutant and wild-type 
  subunits were expressed together in the same cells (ʱ1+β+β
Ch). 
 
The rational for the latter is as follows: if both wild-type and mutant β subunits are expressed, 
it is likely that some receptors would incorporate them both. A mixture of different receptor 
types  would  then  be  assembled  according  to  the  stoichiometry  of  the  channel  (Table  3.4, 
second column). Each receptor type would have a different single-channel conductance. The 
total number of receptor types in a cell (i.e. the total number of different conductance levels) is 
equal to N+1 where N is the total number of the β subunits in a pentamer. Therefore, if the 
stoichiometry  is  3ʱ:2β,  3  different  conductance  levels  would  appear  (2+1)  whereas  if  the 
stoichiometry is 2ʱ:3β I would expect to see 4 different conductance levels (3+1). The single-
channel conductance of the all-wild-type and all-mutant receptor will be easily identified using 
the control injections mentioned above; the mixed receptors will give one or two intermediate 
single-channel conductances, depending on the stoichiometry (see the summary in Table 3.4).  
 
Table 3.4  Possible subunit combinations for the two presumed stoichiometries when oocytes 
are co-injected with ʱ1+β+β
Ch cRNA.  
 
 
3.2.3 Single-channel conductance of α1 and α1β GlyRs in oocytes (1:40 ratio) 
Before  proceeding  with  the  conductance  mutant,  I  needed  to  measure  the  single-channel 
conductance of wild-type receptors. Single-channel recordings from ʱ1 homomers would allow 
me to recognise homomeric openings occurring as “contaminants” (even when the extreme 
Presumed 
Stoichiometry 
Possible subunit  
combinations 
Single-channel 
conductance levels 
Conductances known 
from control injection 
 
 
ʱ-ʱ-ʱ-β-β 
 
 
3 
 
ʱ1+β 
3ʱ:2β  ʱ-ʱ-ʱ-β-β
Ch  - 
  ʱ-ʱ-ʱ-β
Ch-β
Ch  ʱ1+β
Ch 
   
ʱ-ʱ-β-β-β 
 
 
4 
 
ʱ1+β 
2ʱ:3β  ʱ-ʱ-β-β-β
Ch  - 
  ʱ-ʱ-β-β
Ch-β
Ch  - 
  ʱ-ʱ-β
Ch-β
Ch-β
Ch  ʱ1+β
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ratio of 1:40 is used) and hence exclude them from the analysis. All recordings were performed 
in the cell-attached configuration and at a range of positive holding potentials (negative pipette 
potentials; see Methods) for obtaining I/V plots and the slope conductance of each channel. A 
high glycine concentration was used (1 mM); openings therefore occurred in clusters, each 
cluster representing events from one channel only. 
 
A  representative  example  of  such  an  experiment  is  shown  in  Figure  3.6.  The  traces  are 
obtained from a cell injected with rat ʱ1 cRNA and represent continuous recordings at each 
holding potential from a single patch. Openings occur in clusters (up to ~10 s long), separated 
by long shut times likely to correspond to desensitized states of the channel. Note that although 
channel openings are downwards, the current is outward. This is due to the composition of the 
solutions and because at positive holding potentials chloride is flowing from the pipette to the 
cell.  Only  one  conductance  level  was  seen,  in  agreement  with  other  cell-attached  data  in 
HEK293 cells (Beato et al., 2004). For each patch I plotted the average amplitude at each 
holding potential and the I/V plot was fitted with a linear fit to obtain the slope conductance of 
the channel. For the experiment in Figure 3.6 the slope conductance was 72 pS. The I/V plot in 
Figure 3.6 was plotted from the average amplitude values pooled from all patches (n = 5) and 
had a slope of 68 pS. This was consistent with the average value obtained from individual fits 
to the same experiments (69 ± 1 pS; n = 5).  
 
Figure 3.7 shows the same experiment performed on an oocyte injected with  the rat ʱ1+β 
cRNA  at  a  ratio  of  1:40.  The  range  of  holding  potentials  is  the  same  used  for  the  ʱ1 
experiments  (from  0  mV  to  +60  mV).  As  before,  openings  at  this  concentration  occur  in 
clusters and only one main amplitude level is detected at each holding potential. As seen from 
the scale bar, the average amplitude of heteromeric channels, at equivalent holding potentials, 
is almost half of the amplitude of the homomeric channel in Figure 3.6 (2.1 pA and 4.6 pA 
respectively, +50 mV). This ʱ1β channel has a slope conductance of 32 pS; the average value 
from individual fits of all patches with this combination was 33 ± 2 pS (n = 5). Similarly, the 
linear fit of the pooled I/V plot in Figure 3.7 (containing the average amplitude values from all 
patches) gave a slope conductance of 32 pS. The slope conductance values for the homomeric 
(69  ±  1  pS)  and  heteromeric  (33  ±  2  pS)  channels  in  oocytes  are  consistent  with  those 
previously  reported for  cell-attached recordings from  recombinant  GlyRs  in  HEK293  cells 
(Beato et al., 2004; Burzomato et al., 2003).   85 
 
 
 
 
Figure 3.6  Slope conductance of ʱ1 GlyRs 
Continuous cell-attached recordings (4 s) of outward currents obtained at the specified holding 
potentials from an oocyte expressing ʱ1 GlyRs. Openings are downwards. All traces are from 
the same patch with 1 mM glycine in the pipette. Only one amplitude level is observed. The 
average amplitudes at each holding potential from all patches were used to give rise to the I/V 
plot  shown  below.  The  plot  was  fitted  with  a  straight  line  to  estimate  the  average  slope 
conductance for this receptor subtype.      
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Figure 3.7  Slope conductance of heteromeric ʱ1β GlyRs 
Continuous cell-attached recordings (5 s) of outward currents obtained at different holding 
potentials from a single patch on an oocyte expressing ʱ1β GlyRs (1:40) using 1 mM glycine. 
The pooled data from all patches are plotted against the holding potential and the I/V plot is 
fitted with a straight line to obtain the slope conductance for heteromeric receptors. Note that 
the conductance of these channels is half of that of homomers (compare with Figure 3.6). 
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3.2.4 Homomeric contamination of α1+β injected oocytes (1:40 ratio) 
What  the  experiments  with  wild-type  receptors  show  is  that,  as  previously  reported  by 
Bormann and colleagues,  the incorporation of the  β subunit  leads  to  ʱ1β heteromers with 
single-channel conductance which is half that of ʱ1 homomers (Bormann et al., 1993). In order 
to avoid the formation of ʱ1 homomers, oocytes were injected with ʱ1+β cRNA using an 
excess of β subunit (ratio of 1:40). Burzomato et al. (2003) showed that this ratio is sufficient 
for the expression of a predominant heteromeric population of channels in HEK293 cells: only 
1 out  of 19 cell-attached patches  had homomeric openings  when 1 mM  glycine was  used 
(Burzomato et al., 2003). The situation was very different in oocytes, as I observed homomeric 
openings in most of the patches obtained from ʱ1+β injected oocytes, despite the subunit ratio 
of 1:40. Out of the total of 9 patches (recorded from 4 different oocytes), five patches showed 
homomeric  openings.  For  two  patches  these  occurred  together  with  heteromeric  openings 
(traces in a, b and c of Figure 3.8A) whereas in the other three patches I could only observe 
homomeric openings; an example of such a recording is shown in Figure 3.8A (d).  
 
In order to confirm that the high amplitude channels correspond to homomers contaminating 
ʱ1+β  injected  cells,  I  calculated  their  slope  conductance  from  the  I/V  plots  (these  were 
obtained  in  8  out  of  the  9  patches  and  the  summary  is  shown  in  Figure  3.8B.  The  high 
amplitude channels have an average slope conductance of 64 ± 3 pS (n = 4), a value which is 
similar to what was observed for homomers from oocytes injected only with ʱ1. Importantly, 
the summary shows that ~50% of patches contain a homomeric channel, indicating that an ʱ:β  
ratio of 1:40 in oocytes is not as efficient in eliminating homomeric channels in oocytes as it is 
in HEK293 cells (Burzomato et al., 2003).  
 
3.2.5 α1β
Ch channels have a homomer-like conductance in oocytes 
After  measuring  the  slope  conductance  of  wild-type  channels  I  went  on  to  test  the  TM2-
chimeric subunit. Despite the high contamination by homomers I continued to use the 1:40 
ratio for the heteromeric combinations hoping to be able to distinguish homomeric channels if 
they appeared in a patch. First, oocytes were injected with the ʱ1+β
Ch combination (1:40) or 
the β
Ch subunit cRNA alone, and I tested their level of expression by acquiring macroscopic 
currents using TEVC recording (1 mM glycine; see Table 2.2 in Methods). This was done in 
order to check that: (1) the ʱ1+β
Ch combination gives sufficient current for single-channel 
recordings and (2) that the β
Ch subunit alone does not form functional receptors. 88 
 
 
 
Figure 3.8  Homomeric contamination in oocytes injected with ʱ1+β cRNA 
A, Cell-attached traces in which homomeric openings are detected. Currents were obtained 
with 1 mM glycine from cells injected with ʱ1+β (1:40). In the first three traces (a, b, c) the 
patches  contained  both  heteromeric  and  homomeric  channels,  the  latter  having  higher 
amplitude. The patch in d contained only homomeric openings. The traces in a and b are from 
the same patch. The summary from all experiments for this combination is shown in B.    
 
 
As expected I could not record any current from β
Ch-injected cells. On the other hand, the 
current  produced  by  ʱ1+β
Ch  cells  was  comparable  with  that  from  control  ʱ1+β
  injections 
(ranging from 100-400 nA, -70 mV; data not shown), reassuring me that I could proceed to 
single-channel recordings from this combination.  
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Cell-attached  recordings  from  ʱ1+β
Ch  oocytes  were  performed  similarly  to  the  wild-type 
combinations, using 1 mM glycine and a range of positive holding potentials to obtain I/V 
plots. An example is shown in Figure 3.9. The traces represent continuous 5 s recordings at 
each holding potential from an individual patch. At this concentration and similarly to wild-
type channels, openings occur in clusters. The behaviour of these channels is different from 
wild-type ones: as seen from the traces, at each holding potential the openings occur at more 
than  one  amplitude  levels.  These  subconductances  are  always  directly  connected  to  the 
openings of the full conductance and are therefore produced by the same channel. The main 
amplitude  of  the channel  in  Figure 3.9 gave a slope conductance of 64 pS. Similarly, the 
average from 11 patches was 65 ± 1 pS, very similar to the slope obtained by pooling all 
patches into the I/V plot in Figure 3.9 which gave a conductance of 61 pS.  
 
These values show that the main conductance of channels recorded from oocytes expressing 
the ʱ1+β
Ch combination is similar to that of homomers. Considering that in oocytes injected 
with  ʱ1+β  there  was  ~50%  contamination  by  homomers,  there  is  the  possibility  that  the 
patches recorded from ʱ1+β
Ch oocytes have channels that are mostly, or only, ʱ1 homomers. In 
at least 6 out of the 11 patches however it is obvious that the β
Ch subunit is indeed incorporated 
into functional ʱ1β
Ch heteromers: channels from these patches have a very long duration of 
clusters (more than 40 s) and the openings occur at more than one amplitude levels. These 
characteristics do not appear in ʱ1-injected cells (see Figure 3.6). I was therefore confident that 
at least in these six 6 patches I have been recording from ʱ1β
Ch heteromers. The average slope 
conductance for these was 62 ± 1 pS; these data are consistent with data from HEK293 cells 
where this chimeric combination was first tested (Bormann et al., 1993). 
 
3.2.5 The α1+β+β
Ch combination gives a mixture of single-channel conductances  
After  confirming  the  formation  of  ʱ1β
Ch  channels  with  a  2-fold  difference  in  the  slope 
conductance compared with ʱ1β, I went on to co-inject both wild-type and mutant β subunits 
in the same cells. This difference of ~30 pS, between the all-mutant (ʱ1β
Ch) and the wild-type 
channels  (ʱ1β),  should  be  enough  for  recognising  one,  or  two,  intermediate  conductances, 
which would mean a 3ʱ:2β or a 2ʱ:3β stoichiometry of ʱ1β GlyRs, respectively (Table 3.4). 
Oocytes  were injected  with  the  ʱ1+β+β
Ch  combination and  I  recorded single channels. As 
before, recordings were performed in the cell-attached configuration and at positive holding 
potentials to obtain I/V plots. The pipette contained 1 mM glycine.  90 
 
 
 
Figure 3.9  Properties of ʱ1β
Ch channels in oocytes  
Cell-attached  recordings  (5  s  sweeps)  from  oocytes  injected  with  the  ʱ1+β
Ch  combination 
(1:40). All traces are from the same patch, held at the specified potentials, with 1 mM glycine 
in the pipette. With this combination openings occur at multiple conductance levels with direct 
links  to  the  highest  amplitude  level.  A  maximum  of  two  sublevels  are  detected  for  all 
concentrations. The highest (main) amplitudes at each potential were pooled for all patches to 
obtain  the  I/V  plot  at  the  bottom.  The  linear  fit  of  the  plot  gave  a  homomer-like  slope 
conductance.      
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As  expected,  this  combination  expressed  channels  that  differed  in  their  single-channel 
conductance. Figure 3.10 shows an example of a cell from which I was able to record openings 
at two different amplitude levels in the same patch. There are never direct transitions between 
the two levels suggesting that the openings derive from two different channels. Confirming 
this, the points of the average amplitude at each holding potential, for this patch, can be fitted 
with two linear fits, giving the I/V plot below the trace. The slopes correspond to conductances 
of 67.5 pS for the high-amplitude points and 45.7 pS for the low-amplitude points. The high-
conductance channel is likely to be a ʱ1 GlyR homomer since it does not appear to have the 
features of the ʱ1β
Ch heteromers mentioned before.  
 
 
Figure 3.10  Mixture of conductances with the ʱ1+β+β
Ch combination 
Example  of  a  cell-attached  patch  in  which  two  channels  with  different  conductances  are 
detected, obtained from an oocyte injected with the above combination. Glycine was 1 mM. 
The patch was held at different holding potentials and the fits to the I/V plots for the two 
channels are shown below.  
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Figure 3.11A shows a summary of all the patches obtained with the ʱ1+β+β
Ch combination, 
comparing the channels‟ slope conductance with that of channels in the control experiments.  
With this combination I expected to see at least one group of channels with an intermediate 
single-channel conductance between the homomer-like ʱ1β
Ch (62 ± 1 pS) and the wild-type 
ʱ1β conductance (33 ± 2 pS). A total of 10 different patches were obtained, out of which: one 
patch (#30) had two different channels (with two different conductances, see Figure 3.10) and 
three other patches (#25, 27 and 34) had only one type of channel whose properties suggested 
that they were ʱ1β
Ch heteromers (i.e. homomer-like conductance, with sublevels (66 ± 2 pS). 
The remaining 7 patches had only one conductance, clearly lower than the homomer level. If 
considered as one group, these 7 patches (#26, 28, 29, 30, 31, 32 and 33) have channels with a 
mean slope conductance of 41 ± 2 pS. This average value is higher than the highest-conducting 
ʱ1β channel (dash line in Figure 3.11; p = 0.016). This difference of ~7 pS however, is not big 
enough to allow us to group these channels as separate from ʱ1β channels. 
 
In other words, based on these 7 patches alone, I cannot conclude on the presence of channels 
with  an intermediate conductance. More patches  are needed in  order to clarify how many 
classes there are in this group. Unfortunately, the ʱ1+β+β
Ch combination resulted in a low yield 
of  recordings.  As  shown  in  Figure  3.11B,  the  vast  majority  of  the  cell-attached  patches  I 
obtained had no channel activity and only 10 patches out of approximately 700 had some 
detectable channel openings. These were results from 6 different oocyte batches. I therefore 
tested a lower concentration of glycine (50 μΜ) in order to eliminate the possibility that the 
lack  of  channel  activation  is  a  result  of  intense  desensitization  of  the  channels  at  1  mM. 
Decreasing the agonist concentration however did not increase success. I managed to record 
from only 1 patch (out of 40 „empty‟ ones) in which the slope conductance was 37 pS. This 
value is close to the average value of 41 ± 2 pS, obtained from the 1 mM traces. The low 
number  of  events  observed  with  the  low  concentration  suggests  that  the  low  activity  I 
encountered is not a result of desensitization, but may be due to poor expression. 
 
From the above, it was obvious that I could not continue with this combination. I therefore 
tested two alternatives: (1) repeat the same recordings in the outside-out configuration (2) test a 
different chimeric subunit.  
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Figure 3.11  Summary for the ʱ1+β+β
Ch combination in oocytes 
A,  Slope  conductances  of  all  channels  recorded  from  oocytes  injected  with  the  ʱ1+β+β
Ch 
mixture alongside data from the control injections for comparison. All recordings are from 
cell-attached patches with 1 mM glycine. The two points for patch 30 correspond to the two 
channels in Figure 3.10. The dash horizontal line represents the average of the 7 patches with 
the low-conducting channels from this combination (41 ± 2 pS). B, Total number of cell-
attached patches (in brackets) in which GlyR activations were detected, compared with empty 
patches, for oocytes injected with the ʱ1+β+β
Ch combination.  
 
 
3.2.6 Chord conductances of oocyte-expressed GlyRs in the outside-out configuration 
I switched to the outside-out configuration because of the low success in detecting channel 
openings  in  the  cell-attached  patches.  The  success  rate  should  increase,  because  excised 
patches have a larger surface area (Ogden and Stanfield, 1987). The problem is that wild-type 
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GlyRs  open in  several  conductance levels  when recorded in  this  configuration (Beato  and 
Sivilotti, 2007; Bormann et al., 1987, 1993; Takahashi and Momiyama, 1991; Twyman and 
MacDonald,  1991).  That  of  course  makes  the  interpretation  of  the  results  in  terms  of 
stoichiometry difficult since the aim is to measure different conductance levels that appear in 
the patch.  
 
Recordings were performed with 1 mM glycine applied via bath, at -100 mV. Glycine was only 
applied to patches where no channel activations were detected for at least 1 min. As expected, 
the properties of the channels in the outside-out configuration differed from the cell-attached 
recordings due to the presence of more than one different amplitude levels. This is shown in 
Figures 3.12 and 3.13 where representative currents from the control injections are shown. 
From the traces it is evident that: (i) in some cases there are direct transitions between different 
amplitude  levels,  suggesting  that  they  can  be  attributed  to  the  same  channels,  but  most 
commonly all openings occur independently, (ii) channels from ʱ1-injected oocytes open at 4 
different amplitude levels with the predominant level being that of 8.8 ± 0.1 pA (Figure 3.12A; 
Table 3.5), (iii) the data from the homomeric channels are identical to those from ʱ1+β
Ch 
injected cells, indicating the homomer-like behaviour of ʱ1β
Ch heteromers (Figure 3.12B), (iv) 
the  presence  of  the  wild-type  β  subunit  decreases  the  single-channel  conductance  to  a 
predominant value of 43 ± 1 pS (assuming a chloride reversal potential of 0 mV), almost half 
that  of  homomers  (Figure  3.13)  and  finally  (v)  the  contamination  by  homomers  in  ʱ1+β 
injected cells is high, with at least 20% of openings deriving from ʱ1 channels (in 12 out of 12 
patches; first trace in Figure 3.13; Table 3.5). These results are in agreement with the cell-
attached experiments. Τhe exception is that in the cell-attached configuration the frequency of 
sublevels is much higher for ʱ1+β
Ch recordings compared with ʱ1.  
 
The  big  number  of  different  conductance  states  I  observed  from  the  controls  makes  it 
impossible to deduce any reliable conclusions concerning the stoichiometry simply from the 
number of the different conductance states for the ʱ1+β+β
Ch combination. On the other hand, 
the frequent appearance of different conductances with this configuration might answer the 
following question that was raised from the cell-attached data: does the mixed combination 
truly produce functional „mixed‟ receptors (with both wild-type and mutant β)? This could be 
proved if we detected conductance levels additional to those measured for ʱ1β and ʱ1+β
Ch 
channels.  95 
 
 
Figure 3.12  Conductance states of GlyRs in oocytes injected with ʱ1 and ʱ1+β
Ch cRNA 
Recordings were performed in the outside-out configuration from oocytes injected with ʱ1 (A) 
and ʱ1+β
Ch cRNA (B). Channels were recorded at -100 mV with 1 mM glycine in the bath. 
The  horizontal  dash  lines  mark  the  different  conductance  levels,  numbered  with  Roman 
numerals. Four different conductance levels appear for ʱ1 homomers (A) and five for ʱ1+β
Ch 
cells. Note how the conductance states I-IV are identical for the two combinations. Each line of 
traces is from a different patch. 
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Figure 3.13  Conductance states of heteromeric ʱ1β GlyRs  
The  traces  (from  three  different  patches)  represent  outside-out  recordings  from  oocytes 
obtained at -100 mV with 1 mM glycine in the bath. Horizontal dash lines show the different 
conductance levels, numbered with Roman numerals. The first trace shows contamination by 
homomeric openings, appearing together with heteromers. Four conductance levels appear for 
ʱ1β heteromers (VI-IX). 
 
 
As expected, the greater patch surface in the outside-out configuration increased my recording 
success  rate  for  the  ʱ1+β+β
Ch  combination  and  glycine-evoked  channel  activations  were 
observed in the majority of patches. As summarized in Table 3.5, I was able to identify at least 
8  different  conductance  states.  Examples  of  such  channels  from  two  different  patches  are 
shown in Figure 3.14. The majority of the channels from this combination open at ʱ1β-like 
conductance  states  (VI-IX)  with  the  predominant  state  being  that  of  45  ±  1  pS  (~48%  of 
openings), similar to the ʱ1+β combination. The rest of openings were homomer-like, with the 
most common state being that of 90 ± 1 pS. 
 
These results show that none of the conductance states was unique for the mixed combination. 
The  presence  of  unique  conductances  would  indicate  the  presence  of  functional  „mixed‟ 
receptor  subtypes.  Lack  of  intermediate  states  suggests  that  either  these  receptors  are  not 
formed or that their conductance states overlap with those from the control patches.   
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Figure 3.14  Conductance states from ʱ1+β+β
Ch injected oocytes 
Examples  of  outside-out  recordings  at  -100  mV  from  oocytes  injected  with  the  mixture 
combination. Glycine was 1 mM. Horizontal dash lines show the observed conductance levels, 
numbered with Roman numerals.  
 
Table 3.5  Chord conductance levels for the different cRNA combinations in oocytes. 
   
  I 
 
(94-102) 
 
II 
 
(84-91) 
  
   III 
 
(77-83) 
    
IV 
 
(66-72) 
 
V 
 
(51-57) 
  
VI 
 
(40-46) 
  
 VII 
 
(33-39) 
  
 VIII 
 
(22-27) 
 
  IX 
 
(-17) 
 
α1 
N = 6 
 
98 ± 2 
n = 3 
12% 
 
88 ± 1 
n  = 4 
31% 
 
79 + 1 
n = 2 
27% 
 
70  
n = 1 
30% 
 
 
 
 
 
 
 
 
 
 
 
 
α1+β
Ch 
N = 7 
 
95 ± 1 
n = 4 
15% 
 
87 ± 1 
n = 6 
39% 
 
80 ± 1 
n = 5 
32% 
 
69 ± 2 
n = 3 
10% 
 
53 ± 2 
n = 3 
5% 
 
 
     
 
α1+β 
N = 12 
 
96 ± 1 
n = 2 
1% 
 
87 ± 1 
n = 6 
6% 
 
78 ± 1 
n = 4 
3% 
 
67 ± 1 
n = 3 
6% 
 
56 ± 1 
n = 3 
4% 
 
43 ± 1  
n = 5 
39% 
 
37 ± 3 
n = 4 
11% 
 
26 ± 1 
n = 4 
27% 
 
17 
n = 1 
3% 
 
α1+β+β
Ch 
N = 15 
 
102 ± 1 
n = 2 
7% 
 
90 ± 1 
n = 5 
9% 
 
 
 
 
71 ± 1 
n = 2 
1% 
 
54 ± 1 
n = 4 
4% 
 
45 ± 1 
n = 14 
47% 
 
35 ± 1 
n = 9 
25% 
 
26 ± 1 
n = 4 
5% 
 
17 
n = 1 
2% 
 
The conductance levels are numbered with Roman numerals (I to IX); the range for each state 
is denoted in brackets. Average values ± SEM are in pS, n is the number of patches where each 
state is observed, % is the frequency of openings at each state; N is the total number of patches 
for each cRNA combination.  
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3.2.7 The α1+β+β
Ch combination gives only two conductance states in HEK293 cells 
To  distinguish  between  the  two  possibilities  I  tested  the  mixed  ʱ1+β+β
Ch  combination  in 
HEK293 cells. The advantage of using these cells is that the stoichiometry of ʱ1β GlyRs is 
already established as 3ʱ:2β using the 9΄LT mutation and that homomer contamination can be 
reduced with the appropriate ʱ:β ratio (Burzomato et al., 2003). Hence, with this information at 
hand, any data from HEK293 cells might be useful in interpreting the oocyte data.  
 
Cells  were  transfected  with  ʱ1+β+β
Ch  cDNA  and  recordings  were  performed  in  the  cell-
attached configuration using 1 mM or 200 μM glycine in the pipette. I recorded channels at a 
range of holding potentials (typically between 0 mV and -100 mV) and fitted the I/V plots with 
a linear fit to get the slope conductance. Figure 3.15Α shows example traces from such an 
experiment. This patch was held at holding potentials ranging from -100 mV to +40 mV, with 
1 mM glycine in the pipette. As for oocytes, at this concentration channel openings occur in 
clusters. This patch was idealised by time course fitting with SCAN and EKDIST was used for 
the distributions of fitted amplitudes. From the distributions it was evident that only one main 
amplitude  level  appears  at  each  holding  potential.  For  example,  the  distribution  for  fitted 
amplitudes at a holding potential of -100 mV can be well fitted by a single Gaussian curve, 
giving a peak at 3.22 pA and a standard deviation value of 0.32 pA (Figure 3.15Β). All fitted 
amplitude values for this patch are shown in the stability plot in Figure 3.15C. For the I/V plot 
shown below (Figure 3.15D) the mean fitted amplitudes taken from the Gaussian fits were 
plotted against the holding potentials, giving a slope conductance of 31.9 pS for this channel. 
The chloride reversal potential was ~0 mV. This value of 31.9 pS, obtained from the idealised 
record, is identical to the value of 31.1 pS, obtained by analysing the same patch with cursor 
measurements  in  Clampfit.  This  confirms  the  validity  of  the  oocyte  data,  which  were  all 
analysed by Clampfit.  
 
The average slope conductance from all ʱ1+β+β
Ch transfected HEK293 cells was 30 ± 1 pS (n 
= 27) for 1 mM patches and 31 ± 3 pS (n = 6) for 200 μΜ patches. A summary of all data is 
shown in Figure 3.16. As mentioned previously, the stoichiometry of ʱ1β channels in HEK293 
cells is 3ʱ:2β which means that the ʱ1+β+β
Ch combination is expected to produce 3 different 
receptor types, distinguished by different single-channel conductances. From the summary it is 
obvious that only two different conductance levels appear: one with an overall average of 30 ± 
1 pS (both concentrations, 33 patches) and a homomer-like conductance of 66 ± 2 (n = 3).  99 
 
 
Figure 3.15  Conductance of GlyRs in HEK293 cells transfected with ʱ1+β+β
Ch 
A, Cell-attached traces  of GlyRs  expressed in  HEK293 with  the mixture combination. All 
traces are from the same patch, held at a range of holding potentials. Glycine was 1 mM. This 
patch was idealised by time course fitting using SCAN. The distribution of fitted amplitudes at 
-100 mV is shown in B. The distribution is fitted with a single Gaussian component. In C is the 
stability  plot  of  fitted  amplitudes  for  the  entire  patch.  The  numbers  on  top  are  the 
corresponding holding potentials (in mV). Note that only one amplitude level is detected for 
cell-attached recordings. The I/V plot for this patch is in D.   
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The data from HEK293 cells are similar to what was observed for the same combination in 
oocytes.  To  summarise,  the  HEK293  cell  data  confirm  the  cell-attached  and  outside-out 
experiments  of  oocytes:  the  mixed  combination  of  ʱ1+β+β
Ch  does  not  give  intermediate 
conductance levels. Based on this, I cannot conclude on the stoichiometry of oocyte expressed 
ʱ1β channels using this approach.  
 
 
 
Figure 3.16  Summary of experiments in HEK293 cells transfected with ʱ1+β+β
Ch 
The plot summarises all data obtained from HEK293 cells transfected with this combination. 
All recordings were performed in cell-attached with either 1 mM (squares) or 200 μΜ Gly 
(circles) in the pipette. Only two conductance levels were detected for this combination.  
 
 
As a last alternative the ʱ1
Ch subunit was constructed: this is the ʱ1 subunit that carries the 
TM2 domain of the β subunit (see Figure 2.3, Methods). The rational of this is the same as 
with the β
Ch construct: a mixed ʱ1+β+ʱ1
Ch combination injected into oocytes would produce 
an N+1 number of receptor subtypes, depending on the stoichiometry of the ʱ1β heteromer. 
The subtypes would be distinguishable because of different single-channel conductances. Prior 
to proceeding to single-channel recording I tested whether injections into oocytes of the ʱ1
Ch+β 
(1:40  ratio)  and  the  ʱ1
Ch  combinations  would  produce  enough  current  for  single-channel 
recordings. TEVC recordings from ʱ1
Ch+β injected cells using 1 mM glycine did not produce 
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any macroscopic current (n = 5), whereas cells injected with the ʱ1
Ch subunit alone produced 
an average current of -11 nA (n = 4, data not shown). This amount of current is not sufficient 
for single-channel recordings. I therefore abandoned this approach.  
 
Similarly to  the  9΄  mutation data, the conductance mutation approach  I have followed for 
investigating the stoichiometry of ʱ1β GlyRs in oocytes resulted in inconclusive data. Attempts 
to explain the data are considered in the Discussion section (Chapter 4).  
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3.3 Activation mechanism of α2 GlyRs  
 
3.3.1 The α2 GlyR  
In the immature nervous system the reversal potential for chloride is depolarizing and this 
means  that  the  activation  of  a  chloride-permeable  channel  such  as  the  glycine  receptor  is 
effectively excitatory. The depolarization of immature neurons leads to the entry of calcium 
into the cells and finally to the modulation of processes such as proliferation, cell migration 
and differentiation. The ʱ2 subunit is likely to play a major role in the embryonic form of 
GlyRs (Legendre, 2001); ʱ2 transcripts are abundant in the embryonic and neonatal rat but are 
gradually replaced by the ʱ1 subunit (Akagi and Miledi, 1988; Akagi et al., 1991; Malosio et 
al., 1991a; Watanabe and Akagi, 1995). Also, Takahashi et al. (1992) showed that the single-
channel properties of embryonic (E20) and adult (P22) rat spinal GlyRs correspond better to 
recombinant ʱ2 and ʱ1 receptors, respectively (Takahashi et al., 1992). The developmental 
switch of GlyRs is completed at approximately P20 in the rat, so in the early postnatal period, 
both ʱ1 and ʱ2 subunits may be present (Legendre, 2001; Bowery and Smart, 2006). The 
consensus  view  is  that  GlyRs  on  embryonic  and  neonatal  neurons  are  predominantly 
homomers of ʱ2, whereas adult receptors are ʱ1β heteromers (Akagi and Miledi, 1988; Becker 
et al., 1988; Hoch et al., 1989; Pfeiffer et al., 1982).  
 
Despite the abundance  of the  ʱ2  subunit in  the embryonic brain,  it is unclear whether  ʱ2 
homomeric receptors are involved in glycinergic synaptic transmission. This is because: firstly, 
homomeric GlyRs cannot cluster at the synapse because only β subunits can interact with 
gephyrin  (Meyer  et  al.,  1995;  see  section  1.2.7ii).  Secondly,  ʱ2  is  expressed  in  neuronal 
regions  where  no  glycine-mediated  synaptic  transmission  has  been  detected  and  in  non-
neuronal cells such as glial cells or progenitor cells (Belachew et al., 1998; Flint et al., 1998; 
Mangin et al., 2002; Nguyen et al., 2002). Finally, Legendre and colleagues have shown that 
ʱ2 homomeric receptors have kinetic properties that make them unsuitable to mediate fast 
synaptic  transmission:  they  activate  and  deactivate  slowly  and  have  a  low  probability  of 
opening in response to the rapid application of brief pulses of glycine (Mangin et al., 2003). It 
has been suggested that ʱ2 homomeric receptors may be extrasynaptic channels that can be 
activated by a paracrine-like release of glycine or taurine, even at low concentrations, making 103 
 
them potential players for neuronal development (Legendre, 2001; Mangin et al., 2003; see 
also Clements, 2002).    
 
3.3.2 Aim 
A  detailed  description  of  receptor  behaviour  both  at  steady-state  and  in  response  to  non-
equilibrium conditions (i.e. at the synapse) consists of a scheme that links together all the 
functional states of the channel (open, closed, desensitized) together with the rate constants for 
the reactions that link the states. Such a kinetic mechanism also allows some understanding of 
the role of specific residues in the channel molecule: if for example a mutation in a specific 
position alters the gating but not the binding rates then it stands to reason that this residue 
forms part of the channel gate, or is indirectly involved in gating. Hence, kinetic modeling 
provides a link between structure and function, allowing conclusions to be drawn concerning 
the role of particular channel domains.   
 
The aim of this section was to establish a quantitative activation mechanism for the kinetic 
behaviour of recombinant ʱ2 GlyRs. The goal is to find the simplest model that can describe 
the  data.  The  model  has  of  course  to  be  consistent  with  the  available  information  on 
biochemical, pharmacological, and structural properties of the channel. 
 
3.3.3 General features of α2 GlyR channel openings  
Single-channel  recordings  from  HEK293  cells  transfected  with  rat  ʱ2  GlyR  cDNA  were 
performed  in  the  cell-attached  configuration,  at  -100  mV  (pipette  potential  of  +100  mV). 
Representative recordings at different glycine concentrations, ranging from 20 μM to 10 mM 
are shown in Figure 3.17. The first thing to be noted was that the success rate in obtaining 
patches with channel activity was low (~1 in 5 patches) at all concentrations. In the case of ʱ1 
(Beato et al., 2004) and ʱ1β GlyRs (Burzomato et al., 2004), at low agonist concentrations 
openings  occur  in  short  bursts  which,  at  high  concentrations,  become  grouped  into  long 
clusters of openings, separated by long shut periods. Bursts within the clusters get closer and 
closer as the glycine concentration increases, and because of that the proportion of open time 
within the cluster steadily grows. For the ʱ2 receptors, on the other hand, it was impossible to 
distinguish between bursts and clusters as channel activity presented a very similar appearance 
at all concentrations.  104 
 
 
Figure 3.17  Activation of ʱ2 GlyRs in HEK293 cells 
Continuous (50 s) sweeps of single-channel recordings of ʱ2 homomeric receptors evoked by 
different  concentrations  of glycine. Patches  were obtained from  HEK293 cells  in  the cell-
attached configuration at a pipette potential of 100 mV. Traces were filtered at 5-7 kHz. The 
dotted lines under the 20 μΜ and 10 mM traces represent the regions expanded in Figure 3.18. 
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I  never  saw  short  bursts,  and  even  at  the  low  glycine  concentrations  groups  of  channel 
openings  were  long  and  separated  by  long  shuttings  (usually  lasting  for  minutes).  Each 
recording contained a relatively small number of these groups of openings. This is evident in 
Figure 3.18A where  channel  activity  at 20  μΜ (lowest  concentration) and 10 mM  glycine 
(saturating concentration) are shown on an expanded time scale. Both traces have a high Popen 
and contain few short shuttings, unlike ʱ1 and ʱ1β channels in which the Popen is concentration 
dependent (Figure 3.18B). Despite the high Popen observed at 20 μΜ glycine I was never able to 
observe channel openings in patches exposed to lower glycine concentrations (n = 10).  
 
 
Figure 3.18  ʱ2 GlyR clusters 
A, The displays are parts of the clusters shown in Figure 3.17 (dotted lines) for the lowest (20 
μΜ)  and  highest  (10  mM)  glycine  concentration,  expanded  on  the  same  time  scale  for 
comparison. Note how the open probability is similar for both concentrations, with few shut 
times within the cluster. The same traces are more expanded in the left panel of B (50 ms 
sweeps; dotted lines in A) and are shown against parts of ʱ1β GlyR clusters for comparison 
(right panel). The lack of concentration dependence in the Popen is evident for ʱ2 receptors. The 
ʱ1β traces are reproduced from Burzomato et al. (2004).  
 
 
Only one channel amplitude was detected in each patch. This is shown from the amplitude 
distributions in Figure 3.19 which are all fitted with a single Gaussian curve. The average 
amplitude from a total of 25 patches was 5.9 ± 0.2 pA. The mean fitted amplitude varied 
considerably between the 25 patches, ranging from 4.5 to 9.1 pA. This was expected for cell-
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attached recordings since the amplitude of channel openings depends on both the intracellular 
chloride ion concentration and the resting membrane potential, both of which vary from cell to 
cell.   
 
 
 
 
Figure 3.19  Fitted amplitude distributions for ʱ2 GlyRs 
The fitted amplitude distributions correspond to the traces in Figure 3.17. All distributions are 
fitted  with  a  single  Gaussian  component,  indicative  of  only  one  amplitude  level  for  these 
channels and this configuration. Only openings that are longer than two filter risetimes are 
included.  
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3.3.4 Dwell-time distributions 
In ideal conditions, the number of components in the open or shut-time distributions is equal to 
the number of open or shut states in the activation scheme. It is likely however that, in real 
data,  one  or  more  components  will  be  undetectable.  Therefore,  fitting  real  distributions 
provides information about the minimum number of open or shut states needed.  
 
Open-period  distributions,  examples  of  which  are  shown  in  Figure  3.20  for  the  six 
concentrations, have up to three exponential components (fitted using EKDIST, see Methods). 
The summary in Table 3.6 shows that a fast component (ranging from 8 to 51 μs) is almost 
always present in the distributions. The mean lifetime of this component is often faster than the 
resolution  (20  μs)  and  only  few  events  can  be  resolved  in  each  patch.  When  fitted  with 
EKDIST this component reached an area of up to 12% at low concentrations but gradually 
decreased to only 2% at 10 mM. The slowest component was predominant in all concentrations 
with  an  average  area  of  82-98%.  An  intermediate  component  of  0.2-0.5  ms  is  sometimes 
detected, but its contribution is minimal.   
 
In other channels which can open at different levels of liganding, it is common to see that the 
mean  open  time  increases  with  agonist  concentration,  as  the  longer  open  components 
(corresponding to the higher levels of ligation) increase in frequency. This is seen with ʱ1 and 
ʱ1β glycine receptors (Beato et al., 2002; Burzomato et al., 2004) but, as Table 3.6 shows, 
there is very little sign of this for the ʱ2 channel. There is a shift to more prolonged openings 
as the glycine concentration increases from 20 to 30 M, but the mean open period is similar 
for all concentrations above 30 M (ranging from 27 to 34 ms).  
 
Apparent shut-time distributions were fitted with three or four components (Figure 3.21, see 
Table 3.6). For all concentrations most shuttings belong to a very fast component which is 
predominant  irrespective  of  glycine  concentration.  This  component,  with  average  time 
constants of 5-10 μs, is faster than the experimental resolution of 20 μs and most events in this 
component will be missed. Inspection of the values in Table 3.6 shows that the time constants 
for the first three components are similar across concentrations. On the other hand, the last 
component (τ4) becomes shorter at higher concentration (from 6 to 1 ms). 108 
 
 
 
Figure 3.20  Open-period distributions for ʱ2 GlyRs 
The  distributions,  corresponding  to  the  traces  in  Figure  3.17,  are  fitted  with  mixtures  of 
exponential  probability  density  functions.  Open  periods  denote  the  time  duration  that  the 
channel is continuously open, irrespective of amplitude level, between adjacent shut times that 
are longer than the resolution.  Up to  three exponential  components  were needed for these 
distributions (Table 3.6). 
 
 
Given the aim of fitting a mechanism to the data, examining the concentration dependence of 
the shut-time distributions should help to understand which events are bursts and which are 
clusters of bursts and to set tcrit values to divide the low concentration records into bursts and 
the high concentration records into clusters. For the ʱ2 data, the concentration dependence of 
the longest shut time is rather small, making the task of determining a tcrit for bursts very 
difficult and somewhat arbitrary.  
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Figure 3.21  Shut-time distributions for ʱ2 GlyRs 
The shut-time distributions  corresponding to  the patches  in  Figure 3.17 were fitted with  a 
mixture of up to four exponential probability density functions (Table 3.6). 
 
 
In the first instance, I decided to divide all records (even those at low concentrations) into 
clusters  and  I  have  chosen  a  tcrit  value  of  7-10  ms  for  classifying  events  as  being  within 
clusters. In the distributions in Figure 3.21 there are only a few shuttings longer than 10 ms at 
all  concentrations.  These  may  be  due  to  desensitization  and  therefore  be  the  reflection  of 
shuttings that occur between clusters (Colquhoun and Ogden, 1988). The same value was used 
for determining the Popen (see below). In the mechanism fits I also tested the effect of using 
different values of tcrit, (lower than 7 ms) and of classifying as bursts the groups of openings at 
the lower concentrations (20-100 M, see below).  
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Table 3.6  Dwell-time distributions for ʱ2 GlyRs. 
 
 
Apparent open periods 
[Gly]  τ1 (ms) 
Area (%) 
τ2 (ms) 
Area (%) 
τ3 (ms) 
Area (%) 
Mean (ms) 
 
   
20 μΜ 
 
0.017 ± 0.009 
(12 ± 8%) 
 
0.200 
(5%) 
 
13.1 ± 1.5 
(83 + 12%) 
 
12.46 ± 1.82 
 
30 μΜ 
 
0.011 ± 0.001 
(12 ± 2%) 
 
0.521 ± 0.134 
(6 ± 1%) 
 
37.4 ± 7.3 
(82 ± 3%)  
 
34.39 ± 7.48 
 
50 μΜ 
 
0.051 
(2%) 
 
– 
 
 
29.0 ± 2.6 
(98 ± 2%) 
 
28.68 ± 2.88 
 
100 μΜ 
 
– 
 
 
0.562 ± 0.449 
(4 ± 1%) 
 
32.8 ± 8.3 
(96 ± 1%) 
 
31.59 ± 7.80 
 
1 mM 
 
0.023 ± 0.011 
(11 ± 8%) 
 
– 
 
 
32.7 ± 1.3 
(89 ± 8%) 
 
31.89 ± 1.65 
 
10 mM 
 
0.012 
(2%) 
 
– 
 
 
30.2 ± 0.1 
(98 ± 2%) 
 
27.05 ± 3.04 
 
 
Apparent shut times 
[Gly]  τ1 (ms) 
Area (%) 
τ2 (ms) 
Area (%) 
τ3 (ms) 
Area (%) 
τ4 (ms) 
Area (%) 
   
20 μΜ 
 
0.010 ± 0.002 
(88 ± 3%) 
 
0.092 ± 0.028 
(8 ± 1%) 
 
0.589 ± 0.027 
(3 + 1%) 
 
6.06 ± 0.01 
(1 + 0.4%) 
 
30 μΜ 
 
0.006 ± 0.001 
(89 ± 2%) 
 
0.044 ± 0.014 
(8 ± 2%) 
 
0.479 ± 0.055 
(2 ± 0.2%)  
 
5.16 ± 2.54 
(1 ± 0.2%)  
 
50 μΜ 
 
0.005 ± 0.003 
(99 ± 1%) 
 
0.085 ± 0.071 
(0.8 ± 0.8%) 
 
– 
 
 
2.83 
(0.2%) 
 
100 μΜ 
 
0.005 ± 0.001 
(97 ± 1%) 
 
0.034 
(3%) 
 
0.171 ± 0.027 
(1.0 ± 0.3%) 
 
1.38 ± 0.22 
(0.7 ± 0.1%) 
 
1 mM 
 
0.007 ± 0.001 
(91 ± 3%) 
 
0.047 ± 0.025 
(6 ± 2%) 
 
0.262 
(2%) 
 
1.63 ± 0.01 
(1.3 ± 0.3%) 
 
10 mM 
 
0.005 ± 0.000 
(98 ± 1%) 
 
0.029 ± 0.002 
(2 ± 1%) 
 
– 
 
 
1.06 ± 0.07 
(0.3 ± 0.2%) 
Distributions were fitted with a mixture of exponential probability density functions. Two 
idealized patches were used for each concentration. Time constant value and area (in brackets) 
of each component are the average ± SEM for each concentration.  
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3.3.5 Popen for clusters 
The Popen value for each patch was calculated from clusters (groups of bursts). The Popen (7-10 
ms) was estimated as the ratio between the cluster‟s total open time and cluster length. Values 
of the total open time and cluster length were taken from the idealised records, using two 
idealised patches for each concentration.  
 
As expected from the inspection of the records, the mean Popen is similar for low and high 
concentrations, being always close to unity (Table 3.7). Popen values are plotted against glycine 
concentrations in Figure 3.22. As mentioned above, channel openings were never observed for 
concentrations  lower  than  20  μΜ.  It  is  obvious  from  Figure  3.22  that  the  Popen  is  not 
concentration dependent. This suggests that the channel can only give rise to one type of (high 
Popen) activation; either the channel opens only when saturated with agonist, or activations at 
lower states of ligation also have very high Popen. 
 
Table 3.7  Mean Popen for clusters at different glycine concentrations.  
[glycine]  Number of clusters  Cluster duration (ms)  Popen 
20 μΜ  28  358.1 ± 44.2  0.977 ± 0.003 
30 μΜ  33  2050.4 ± 308  0.992 ± 0.001 
50 μΜ  29  791.0 ± 97.2  0.996 ± 0.001 
100 μΜ  24  1558.1 ± 274.1  0.993 ± 0.001 
1 mM  41  583.8 ± 59.9  0.992 ± 0.001 
10 mM  31  692.9 ± 65.4  0.994 ± 0.001 
The Popen for each cluster was calculated as the ratio between total open time and total cluster 
duration. All data are pooled for each concentration to give the average Popen ± SEM. Two 
idealised records were used for each concentration. The tcrit value, chosen from the shut-time 
distributions, was 7 ms (for 50 μΜ and 10 mM) and 10 ms for the other concentrations.  
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Figure 3.22  Open probability of ʱ2 GlyR clusters 
Each  point  in  the  plot  represents  the  average  Popen  (±  SEM)  obtained  after  pooling  the 
individual Popen values from all the clusters recorded at each glycine concentration. The Popen 
value for each cluster was obtained as the ratio between the cluster‟s total open time and total 
duration. Two idealised records were used for each concentration. Concentrations lower than 
20 μM did not produce any channel activity. The insert shows the same plot rescaled.   
 
 
3.3.6 Fits to putative mechanisms 
For fitting putative mechanisms to the data using HJCFIT patches were grouped into sets, so 
that  each  set  contained  2-3  patches  spanning  the  range  of  glycine  concentrations  (see 
Methods).  For  the  initial  fits  the  tcrit  was  set  to  7-10  ms  for  both  the  low  and  the  high 
concentrations and data were fitted as clusters (steady-state vectors). Resolution was set to 20 
μs. The following figures show the results of fitting different models to the same set of two 
patches (30 μΜ and 1 mM glycine). Similar results were obtained for other sets, tables of 
which are in Appendix C. For testing the quality of a model the predictions from a fit are 
compared with the experimental data (shut-time and open-period distributions). The quality of 
a  mechanism  is  also  evaluated  based  on  how  physically  plausible  and  consistent  the  rate 
constant values are. The predicted Popen curve was compared with the experimental Popen values 
from single-channel data (i.e. maximum Popen close to unity and EC50 lower than 20 μΜ) and 
also from macroscopic recordings (see section viii).  
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i. Models of sequential binding steps 
Given that ʱ2 GlyRs are homomers of five ʱ subunits, the maximum number of binding sites 
they might have is five. However, it has been shown that only three binding sites are required 
to  maximally  activate  homomeric  pLGICs  (Beato  et  al.  2004;  Rayes  et  al.  2009).  To 
investigate the necessary number of ʱ2 GlyRs binding sites I tested simple mechanisms with 
sequential binding steps and openings from all liganded resting states (for example see Figure 
3.23), by varying the number of binding steps.  
 
I tested different variations of these models, such as the presence of identical binding sites or 
the lack of interaction  between binding sites.  Lack of interactions  means  that binding and 
unbinding rate constants stay the same irrespective of how many sites are already occupied by 
glycine. This  is  done by  fitting with  the following  constraints  (see  also  Burzomato  et  al., 
2004):  k(+1) = k(+2) = k(+3) = k(+4) = k(+5)  and k(-1) = k(-2) = k(-3) = k(-4) = k(-5).  
 
 
 
Figure 3.23  Sequential models with openings from all liganded states 
This kinetic scheme (model 1) has five binding sites for glycine and openings can occur from 
any of the bound resting states. Variations of this model, with up to two binding sites (models 
2-4) were tested. In all schemes the agonist is indicated by A, the resting states by R and the 
open states by R*. The names for all the different rate constants for the reaction steps are 
shown, also taking into account the statistical factors for the binding rate constants.  
 
 
The first model tested was one with 5 binding steps and five open states (Figure 3.23). With or 
without the constraints for interacting binding sites, HJCFIT was unable to converge for any of 
the sets. Therefore I proceeded to fit data with a lower number of binding sites.  
 
Fits of different data sets to a model of four binding sites and four open states were able to 
converge (scheme 2; Table A1, Appendix C). Although the major component of the open-
period distributions is predicted well, the model failed to describe the smaller components. The 
predicted maximum of the Popen curve is close to the experimental observations (Table 3.8) but 
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the curve itself is not informative for any of the sets tested (Table A1, Appendix C). More 
importantly,  this  mechanism  completely  failed  to  predict  the  shut-time  distributions.  This 
model was not considered adequate to describe the data. Note that for the set in Table 3.8 the 
estimate for the fully liganded efficacy (E4) is zero, lower than any of the efficacy values at 
lower levels of ligation.  
 
Table 3.8  Estimated parameters from fits of the same set of data with schemes 2-4 
  Unit  Scheme 2 
4 binding sites 
4 open states 
Scheme 3 
3 binding sites 
3 open states 
Scheme 4 
2 binding sites 
2 open states 
 
30 μΜ and 1 mM 
Vectors 
Free parameters 
 
tcrit = 10 ms  
steady-state 
10 
 
tcrit = 10 ms 
steady-state 
6 
 
tcrit = 10 ms 
steady-state 
4 
 
ʱ1           
 
s
-1 
 
56 
 
877366 
 
14116 
β1            s
-1  17018  0.00  377 
ʱ2            s
-1  243804  14387  68 
β2          s
-1  96801  375  37088 
ʱ3          s
-1  155  65  - 
β3         s
-1  89179  34782  - 
ʱ4         s
-1  6  -  - 
β4            s
-1  0.00  -  - 
k-   s
-1  439  688  1366 
k+  M
-1s
-1  5.9x10
6  3.3x10
6  3.4x10
6 
E1    305  0.00  0.03 
E2    0.40  0.03  549 
E3    575  534  - 
E4    0.00  -  - 
KR  μM  74  207  402 
max Popen     0.993  0.998  0.998 
EC50  μΜ  undetermined  29  18 
nH    undetermined  2.64  1.92 
Lmax (log)    12262  11900  11939 
Rate constant estimates for fits with models of simple sequential binding steps to the same set 
of data (set 1 with 30  μΜ  and  1  mΜ  glycine).  Fits  were  done  with  constraints  for  non-
interacting binding sites. The tcrit value, the type of vectors used for each patch and the number 
of free parameters are also shown. The efficacies (E = β/ʱ) and the dissociation equilibrium 
constant for the resting states (KR = k-/k+) are calculated from the fitted rates. Also listed are 
the max Popen, EC50 and Hill slope predicted by HJCFIT. Lmax is the maximum likelihood for 
each fit. 
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Figure 3.24  Fits of data with scheme 3  
The first two rows show the comparison of the experimental data with the fit predictions for 
one set with two patches (at 30 μΜ and 1 mM). tcrit was 10 ms and steady-state vectors were 
used for both patches. Fits were performed with constraints for identical binding sites. The 
histograms are the experimental data, the solid lines are the calculated HJC distributions and 
the dash lines are the predicted fits at ideal resolution. The experimental Popen values (black 
circles) for all patches are plotted against glycine concentrations below. The solid line is the 
predicted  Popen-concentration  curve  using  this  model  and  data  set  and  the  dash  line  (here 
overlapping the solid one) is the prediction at ideal resolution. The reaction rates for this fit are 
shown in Table 3.8.  
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This last finding suggests that better fits might be obtained if the number of binding sites is 
reduced  further.  Indeed,  fits  with  a  model  with  three  binding  steps  and  three  open  states 
(scheme 3) gave more reasonable rate constants for the sets tested (Table A2, Appendix C). 
Figure 3.24 shows the results of a fit with this model, using constraints for non-interacting 
binding sites. Not much difference was observed between these fits and those with four binding 
sites however: the major component of the open-period distributions is predicted reasonably 
well but the smaller components are overestimated for the low concentration. The predicted 
max  Popen  was  reasonable  (0.998).  However,  the  model  failed  to  describe  the  shut-time 
distributions, especially in the range of the short shut times. From the above, this model was 
also considered inappropriate for the data. Similar results were also obtained with a model of 
two binding sites and two open states (scheme 4, Table 3.8). The summary for fits to the same 
set of data with this group of schemes is shown in Table 3.8.  
 
It is clear from Figure 3.24 that simple sequential binding site mechanisms are not suitable for 
the kinetics of ʱ2 channels. From the above fits however it was evident that models with three 
or two binding sites gave more reasonable rate constants as the efficacy increased with the 
level of ligation. The same did not occur for scheme 2 (Table 3.8).  
 
ii. The „flip‟ mechanism 
What else can we change in the model? Clearly the shut-time distribution is a problem, so 
adding  more  shut  states  may  help.  Both  the  homomeric  and  the  heteromeric  receptors 
containing the ʱ1 subunit are well described by the „flip‟ model (Burzomato et al., 2004), 
which introduces more shut states for each bound state of the receptor (Figure 1.8 in Chapter 
1).  A  possible  physical  interpretation  of  these  states  is  that  they  represent  activation 
intermediates  in  which  the  extracellular  domain  has  already  changed  its  conformation  in 
response to the binding of glycine, but the channel has not yet opened. I proceeded to test 
whether the same can occur for ʱ2 receptors.  
 
As shown in Figure 3.25, incorporation of flip states improves greatly the fits of the shut-time 
distributions. This model fitted very well both the shut-time and the open-period distributions 
and it predicted high Popen values, similar to the experimental observations. Also, the predicted 
EC50 was lower than the value of 20 μΜ expected from the experimental Popen values (Figure 
3.22).  117 
 
 
 
 
Figure 3.25  Fits of data with the „flip‟ mechanism (scheme 5) 
The introduction of additional shut states (flipped states, F) in scheme 5 („flip‟ mechanism; 
Burzomato et al., 2004), improves the fits to the experimental distributions for both shut times 
and open periods. The same set of data is shown as in Figure 3.24 for comparison. The tcrit was 
10  ms  and  steady-state  vectors  were  used  for  both  patches.  Fits  were  performed  with 
constraints for all the binding steps for states R and F to have the same rate constants (same 
equilibrium dissociation constants KR and KF). Two rate constants (one for each cycle) were 
fixed to satisfy the requirements of microscopic reversibility. The predicted Popen curve is also 
shown. The solid lines are the calculated HJC distributions (at the experimental resolution) and 
the dashed lines are the distributions that would be observed if no events were missed. The 
reaction rates are in Table 3.9.  
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Table 3.9  Estimated parameters from fits to set 1 with the „flip‟ model. 
   
  Unit  Scheme 5 
„flip‟ model with 3 binding sites 
 
30 μΜ 
1 mM 
Vectors 
   
tcrit = 10 ms 
tcrit = 10 ms 
steady-state 
 
tcrit = 0.1 ms 
tcrit = 2 ms 
CHS 
 
ʱ1           
 
s
-1 
 
14037 
 
7705 
β1            s
-1  1531  804 
ʱ2            s
-1  186  249 
β2          s
-1  100624  114538 
ʱ3          s
-1  18244  53546 
β3         s
-1  337120  374572 
k-   s
-1  813  0.243 
k+  M
-1s
-1  9.8x10
6  75600 
kF-   s
-1  1381  3876 
kF+  M
-1s
-1  2.9x10
7  6.5x10
7 
γ1  s
-1  994919  3896 
δ1  s
-1  728018
  4.3x10
6 
γ2  s
-1  7505  96 
δ2  s
-1  9670  5640 
γ3  s
-1  0.01  704 
δ3  s
-1  0.03  2223 
E1    0.11  0.10 
E2    542  460 
E3    19  7 
F1    0.73  1102 
F2    1.29  58.98 
F3    2.27  3.16 
KR  μM  83  3.21 
ΚF  μM  47  60 
max Popen     0.993  undetermined 
EC50  μΜ  2  undetermined 
nH    1.89  undetermined 
Lmax (log)    12382  11038 
 
Fits were performed with constraints for equal binding sites, for all conformations. Two rates 
were set by microscopic reversibility. The tcrit values and the type of vectors used are shown. 
The  efficacies  (E  =  β/ʱ),  the  equilibrium  constants  for  the  flip  states  (F  =  δ/γ)  and  the 
dissociation equilibrium constant for the resting (KR = k-/k+) and flip states (KF = kF-/kF+) are 
calculated from the fitted rates. Also listed are the predicted max Popen, EC50 and Hill slope. 
Lmax is the maximum likelihood for each fit. 
 
 
However, only two data sets could be fitted with this model and the fits were not consistent 
between them: specifically, the values of the gating rate constants for the monoliganded state 119 
 
(ʱ1, β1) varied considerably (14037 and 1531 for set 1, shown in Figure 3.25 vs. 0.3 and 3621 
for set 3, see Table A3 in Appendix C). Furthermore the results of the fits suggest that opening 
was  most  efficacious  when  the  channel  is  diliganded,  rather  than  fully  liganded.  For  this 
scheme I also tested the effect of lowering the tcrit value and classifying concentrations lower 
than 100 μM as „burst concentrations‟. This attempt resulted in very poor fits for the set shown 
in this chapter and HJCFIT could not predict a Popen curve. The rate constants for this fit are 
shown in Table 3.9.  
 
iii. Variants of the „flip‟ mechanism: two open states 
Considering that the introduction of flip states improved the fits, I went on to test different 
variations of „flip‟ models in order to achieve consistency between sets. Some of these schemes 
are shown in Figure 3.26, where the number of open states is gradually reduced to account for 
the low efficacy predicted for partially liganded states. Different tcrit values were also tested. 
Data at concentrations lower than 100 μΜ were analysed both as clusters and as bursts (i.e. in 
the latter case using CHS vectors; see Methods). 
 
I tested whether model 6A (Figure 3.26) would fit better than model 5. For initial fits with this 
model I used the same value of tcrit (10 ms) and steady-state vectors, as with models 1-5. Figure 
3.27 (left panel) shows an example of such a fit with model 6A, using the same set of data as 
before. Again, using flip states resulted in a very good agreement of the experimental data with 
the HJC fits. The model fitted well more than two data sets, making it a better candidate 
compared with scheme 5 (see Table A4, Appendix C). The presence of only two instead of 
three open states resulted in a higher efficacy for the fully liganded instead of the partially 
liganded state and overall this model produced more reasonable rate constants than model 5.  
 
As a second step, I tested lower tcrit values. Figure 3.27 (right column) shows the effect of 
lowering the tcrit and fitting with model 6A (concentrations lower that 100 μΜ were classed as 
“burst” and CHS vectors were used; note that this also means that the cluster Popen curve can 
only include concentrations higher than 100 μΜ). As expected, decreasing the tcrit did not alter 
the fits of the open-period distributions but somewhat improved the shut-time distribution fits. 
The results of fits with the lower tcrit predicted a 10-fold lower potency of glycine (from 3.7 μM 
to 47 μΜ). This is a direct result of an increase in the equilibrium dissociation constant (KR; 
see Table 3.10). 120 
 
 
 
Figure 3.26  Different variations of „flip‟ mechanisms used for fitting 
Some of the kinetic mechanisms tested for ʱ2 GlyRs. These models have either three (A) or 
two (B) binding sites and they all contain flip states. Fits to these models were performed with 
constraints for association and dissociation rate constants to be the same for all binding sites. 
For  models  6A  and  6B  an  additional  rate  (kF(+))  was  fixed  for  microscopic  reversibility. 
Statistical factors in the binding rate constants are included.  
 
 
These changes with low tcrit were similar across all data sets (Table A4, Appendix C). Despite 
the  good  fits  produced  by  this  scheme  with  the  above  conditions,  I  did  not  consider  it 
appropriate for the data. The reason is that the values for ʱ2 and β2 were not consistent across 
different sets of data, giving a big scatter in the values for E2, ranging from 0.6 to 24 (see 
Table A4, Appendix C). Also, in most sets (including the one shown here), the association rate 
constant for the flipped states, kF(+), had reached its diffusion limit of 10
9 M
-1s
-1, making it 
physically impossible, and these values unrealistic.
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Figure 3.27  Effects of low tcrit values to fits with model 6A 
Fits to the same data set using high (left) or low (right column) values for tcrit. The open-period 
distributions are unaffected but reducing tcrit improves the fit of the shut-time distribution for 
the 1 mM patch and shifts the Popen curve to the right. The fits were performed with constraints 
for identical binding sites. The solid lines are the calculated HJC distributions and the dash 
lines  are  the  predicted  fits  at  ideal  resolution.  In  the  Popen  curves  the  experimental  points 
correspond  only  to  cluster  concentrations  (at  which  steady-state  vectors  were  used).  CHS 
vectors were used for concentrations lower than 100 μΜ (for tcrit < 7 ms). The rates for the fits 
can be found in Table 3.10.  
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iv. Variants of the „flip‟ mechanism: one open state 
Inspection of the E and F values in Table 3.10 shows that in all the fits of scheme 6A overall 
gating is much more efficacious for the tri- vs. the diliganded states (the product of E is at least 
100-fold smaller for the diliganded openings and F2 is almost 0). I therefore chose to remove 
the first gating step from the scheme. The resulting model (7A) is shown in Figure 3.27.  
 
Initial fits with high tcrit values provided very good agreement with the experimental data, as 
shown in Figure 3.28 (left). Due to the presence of only one open state in model 7A, the HJC 
fits of the open-period distributions do not fit the fastest component (compare with model 6, 
Figure 3.27) but this component only accounts for a very low number of events in each patch 
(see  also  Table  3.6).  On  the  other  hand,  the  predominant  slow  component  is  predicted 
extremely  well  (Figure  3.28).  Again,  reducing  tcrit  and  using  CHS  vectors  for  the  low 
concentrations  profoundly  improved  the  fits  with  scheme  7A,  especially  for  the  shut-time 
distributions (Figure 3.28). This improvement was not only evident for the slow shut-time 
components but also for the very fast component of 5-10 μs, which, as seen from the EKDIST 
distributions, represents ~90% of all shut times. This improvement was not observed for model 
6A. Overall, the fits from model 7A provide the best agreement with the data. This is despite 
the fact that the free parameters in this model are fewer than in the previous models tested (n = 
6 for model 7A). This scheme fitted three other sets of patches with equally good fits for the 
distributions and similar values for the fitted rate constants, showing its consistency between 
different  sets  (see  Table  A6,  Appendix  C).  The  predicted  Popen  curve  gave  a  reasonable 
maximum Popen value (close to 1).  
 
Model 7A denotes that the channel can only reach one single open state after three sequential 
(identical) agonist binding steps, implying that the binding sites do not interact. For the same 
model I also tested the effect of releasing the constraints of independence between the binding 
sites, meaning that the binding rate constants for one binding site might be affected by the 
binding of glycine to other binding sites. I therefore refitted all of the 10 rate constants as free 
parameters (four different sets; Table A8, Appendix C). The predicted distributions with the 
free fits were identical to those of model 7A with the constraints (Figure 3.28) though the 
release of the constraints resulted in a decrease in the slope and EC50 of the Popen curve. 
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Table 3.10  Effect of decreasing tcrit to fits of the same data set with models 6A and 7A 
   
Unit 
 
Scheme 6A  
 
Scheme 7A 
30 μΜ 
1 mM 
Vectors 
Parameters 
  tcrit = 10 ms 
tcrit = 10 ms 
steady-state 
11 
tcrit = 0.6 ms 
tcrit = 2 ms 
CHS 
11 
tcrit = 0.1 ms 
tcrit = 2 ms 
CHS 
11 
tcrit = 10 ms 
tcrit = 10 ms 
steady-state 
6 
tcrit = 0.1 ms 
tcrit = 2 ms 
CHS 
6 
 
ʱ2           
 
s
-1 
 
103496 
 
97425 
 
68266 
 
- 
 
β2          s
-1  315032  324677  995366  -   
ʱ3          s
-1  156  163  171  123  603 
β3         s
-1  83917  87275  91679  71838  183984 
k-   s
-1  0.31  323  2133  143  4078 
k+  M
-1s
-1  14157  3.9x10
6  5.4x10
6  2.6x10
7  6.7x10
6 
kF-   s
-1  9980  10182  7462  -  - 
kF+  M
-1s
-1  3.7x10
8  4.6x10
8  2.0x10
9  -  - 
γ2  s
-1  710  905  9460  -  - 
δ2  s
-1  473  176  135  -  - 
γ3  s
-1  4132  4948  6644  7833  8735 
δ3  s
-1  2174  3659  10170  2248  23065 
E2    3.04  3.33  14.58  -  - 
E3    538  535  536  584  305 
F2    0.67  0.19  0.01  -  - 
F3    0.53  0.74  1.53  0.29  2.64 
KR  μM  22  83  395  5.6  610 
ΚF  μM  27  22  4  -  - 
max Popen     0.996  0.997  0.998  0.993  0.998 
EC50  μΜ  4  13  47  1  73 
nH    2.41  2.56  2.68  2.47  2.68 
 
Estimated rate constants for schemes 6A and 7A using high, intermediate and low t crit values. 
The same set of data is used for both models. Fits were performed with constraints for non-
interacting binding sites. kF- was set by microscopic reversibility (scheme 6A). When stated, 
CHS vectors were used instead of steady-state vectors for the 30 μM patch, for separating 
openings into bursts. The efficacies, the equilibrium constants for entering a flip state and the 
dissociation equilibrium constants are calculated from the fitted rates. The fits with the high 
and low tcrit are shown in Figures 3.27 (scheme 6A) and 3.28 (scheme 7A). 
 
 
The results of the fits suggest that the binding affinity is very high for the first binding step 
(KR1 ranges from 0.01 to 110), it decreases to more than 1000-fold for the second binding (KR2 
is between 762 and 9523) and increases again after two agonist molecules are bound (Table 
A8,  Appendix  C).  These  fits  suggest  that  the  binding  of  one  agonist  molecule  somehow 
prevents the binding of a second molecule but the binding of both finally allows for a third 
molecule to bind and the channel to open.  124 
 
 
Figure 3.28  Effects of low tcrit values to fits with model 7A 
Fits to the same data set (see Figure 3.27) using high and low tcrit values (both with constraints 
for equal, non-interacting binding sites). The solid lines are the calculated HJC distributions 
and the dash  lines  are the  predicted fits  at  ideal  resolution.  Model 7A has one open state 
(A3R*) and open-period distributions are fitted with a single component. The fits of the shut-
time distributions of both patches are very good with the low tcrit, including the predominant 
fast component (right column). The fits are very poor for high tcrit values (left column). As with 
model 6A, the Popen curve is shifted to the right. The rates for the fits are in Table 3.10.  
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The above interpretation of a negative interaction between binding sites and the big variability 
in the binding rate constants across sets do not make these free fits very reliable. Due to these, I 
continued fitting the data with constraints of non-interacting binding sites since the quality of 
the fits is good, even with fewer free parameters (n = 6 for model 7A with constraints).  
 
v. Variants of the „flip‟ mechanism: number of binding sites 
It is obvious that the best fits are obtained with a model of only one open state, after flipping 
(scheme 7). Beato et al., (2004) found that in ʱ1 GlyRs maximum gating efficacy is reached 
when three molecules of glycine have bound. Model 7A, with three binding sites, agrees with 
the above, but I also tested the effect of changing the number of binding sites. The models 
ranged from one to five binding sites; an example of such a model, with two binding sites is 
shown in Figure 3.26 (scheme 7B). The same sets and settings (constraints and low tcrit values) 
were used for fitting. Surprisingly, the fitted rate constants for all schemes (and consequently 
the fits to the experimental distributions) were almost identical with those from scheme 7A 
(Table 3.11). Similar results were obtained with other data sets and also when a different pair 
of models was used (scheme 6A and 6B, Figure 3.26; see Tables A4-A7, Appendix C).  
 
Table 3.11  Number of binding sites to models with 1 open state, after flipping. 
   
Unit 
 
5 binding 
sites 
 
4 binding  
sites 
 
3 binding  
sites (7A) 
 
2 binding  
sites (7B) 
 
1 binding 
site  
 
ʱ         
 
s
-1  606  604 
 
603 
 
598  572 
β        s
-1  184268  184377  183984  183331  179904 
k-   s
-1  2477  3083  4078  6019  11462 
k+  M
-1s
-1  7.5x10
6  7.2x10
6  6.7x10
6  5.8x10
6  3.7x10
6 
γ  s
-1  8740  8736  8735  8737  8792 
δ  s
-1  23214  23171  23065  22822  21851 
E    304  305  305  306  315 
F    2.66  2.65  2.64  2.61  2.49 
KR  μM  330  429  610  1042  3131 
max Popen     0.998  0.998  0.998  0.998  0.998 
EC50  μΜ  117  99  73  38  4 
nH    3.70  3.26  2.68  1.93  1.00 
Lmax    10922  10922  10922  10922  10922 
 
Estimated rate constants for  the same set, fitted with schemes containing up to five binding 
sites. Identical constraints are used (non-interacting binding sites) and also the same tcrit values 
(0.1 ms for 30 μΜ; 2 ms for 1 mM) for all models. CHS vectors were used for the 30 μM 
patch. The fits for the experimental distributions for all schemes are identical to those of model 
7A (shown in Figure 3.28, right).  126 
 
As shown in Table 3.11, in all cases the only effect of reducing the number of binding sites 
was a reduction in the EC50 and slope of the Popen curve. This is represented in Figure 3.29 for 
models 7A and 7B. A decrease in the binding affinity was also noticed (increase in KR). From 
the above it is  evident  that the major determinant  for choosing between the five different 
models was the Popen curve. Unfortunately, the experimental Popen values are all high and do 
not give any information on EC50 and slope (Figure 3.22). Because of that, we decided to 
obtain macroscopic responses from cells expressing ʱ2 channels, using fast agonist application 
in  order  to  minimise  the  effect  of  desensitization.  Ideally,  the  information  obtained  from 
macroscopic  concentration-response  curves  would  help  to  choose  between  the  models. 
Recordings of macroscopic currents were performed both in the whole-cell patch configuration 
by means of a U-tube system and in the outside-out configuration using a theta tube.  
 
 
 
Figure 3.29  Two vs. three binding site models 
Popen-concentration response curves calculated by the fits of the same data set with a model 
containing three (scheme 7A) and two (scheme 7B) binding sites. The models are shown in 
Figure 3.26. The set is the same used for Figures 3.27 and 3.28. Fits were performed with 
identical constraints for non-interacting binding sites and with the same low tcrit values. The 
rate constants for the two models are identical (see Table 3.11) and fits to the experimental data 
are shown in Figure 3.28 (right column). The two fits differ only in the predicted Popen curve, 
with an EC50 of 73 μM for model 7A and 38 μM for model 7B. 
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3.3.7 Properties of macroscopic currents from α2 GlyRs 
Whole-cell currents  from  ʱ2 GlyRs  (examples  of which are shown in Figure 3.30A) were 
recorded  at  -60  mV  and  individual  concentration-response  curves  were  fitted  to  the  Hill 
equation. For 8 cells, the currents had an average fitted maximum of 8.96 ± 2.09 nA (range 
2.8-22 nA), and EC50 and Hill coefficient of 379 ± 36 μΜ and 1.58 ± 0.09 respectively. These 
data were normalised and pooled to obtain the plot in Figure 3.30C; when fitted to the Hill 
equation, the curve gave an EC50 of 363 μΜ and a slope of 1.53, similar to the average values.  
 
I also obtained responses to fast agonist application with a theta tube, recording from outside-
out patches (in symmetrical chloride, 130 mM; see Methods). As shown in Figure 3.30B, I 
applied 1 s pulses of three different glycine concentrations (100 μΜ, 500 μΜ and 10 mM) and 
fitted the measured peak current responses (normalised to currents at 10 mM; -100mV) to the 
Hill equation, to characterize the concentration-response curve. These data are plotted with 
those obtained from the whole-cell recordings in Figure 3.30C for comparison. Note that even 
though only three concentrations are available for plotting, the data from concentration jumps 
are in agreement with those from whole-cell recordings. Individual fits with the Hill equation 
gave an average EC50 of  355 ± 72 μM and a slope of 1.23 ± 0.22 (n = 4).  
 
The Hill slope values obtained from the whole-cell and outside-out recordings are in good 
agreement with the range of 1.6-1.9 reported in the literature for macroscopic ʱ2 currents (see 
Mangin et al., 2003; Han et al., 2004; Hawthorne et al., 2006; Yang et al., 2007). On the other 
hand, the EC50 values vary significantly between different studies, as observed for other GlyR 
subtypes  (Beato  et  al.,  2002).  This  is  expected,  however,  since  both  the  speed  of  glycine 
application  and  the  method  of  recording  can  affect  EC50  values  by  altering  the  level  of 
desensitization  which,  by  definition,  is  a  high  affinity  state  (faster  drug  applications  are 
expected to decrease desensitization and hence increase the EC50).  
 
The value of the Hill slope from macroscopic currents does not match, but is closer to two out 
of the five models of Table 3.11: the two binding site model (7B), which predicts nH values of 
1.93 ± 0.01, and the three binding site model (7A), with a slope of 2.68 ± 0.04 (average of 4 
sets, shown in Tables A6 and A7, Appendix C). On the other hand, the observed EC50 value is 
much larger than the predictions of either of the two models (model 7A: 53 ± 15 μΜ; model 
7B: 27 ± 7 μΜ).  128 
 
 
Figure 3.30  Concentration-response relations from macroscopic currents 
Traces in A are representative glycine-evoked whole-cell currents from a HEK293 cell (held at 
-60 mV) expressing ʱ2 GlyRs. The traces in B are average outside-out currents (at -100 mV) 
elicited  by  1  s  application  of  three  different  glycine  concentrations  on  the  same  patch. 
Recordings  for  both  A  and  B  were  performed  with  equimolar  bath  and  pipette  solutions 
(containing  130 mM  chloride).  C,  Concentration-response curve for  glycine obtained from 
pooled whole-cell data (filled circles) and fitted with the Hill equation (continuous line). The 
open circles are average data from 1 s concentration jumps, normalised to the 10 mM response 
for each patch.     
 
 
Note that both the EC50 and the Hill slope predictions from kinetic models would be applicable 
to a Popen curve, not to one obtained from macroscopic data, as the latter is inevitably distorted 
by  desensitization  (which  is  not  included  in  the  models  fitted  to  single-channels,  as 
desensitized shut states cannot be analysed). For this reason, the macroscopic data alone are 
not sufficient for choosing the two binding site model (7B) over model 7A.    
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In addition to that, the macroscopic experiments described above were all completed before my 
colleagues identified internal chloride as a major determinant of ʱ1β glycine channel kinetics 
(Pitt et al., 2008). The study shows that the deactivation of macroscopic currents predicted by 
cell-attached single-channel recordings is much faster than that observed with concentration 
jumps at high pipette chloride. The deactivation after jumps becomes faster (and similar to the 
single-channel model predictions) when low chloride is used in the pipette (resembling a more 
physiological intracellular chloride concentration). In the light of these results, it is now clear 
that the kinetic information from single-channel data can be combined with macroscopic data 
only if they are obtained in similar conditions and this means low internal chloride.  
 
It is important to know whether intracellular chloride levels affect also the time course of 
macroscopic currents from ʱ2 homomeric receptors. I compared the concentration jumps I had 
performed with high chloride in the pipette (130 mM; equimolar to the bath solution) with 
those  using  a  low-chloride  pipette  solution  (10  mM,  also  at  -100  mV).  I  first  examined 
responses to long (1 s) applications of saturating glycine (10 mM). The traces in Figure 3.31A 
show that the first noticeable difference is that at low chloride concentration in the pipette, 
glycine currents were much smaller (average of 83 ± 28 pA, n = 4 vs. 402 ± 11 pA, n = 6; see 
the calibration bars) because the driving force for chloride is smaller (100 mV in symmetrical 
chloride, ~35 mV in low chloride). More importantly, even with these long 1 s jumps (where 
desensitization is high) it is evident that reducing the pipette chloride concentration led to a 
~3.5-fold decrease in the deactivation time constant, from an average of 383 ± 70 ms (n = 6) to 
112 ± 26 ms (n = 4; see the inset with the scaled currents at the end of the pulse in Figure 
3.31A). The use of more physiological intracellular chloride concentrations therefore speeds up 
the decay of both ʱ1β and ʱ2-mediated glycine currents.  
 
When the application of agonist is short (1-2 ms jumps at saturating glycine), the decay of the 
current is thought to reflect the duration of the burst (Wyllie et al., 1998). In these conditions, 
ʱ1β channels deactivate with a time constant of ~10 ms (in low chloride; Pitt et al., 2008). The 
deactivation of ʱ2 currents elicited by a short glycine pulse is much slower than that of ʱ1β 
channels. The off-current can be best fitted with two exponential components at saturating 
glycine (10 mM) and with either one or two exponentials at lower glycine concentrations (500 
μΜ, 1 mM). Representative currents elicited by the three concentrations are shown in Figure 
3.31B. The average time constants and areas for the exponential components are shown in 130 
 
Table 3.12. The slow component, which is predominant at all concentrations, is ~8-11 times 
slower than the 10 ms decay of ʱ1β channels. Note that the second, faster component is smaller 
at lower glycine concentrations, to a point where at  some 500 μΜ patches it is rarely big 
enough to be detectable. These data differ from those of Mangin et al. (2003), who reported a 
single decay time constant of 153 ms for ʱ2 channels in CHO cells. However, this discrepancy 
can be explained by the fact that the authors used a high chloride pipette solution for their 
outside-out experiments (~140 mM) which, as shown, would be expected to slow down the 
deactivation (Pitt et al., 2008; see also Figure 3.31A).  
 
Table 3.12  Deactivation time constants from 2 ms concentration jumps. 
[glycine]  τ1   τ2 
 
10 mM 
 
114.4 ± 12.9 ms 
96 ± 1% 
(n = 8) 
 
6.1 ± 1.4 ms 
4 ± 1% 
(n = 7) 
 
 
1 mM 
 
85.8 ± 10.1 ms 
97 ± 1% 
(n = 9) 
 
5.4 ± 2.2 ms 
5 ± 2% 
(n = 5) 
 
 
500 μΜ 
 
80.7 ± 8.8 ms 
95 ± 4% 
(n = 6) 
 
4.9 ± 1.8 ms 
7 ± 5% 
(n = 4) 
 
Data are average ± SEM from individual fits of average currents with exponential curves. The 
areas  of  each  component  and  the  number  of  patches  are  also  shown.  Recordings  were 
performed with low (10 mM) chloride in the pipette and at -100 mV.  
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Figure 3.31  Deactivation time course of glycine-evoked currents 
A, The traces on the left are average current responses to a 1 s pulse of saturating glycine (10 
mM) to outside-out patches from HEK293 cells expressing rat ʱ2 GlyRs. Recordings were 
performed at -100 mV with high (130 mM) or low (10 mM) chloride in the pipette solution 
(averages  of  9  and  20  sweeps  respectively).  The  time  course  of  the  glycine  application, 
obtained by the open tip potential recorded at the end of the experiment, is shown above (here 
it  corresponds  to  the  130  mM  Cl
-  patch).  The  two  traces,  normalised  to  their  peak,  are 
superimposed in the right panel of A. In the dashed box they are shown scaled to the beginning 
of deactivation (indicated by the arrow). Note the faster decay for the low chloride patch (grey 
trace).  B,  Average  traces  from  a  patch  exposed  to  a  brief  (2  ms)  pulse  of  glycine  at  the 
indicated concentrations, using the 10 mM chloride pipette solution. In the box is the 10 mM 
glycine trace expanded; note the biexponential decay (τ1 = 107 ms, τ2 = 3.4 ms, area1 = 96%).  
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For testing the two best kinetic models (7A and 7B) I calculated with the SCALCS program 
the decay expected for currents elicited by short pulses of 10 mM glycine. The program has the 
ability to simulate the relaxation of a macroscopic current after a concentration jump, using the 
rate constants of a kinetic scheme. Due to the fact that the rate constants between the two and 
three binding site schemes were almost identical, it was not surprising that the program gave 
similar predictions of the decay: 202.7 ms (7A) and 205.08 ms (7B) for a 1 s jump at 10 mM 
glycine. Identical values were predicted for faster applications. Note that four (7A) and three 
(7B)  additional  components  are  in  theory  predicted  by  the  models  but  the  areas  of  these 
exponentials are negligible. The value of ~200 ms, though not matching, is much closer to the 
decay of macroscopic currents obtained with low chloride in the pipette (112 ± 26 ms) than to 
the ~400 ms deactivation of currents recorded with high chloride. Because of that I continued 
using the low chloride solution for the rest of the concentration jump experiments.  
 
Because we cannot distinguish between models 7A and 7B we proceeded in testing the quality 
of both against the macroscopic currents. The following paragraphs describe the testing of 
model 7A (three binding sites, 1 flip state, 1 open state) against the macroscopic data from 
concentration jumps.  
 
In order to continue testing the validity of model 7A I needed to characterise desensitization for 
these receptors, as this process can affect the decay of macroscopic currents, even after brief 
agonist  applications  (Legendre  et  al.,  2002).  The  single-channel  analysis  that  resulted  in 
schemes 7A and 7B cannot provide any information concerning this phenomenon since long 
sojourns in desensitized states were excluded from HJC fitting when shut times longer than tcrit 
were discarded. For the purpose of investigating the kinetics of desensitization of ʱ2 receptors 
and,  if  possible,  extending  the  mechanism  to  include  appropriate  desensitized  states,  I 
performed long (200 ms) concentration jumps at saturating glycine concentrations (10 mM) 
and recorded outside-out macroscopic currents at low pipette chloride.  
 
Outside-out recordings revealed a large variability in the kinetics of desensitization between 
patches and this was correlated with differences in the amplitude and risetime of macroscopic 
currents. The larger currents had complex kinetics of desensitization that needed to be fitted 
with 2 exponentials (τ1 = 67 ± 8 ms, τ2 = 2.5 ± 0.5 ms; n = 8).  133 
 
 
Figure 3.32  Desensitization of ʱ2 glycine-evoked currents 
A, The traces are average current responses to prolonged (200 ms) application of saturating 
glycine (10 mM) to outside-out patches. The top trace has a high current amplitude and high 
level of desensitization whereas the bottom trace has a low amplitude and little desensitization. 
Recordings were performed at -100 mV with a low chloride pipette solution. The two traces, 
normalised  to  their  peak  and  with  their  desensitization  phase  (200  ms)  expanded,  are 
superimposed in the right panel of A. The plots in B show the inverse relationship between the 
current amplitude and the extent of desensitization (left) or the 10-90% risetime (right) for all 
200  ms  patches  with  10  mM  glycine.  Note  that  low-amplitude  currents  have  little 
desensitization and a slow onset (black circles). The extent of desensitization was taken as the 
residual current at the end of the 200 ms jump. 
 
 
An  example  of  such  a  trace  is  shown  in  Figure  3.32A  (top  trace).  This  current  had  peak 
amplitude of 139 pA and two desensitization exponential components with time constants of 
3.8 ms and 86 ms. On the other hand, currents with low amplitude, like the bottom trace in the 
same  figure  (23  pA,  desensitization  τ  =  82  ms)  desensitized  to  a  lesser  extent  and  their 
desensitization could be fitted by one exponential component (τ = 69 ± 10 ms; n = 3). Similar 
values were obtained with 1 mM and 500 μΜ glycine. The difference in the desensitization 
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kinetics  between  the  two  examples  in  Figure  3.32A  is  more  pronounced  when  they  are 
normalised to their peak and their desensitization phase (200 ms) is expanded (right panel in 
Figure 3.32A). The plot of Figure 3.32B (left) shows that the extent of desensitization of all 
patches is inversely correlated with the current amplitude. In addition to that, only the larger 
currents had the fast desensitization component. Both observations are similar to published 
reports for ʱ1 (Legendre et al., 2002) and ʱ1β GlyRs (Pitt et al., 2008).  The currents that had a 
low current amplitude (38 ± 11 pA, n = 3) and lacked the fast desensitization component also 
had a slower rising phase with an average 10-90% risetime of 5.61 ± 0.89 ms (filled circles in 
Figure 3.32B, right) compared with the rest of the patches (average amplitude of 163 ± 17 pA 
and risetime less than 1 ms; open circles in Figure 3.32B).  
 
3.3.8 Fits to macroscopic currents with scheme 7A  
In order to describe the time course of a macroscopic glycine-evoked current, including the 
observed  fast  and  slow  desensitization,  I  introduced  into  scheme  7A  two  additional 
desensitized states (A3Dslow and A3Dfast, see Figure 3.33A). The new model, 7A-d (with the 
rate  constants  fixed  to  those  obtained  from  single-channel  data),  was  introduced  into 
ChanneLab  software  in  order  to  estimate  the  rate  constants  for  entry  and  exit  from 
desensitization  from  fits  to  macroscopic  currents  (see  Methods).  When  currents  with  high 
amplitude  were  fitted,  both  desensitized  states  were  kept  in  the  model;  only  the  slow 
desensitized state was used for patches with low current. Macroscopic currents evoked by a 
long  (200  ms)  application  of  glycine  were  fitted  well  by  model  7A-d  and  with  the  rates 
obtained from the single-channel data. Examples of such fits are shown in Figures 3.33B and C 
for a high- and a low-amplitude patch respectively. The average rate constants for entry and 
exit from slow desensitization were 202 s
-1 ± 56% and 56 s
-1 ± 44% for the 10 mM traces and 
similar values were obtained for the 1 mM and 500 μΜ traces (n = 6 for each concentration). 
The fast desensitization of the 10 mM traces had average rates of 337 s
-1 ± 66% for entry and 
248 s
-1 ± 37% for exit but these values varied between concentrations and between patches. 
Low-amplitude  currents,  as  noted  before  (see  Figure  3.32B),  had  a  much  more  modest 
desensitization with rate constants that were similar for the entry and exit from the single 
desensitized state (17-38 s
-1 for the 10 mM traces and 15-80 s
-1 for the 1 mM traces).  
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Figure 3.33  Fits of macroscopic currents with model 7A and desensitized states (7A-d) 
A, The model has two desensitized states to account for the intense desensitization of high-
amplitude  currents.  Fits  were  performed  in  ChanneLab  to  estimate  the  rate  constants  for 
desensitization  and  the  association  rate  constant  (k+)  after  a  200  ms  jump.  All  other  rate 
constants were fixed to values obtained from  HJCFIT (Table 3.11). For currents with low 
amplitude only one desensitized state was kept in the model. The traces are average currents 
with high (B) and low (C) amplitude fitted to the model. The fits are shown as black dash lines 
superimposed to the traces (continuous grey lines). Three glycine concentrations are applied on 
each patch. Currents are normalised to their peak prior to fitting. Records were obtained at -100 
mV (10 mM  chloride in the pipette). D, Simultaneous  fits  of the onset  of glycine-evoked 
currents for a patch with fast (left) and slow risetime (right). Currents are normalised to the 
peak of the 10 mM response for each patch. The high- and low-amplitude currents (in B, C, D) 
correspond to the groups of patches in Figure 3.32B (white and black circles respectively).  
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It is interesting to note that single-channel dwells in the desensitized states that are needed in 
order to fit macroscopic current responses would have been excluded from the kinetic analysis 
with HJCFIT since their lifetime (4 ms for the fast desensitized state and 17.8 ms for the slow 
desensitized state with 10 mM glycine and high current patches; 35.7 ms for the desensitized 
state in low current patches) is longer than the highest tcrit chosen for the HJC fits (3 ms).  
 
Using the rates obtained from fitting the desensitization and also the rates from HJCFIT, I 
proceeded to refine the value of the agonist association rate constant (k+3 in Figure 3.33A) by 
fitting  only  the  onset  of  macroscopic  currents.  Similar  to  single-channel  data,  fits  were 
performed with the constraint of identical, non-interacting  binding sites, taking into account 
the available sites for each binding event (i.e. k+1 = k+2 = k+3). As previously mentioned, the 
time course of the risetime for macroscopic responses was dependent on the receptor density 
with  high-amplitude  patches  having  a  faster  onset  (see  Figure  3.32B,  right  panel).  It  was 
therefore expected that the value of k+ would also depend on the current amplitude. As a first 
step, the onset of each current from 200 ms jumps was fitted separately, by fixing all rate 
constants and leaving only k+ free. The results for these fits, averaged for each concentration, 
are shown in Table 3.13. There are slight differences in the estimates across concentrations but 
the only meaningful difference seems to be between patches with high and with low current. 
The data in Table 3.13 summarize the results from patches in which all three concentrations 
were  applied  successfully  (6  high-current  and  2  low-current  patches).  The  overall  average 
value from all individual fits was 2.8x10
6 M
-1s
-1 ± 47% (n = 18) for the high-current patches 
and 1.0x10
6 M
-1s
-1 ± 47% (n = 6) for the low-amplitude patches. As a second step, I selected 2 
high- and 1 low-current patch and fitted all the three responses to the different concentrations 
simultaneously for each patch, in order to estimate a „patch‟ k+. The latter did not differ from 
the average values mentioned above (Table 3.13; Figure 3.33D).  
 
The k+ values obtained from ChanneLab are somewhat lower than the value of 6.23x10
6 M
-1s
-1 
± 52% obtained from the single-channel data in HJCFIT (4 different data sets, see Table A9, 
Appendix C). The determination of the binding rate constant from single-channel data may be 
the weakest point in the global mechanism fits, given the lack of knowledge about the true 
number of channels in a patch (Colquhoun et al., 2003) and the arbitrariness in the choice of 
the tcrit in the case of the ʱ2 data. 
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Table 3.13  Fits of the onset of macroscopic currents to scheme 7A-d.  
[Gly]   High k+  Low k+ 
 
10 mM 
 
2.2x10
6 ± 58%          (6) 
 
0.5x10
6 ± 56%          (2) 
1 mM  3.0x10
6 ± 31%          (6)  1.3x10
6 ± 62%          (2) 
500 μΜ  3.3x10
6 ± 49%          (6)  1.3x10
6 ± 18%          (2) 
Simultaneous fits   2.5x10
6 ± 17%          (2)  1.3x10
6                      (1) 
The first three rows represent the average binding rate constant ± CV for individual fits of the 
rising phase to model 7A-d for currents evoked by 200 ms application of glycine. Patches were 
separated according to receptor density and correspond to the data in the right panel of Figure 
3.32B.  The  number  of  patches  is  shown  in  brackets.  The  last  row  is  the  result  from 
simultaneous fits of the three agonist responses of each patch, to the model. Only one (low k+) 
or both desensitization states (high k+) were included in the model, as in Figure 3.33A.   
 
 
As a last test of the credibility of scheme 7A I proceeded to re-fit the single-channel data with 
HJCFIT,  by  fixing  the  k+  value  to  either  the  high  or  the  low  solution  obtained  from  the 
macroscopic jumps and tested again the quality of the fits. When the k+ was fixed to the high 
value from the jumps, the HJC fits for 4 different sets did not differ much from the initial fits to 
model 7A. The average estimates of rate constants from fits to four sets (summarised in Table 
A8, Appendix C) with free and fixed k+ are shown in Table 3.14. When the low k+ was used 
however, the fits to the distributions were not as good and this value was discarded. It is 
reasonable  to  assume  that  the  cell-attached  single-channel  recordings  were  performed  in 
patches that had similar channel density as the high-amplitude patches from which the high k+ 
value was obtained.  
 
In  summary,  the  combination  of  the  results  from  the  concentration  jumps  and  the  single-
channel data agree that model 7A is a good candidate for the kinetic mechanism of ʱ2 GlyRs: 
it describes well the behaviour of single channels with good predictions of the experimental 
open-period and shut-time distributions, it gives reasonable estimates for the maximum Popen 
and can also describe the time course of macroscopic currents after the model is extended to 
include  desensitization.  The  behaviour  of  these  channels  however  appears  to  be  more 
complicated than what the model suggests: for example, model 7 does not explain the presence 
of two deactivation components after a brief exposure to saturating glycine, or the lack of any 
concentration dependence in the Popen values.  138 
 
Table 3.14  Average estimates of rate constants from fits to four data sets with model 7A. 
   
Unit  Model 7A 
Free k+ 
Model 7A 
Fixed k+(high) 
Model 7A 
Fixed k+(low)   
ʱ         
 
s
-1  410                  (40%)  312                  (28%)  204                  (14%) 
β        s
-1  161763            (15%)  142415            (12%)  110141              (8%) 
γ  s
-1  6226                (18%)   6218                (14%)   6365                  (8%)  
δ  s
-1  15699              (20%)  10414              (15%)  5067                (18%) 
k-   s
-1  2434                (22%)       1250                (18%)       373                  (34%)      
k+  M
-1s
-1  6.23x10
6          (52%)  2.80x10
6         (fixed)  1.00x10
6         (fixed) 
E    412                  (27%)  469                  (23%)  623                  (39%) 
F    2.28                 (42%)  1.66                 (60%)  0.83                 (23%) 
KR  μM  501                  (60%)  447                  (61%)  373                  (38%) 
max Popen     0.998            (0.16%)  0.997            (0.17%)  0.997            (0.15%) 
EC50  μΜ  53                    (55%)  52                    (42%)  40                    (62%) 
nH    2.68                   (3%)  2.65                   (3%)  2.49                 (12%) 
 
dslow(+) 
 
s
-1 
   
202                  (56%) 
 
28                    (54%) 
dslow(-)  s
-1    56                    (44%)  28                         (8) 
dfast(+)  s
-1    337                  (66%)  - 
dfast(-)  s
-1    248                  (37%)  - 
Average rate constants (and % coefficient of variation of the mean) from four different sets of 
cell-attached patches (2 patches per set), fitted in HJCFIT with either all parameters free (first 
column) or with the binding rate constant (k+) fixed to the high and low value obtained from 
the 200 ms concentration jumps. The desensitization rate constants were obtained from fits of 
200  ms  jumps  to  10  mM  glycine  with  low  chloride  in  the  pipette,  from  high-  and  low-
amplitude currents (second and third column respectively).   
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3.4 Appendix C (HJC fitting to additional α2 single-channel data sets) 
The  following  tables  show  results  of  fits  to  sets  of  single-channel  data  using  the  models 
described in Chapter 3.3. These data are complementary to set 1 (30 μΜ and 1 mΜ patches) 
shown in the chapter and are provided for a more detailed description of the quality of each 
kinetic  scheme.  Each  table  column  includes  information  for  each  set,  such  as  the  glycine 
concentration of the patches, the tcrit used for each patch/fit and the type of vector (steady-state 
vector for a „cluster‟ concentration or a CHS vector for a „burst‟ concentration). In most cases 
the fits were performed with constraints for identical, non-interacting binding sites, (i.e. k+1 = 
k+2 = k+3; k-1 = k-2 = k-3). Model 7A was also fitted to sets of data without this constraint (Table 
A8). The tables also include the number of free parameters fitted for each model/fit and, where 
applicable, the number of parameters set by microscopic reversibility (MR).  
 
The last table (Table A9) summarizes the results of fits to model 7A (3 binding sites, 1 flipped 
state, 1 open state) using the high and low values of the binding rate constant (k+) obtained 
from  ChanneLab. These values, fixed for each  fit,  are shown in  bold  numerals.  Fits  were 
performed with the low values of tcrit, as shown for each set. The average of these four sets is in 
Table 3.14.  
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Table A1  Fits to scheme 2 (4 binding sites, 4 open states). 
 
 
 
 
Units  Set 1 
30 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
Set 6 
30 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
Set 9 
20 μM, 0.6 ms 
1 mΜ, 10 ms 
CHS for 20 μM 
constraints
* 
 
ʱ1           
 
s
-1 
 
56  39  131 
β1            s
-1  17018  25480  32022 
ʱ2            s
-1  243804  58233  134192 
β2          s
-1  96801  975  18267 
ʱ3          s
-1  155  134  215 
β3         s
-1  89179  89829  107461 
ʱ4         s
-1  6  0.30  4 
β4            s
-1  0.00  30  0.00 
k-   s
-1  439  402  442 
k+  M
-1s
-1  5.9x10
6  6.5x10
6  3.1x10
6 
E1    305  650  244 
E2    0.40  0.02  0.14 
E3    575  669  501 
E4    0.00  110  0.00 
KR  μM  74  61  141 
max Popen     0.993  0.996  0.995 
EC50  μΜ  undetermined  undetermined  undetermined 
nH    undetermined  undetermined  undetermined 
Lmax (log)    12262  18140  7873 
Free  
parameters 
   
10 
 
10 
 
10 
* k-1 = k-2 = k-3 = k-4 and k+1 = k+2 = k+3 = k+4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 141 
 
Table A2  Fits to scheme 3 (3 binding sites, 3 open states). 
 
 
 
 
Units  Set 1 
30 μM, 10 ms 
1 mΜ, 10 ms 
 
steady-state 
constraints
* 
 
30 μΜ, 0.6 ms 
1 mΜ, 10 ms 
 
CHS 
constraints
* 
Set 3 
20 μM, 0.6 ms 
50 μM, 3ms 
1 mΜ, 10 ms 
CHS < 50 μM 
constraints
* 
 
20 μM, 1 ms 
1 mΜ, 3 ms 
 
CHS (20 μM) 
constraints
* 
 
20 μM, 0.1 ms 
1 mΜ, 3 ms 
 
CHS (20 μM) 
constraints
* 
Set 10 
30 μM, 0.6 ms 
100 μM, 10 ms 
10 mΜ, 10 ms 
CHS (30 μM) 
constraints
* 
 
ʱ1           
 
s
-1  877366  637362  2002  800777  775223  981220 
β1            s
-1  0.00  48  0.00  998848  1.0x10
6  126 
ʱ2            s
-1  14387  14318  71  180392  126349  11306 
β2          s
-1  375  80  546  467  65  212 
ʱ3          s
-1  65  67  111  72  85  39 
β3         s
-1  34782  36768  25050  64406  74551  17872 
k-1  s
-1  688  1305  2698  1571  1772  1223 
k+3  M
-1s
-1  3.3x10
6  3.2x10
6  1.9x10
6  4.5x10
6  4.3x10
6  2.3x10
7 
E1    0.00  0.00  0.00  1.25  1.29  0.00 
E2    0.03  0.01  8  0.00  0.00  0.02 
E3    534  550  225  890  876  458 
KR  μM  207  413  1382  350  414  52 
max Popen     0.998  0.999  0.950  0.999  0.999  0.998 
EC50  μΜ  29  57  223     45  54  8     
nH    2.64  2.64  2.20  2.26  2.25  2.62 
Lmax (log)    11900  11617  12766  8087  7956  14262 
Free 
parameters 
   
6 
 
6 
 
6 
 
6 
 
6 
 
6 
* k-1 = k-2 = k-3 and k+1 = k+2 = k+3 
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Table A3  Fits to scheme 5 („flip‟ model: 3 binding sites, 3 flipped states, 3 open states). 
 
 
 
 
Units  Set 1 
30 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
 
30 μM, 0.1 ms 
1 mΜ, 2 ms 
CHS (30 μM) 
constraints
* 
Set 3 
20 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
 
20 μM, 1 ms 
1 mΜ, 3 ms 
CHS (20 μM) 
constraints
* 
 
ʱ1           
 
s
-1  14037 
 
7705  0.30  87 
β1            s
-1  1531  804  3621  3 
ʱ2            s
-1  186  249  275  249 
β2          s
-1  100624  114538  72877  111487 
ʱ3          s
-1  18244  53546  33510  1070 
β3         s
-1  337120  374572  401860  912166 
γ1  s
-1  994919  3896  226248  360035 
δ1  s
-1  728018  4.29x10
6  998  553649 
γ2  s
-1  7507  96  4200  6488 
δ2  s
-1  9670  5640  2894  8479 
γ3  s
-1  0.01  704  7711  0.00 
δ3  s
-1  0.03  2223  830029  0.00 
k-  s
-1  813  0.24  1.46  1398 
k+  M
-1s
-1  9.8x10
6  75600  1039  2.2x10
6 
kF-   s
-1  1381  3876  723  84 
kF+  M
-1s
-1  2.9x10
7  6.5x10
7  8.0x10
7  113485 
E1    0.11  0.10  13106  0.03 
E2    542  460  265  448 
E3    19  7  12  852 
F1    0.73  1102  0.00  1.54 
F2    1.29  58  0.69  1.31 
F3    2.27  3.16  107  1.11 
KR  μM  83  3.21  1405  629 
ΚF  μM  47  60  13106  0.03 
max Popen     0.993  undetermined  0.994  0.999 
EC50  μΜ  2  undetermined  8  16     
nH    1.89  undetermined  1.04  1.84 
Lmax (log)    12382  11038  8702  8550 
Free 
parameters 
MR rates 
   
14 
2 
 
14 
2 
 
14 
2 
 
14 
2 
* k-1 = k-2 = k-3 and k+1 = k+2 = k+3 
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Table A4  Fits to scheme 6A (3 binding sites, 2 flipped states, 2 open states). 
 
 
 
 
Units  Set 2 
20 μM, 10 ms 
100 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
 
20 μM, 0.1 ms 
100 μM, 0.2 ms 
1 mΜ, 2 ms 
CHS <100 μM 
constraints
* 
Set 3 
20 μM, 1 ms 
1 mΜ, 3 ms 
 
CHS for 20 μM 
constraints
* 
 
20 μM, 0.1 ms 
1 mΜ, 3 ms 
 
CHS for 20 μM 
constraints
* 
Set 4 
50 μM, 0.5 ms 
10 mΜ, 0.2 ms 
 
CHS for 50 μM 
constraints
* 
Set 5 
30 μM, 0.1 ms 
10 mΜ, 0.2 ms 
 
CHS for 30 μM 
constraints
* 
Set 6 
30 μM, 0.3 ms 
1 mΜ, 3 ms 
 
CHS for 30 μM 
constraints
* 
 
ʱ2           
 
s
-1  45690  41707  66476  61754  12417  59438  118664 
β2          s
-1  277381  245405  79824  122536  298494  998777  71687 
ʱ3          s
-1  344  421  390  674  354  373  132 
β3         s
-1  127798  161238  186360  225781  113902  124573  114958 
γ2  s
-1  514  884  5714  3349  216  12436  4487 
δ2  s
-1  2748  358  496  331  4621  1178  85 
γ3  s
-1  1816  3674  3945  4039  4864  4321  5052 
δ3  s
-1  1052  8947  14573  26749  29818  28048  7682 
k-  s
-1  160  1633  854  2521  2302  1005  803 
k+  M
-1s
-1  1.1x10
7  4.4x10
6  2.0x10
6  3.4x10
6  6.8x10
6  4.6x10
6  2.2x10
6 
kF-   s
-1  326640  5.4x10
9  333331  331131  20366  14221  6347 
kF+  M
-1s
-1  2.5x10
9  330055  3.3x10
10  3x10
10  1.7x10
7  4.5x10
9  1.4x10
9 
E2    6.07  5.88  1.20  1.98  24.04  16.80  0.60 
E3    372  383  479  335  322  334  871 
F2    5.34  0.41  0.09  0.10  21.43  0.09  0.02 
F3    0.58  2.44  3.69  6.62  6.13  6.49  1.52 
KR  μM  14  367  435  742  341  216  361 
ΚF  μM  129  61  10  11  1191  3  4 
max Popen     0.995  0.998  0.999  0.999  0.998  0.999  0.999 
EC50  μΜ  1  41   39      62     9     18      36     
nH    1.73  2.62  2.75  2.77  1.89  2.74  2.73 
Lmax (log)    17923  16166  8340  8142  11640  12052  17140 
Free  
parameters 
MR rates 
   
11 
1 
 
11 
1 
 
11 
1 
 
11 
1 
 
11 
1 
 
11 
1 
 
11 
1 
Fits to set 1 with model 6A are shown in Table 3.10
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Table A5:  Fits to scheme 6B (2 binding sites, 2 flipped states, 2 open states). 
 
 
 
 
Units  Set 2 
20 μM, 10 ms 
100 μM, 10 ms 
1 mΜ, 10 ms 
steady-state 
constraints
* 
 
20 μM, 0.1 ms 
100 μM, 0.2 ms 
1 mΜ, 2 ms 
CHS <100 μM 
constraints
* 
Set 3 
20 μM, 1 ms 
1 mΜ, 3 ms 
 
CHS for 20 μM 
constraints
* 
 
20 μM, 0.1 ms 
1 mΜ, 3 ms 
 
CHS for 20 μM 
constraints
* 
 
ʱ1           
 
s
-1  49419  43326  67282  63316 
β1          s
-1  251669  142716  82427  115068 
ʱ2          s
-1  397  443  396  646 
β2         s
-1  150280  186380  187420  222394 
γ1  s
-1  429  3434  5448  3647 
δ1  s
-1  530  272  422  284 
γ2  s
-1  3088  5895  3959  3994 
δ2  s
-1  3256  14836  14808  25037 
k-  s
-1  0.32  2806  1367  3436 
k+  M
-1s
-1  3285  3.8x10
6  1.8x10
6  2.7x10
6 
kF-   s
-1  427033  499739  498467  362728 
kF+  M
-1s
-1  3.7x10
9  2.1 x10
10  3.2x10
10  2.3x10
10 
E1    5.09  3.29  1.23  1.82 
E2    378  421  474  344 
F1    1.24  0.08  0.08  0.08 
F2    1.05  2.52  3.74  6.27 
KR  μM  99  743  748  1263 
ΚF  μM  116  23  15  16 
max Popen     0.997  0.999  0.999  0.999 
EC50  μΜ  4  24  18    28     
nH    1.40  1.92  1.95  1.95 
Lmax (log)    17930  16165  8341  8142 
Free 
parameters 
MR rates 
   
11 
1 
 
11 
1 
 
11 
1 
 
11 
1 
* k-1 = k-2 and k+1 = k+2  
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Table A6  Fits to scheme 7A (3 binding sites, 1 flipped state, 1 open state). 
  Units  Set 3 
20 μM, 1 ms 
1 mΜ, 3 ms 
CHS (20 μM)  
constraints
* 
 
20 μM, 0.1 ms 
1 mΜ, 3 ms 
CHS (20 μM)  
constraints
* 
Set 4 
50 μM, 10 ms 
10 mM, 10 ms 
steady-state 
constraints
* 
 
50 μM, 3 ms 
10 mM, 3 ms 
CHS (50 μM)  
constraints
* 
Set 7 
100 μM, 3 ms 
1 mΜ, 3 ms 
CHS (100 μM)  
constraints
* 
 
100 μM, 0.2 ms 
1 mΜ, 3 ms 
CHS (100 μM)  
constraints
* 
 
ʱ         
 
s
-1  140  308  286  353  96  376 
β        s
-1  105742  159609  104838  117107  95607  186353 
γ  s
-1 
6496  7178  2724  2904  6913  6086 
δ  s
-1 
6622  19399  1373  2509  4038  17822 
k-1  s
-1  1027  2707  100  578  623  2373 
k+3  M
-1s
-1  2.9x10
6  3.9x10
6  1.6x10
7  1.1x10
7  4.1x10
6  3.7x10
6 
E    753.04  517.76  366.42  331.69  996.97  495.38 
F    1.02  2.70  0.50  0.86  0.58  2.93 
KR  μM  357  691  6  54  153  650 
max Popen     0.998  0.999  0.994  0.996  0.998  0.999 
EC50  μΜ  44  68  1  10  21  63 
nH    2.68  2.73  2.49  2.56  2.65  2.74 
Lmax(log)    8179  7979  11955  11888  9795  9486 
Free 
parameters 
 
 
 
6 
 
6 
 
6 
 
6 
 
6 
 
6 
 For Set 1 see Table 3.10 
 
* k-1 = k-2 = k-3 and k+1 = k+2 = k+3 
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Table A7  Fits to scheme 7B (2 binding sites, 1 flipped state, 1 open state). 
  Units  Set 3 
20 μM, 1 ms 
1 mΜ, 3 ms 
CHS (20 μM)  
constraints
* 
 
20 μM, 0.1 ms 
1 mΜ, 3 ms 
CHS (20 μM)  
constraints
*     free 
Set 4 
50 μM, 10 ms 
10 mM, 10 ms 
steady-state 
constraints
* 
 
50 μM, 3 ms 
10 mM, 3 ms 
CHS (50 μM)  
constraints
*    free 
Set 7 
100 μM, 3 ms 
1 mΜ, 3 ms 
CHS (100 μM)  
constraints
* 
 
100 μM, 0.2 ms 
1 mΜ, 3 ms 
CHS (100 μM)  
constraints
*    free 
 
ʱ         
 
s
-1  145  275  1297  286  353  357  105  372  375 
β        s
-1  107734  151523  255267  104836  117083  117815  101484  185525  186116 
γ  s
-1 
6558  7208  4389  2725  2904  2910  7031  6107  6101 
δ  s
-1 
7058  17438  36044  1373  2509  2628  4818  17654  17913 
k-1  s
-1  1627  3673  5685  148  838  910  1156  3494  10544 
k+1  M
-1s
-1  2.7x10
6  3.2x10
6  1.4x10
6  1.5x10
7  8.7x10
6  4.8x10
4  3.9x10
6  3.1x10
6  2.4x10
6 
k-2  s
-1  1627  3673  5599  148  838  1406  1156  3494  3773 
k+2  M
-1s
-1  2.7x10
6  3.2x10
6  7.7x10
6  1.5x10
7  8.7x10
6  3.0x10
7  3.9x10
6  3.1x10
6  7.2x10
6 
E    744  552  197  366  332  330  966  499  497 
F    1.08  2.42  8.21  0.50  0.86  0.90  0.69  2.89  2.94 
KR1  μM  612  1144  4205  10  96  19117  300  1122  4444 
KR2  μM  612  1144  725  10  96  46  300  1122  524 
max Popen     0.998  0.999  0.999  0.994  0.996  0.996  0.998  0.999  0.999 
EC50  μΜ  22  32  44  1  6  54  12  30  40 
nH    1.93  1.95  1.98  1.86  1.89  1.99  1.93  1.95  1.98 
Lmax(log)    8179  7978  7980  11955  11888  11890  9798  9486  9486 
Free 
parameters 
 
 
 
6 
 
6 
 
8 
 
6 
 
6 
 
8 
 
6 
 
6 
 
8 
Set 1 see Table 3.11 
* k-1 = k-2 and k+1 = k+2  
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Table A8  Scheme 7A (free fits vs. constraints for non-interacting binding sites).  
  Units  Set 1  Set 3  Set 4  Set 7 
   
30 μM, 0.1 ms, CHS  20 μM, 0.1 ms, CHS  50 μM, 3 ms, CHS  100 μM, 0.2 ms, CHS 
1 mΜ, 2 ms, steady-state  1 mM, 3 ms, steady-state  10 mM, 3 ms, steady-state  1 mM, 3 ms, steady-state 
    constraints
*  free  constraints
*  free  constraints
*  free  constraints
*  free 
 
ʱ         
 
s
-1  603  615  308  1302  353  357  376  375 
β        s
-1  183984  185559  159609  255474  117107  117810  186353  186222 
γ  s
-1  8735  8760  7178  4380  2904  2910  6086  6096 
δ  s
-1  23065  23813  19399  36065  2509  2628  17822  17920 
k-1   s
-1  4078  15435  2707  295  578  72  2373  10 
k+1  M
-1s
-1  6.7x10
6  1.4x10
8  3.9x10
6  1.7x10
8  1.1x10
7  3.7x10
7  3.7x10
6  1.3x10
9 
k-2   s
-1  4078  2176  2707  2838  578  455  2373  5268 
k+2  M
-1s
-1  6.7x10
6  2.9x10
6  3.9x10
6  1.4x10
6  1.1x10
7  47807  3.7x10
6  2.4x10
6 
k-3   s
-1  4078  4243  2707  3732  578  937  2373  2516 
k+3  M
-1s
-1  6.7x10
6  7.2x10
6  3.9x10
6  7.7x10
6  1.1x10
7  3.0x10
7  3.7x10
6  7.2x10
6 
E    305  302  518  196  332  330  495  496 
F    2.64  2.72  2.70  8.23  0.86  0.90  2.93  2.94 
KR1  μM  610  110  691  2  54  2  650  0.01 
KR2  μM  610  762  691  2100  54  9523  650  2223 
KR3  μM  610  593  691  484  54  31  650  349 
max Popen     0.998  0.998  0.999  0.999  0.996  0.996  0.999  0.999 
EC50  μΜ  73  54  68  44  10  55  63  40 
nH    2.68  2.35  2.73  1.99  2.56  2.01  2.74  1.98 
Lmax(log)    10922  10923  7979  7980  11888  11888  9486  9486 
Free 
parameters    6  10  6  10  6  10  6  10 
* k-1 = k-2 = k-3 and k+1 = k+2 = k+3 
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Table A9  Scheme 7A (with fixed k+ values as obtained from ChanneLab). 
  Units  Set 1      Set 3      Set 4      Set 7     
   
30 μM, 0.1 ms, CHS  20 μM, 0.1 ms, CHS  50 μM, 3 ms, CHS  100 μM, 0.2 ms, CHS 
1 mΜ, 2 ms, steady-state  1 mM, 3 ms, steady-state  10 mM, 3 ms, steady-state  1 mM, 3 ms, steady-state 
constraints
*  constraints
*  constraints
*  constraints
* 
    free k+  k+(high)  k+(low)  free k+  k+(high)  k+(low)  free k+  k+(high)  k+(low)  free k+  k+(high)  k+(low) 
 
ʱ         
 
s
-1  603  266  188  308  231  146  353  347  354  376  403  130 
β        s
-1  183984  124069  99983  159609  139206  108215  117107  116109  117256  186353  190305  115109 
γ  s
-1  8735  9132  8986  7178  7043  6476  2904  2899  2906  6086  5796  7090 
δ  s
-1  23065  8439  5041  19399  13625  6498  2509  2387  2538  17822  17206  6192 
k-   s
-1  4078  939  190  2707  1699  447  578  336  344  2373  2027  511 
k+  M
-1s
-1  6.7x10
6  2.8x10
6  1.0x10
6  3.9x10
6  2.8x10
6  1.0x10
6  1.1x10
7  2.8x10
6  1.0x10
6  3.7x10
6  2.8x10
6  1.0x10
6 
E    305  466  533  518  603  741  332  335  331  495  472  888 
F    2.64  0.92  0.56  2.70  1.93  1.00  0.86  0.82  0.87  2.93  2.97  0.87 
KR  μM  610  335  190  691  607  447  54  120  344  650  724  511 
max Popen     0.998  0.997  0.996  0.999  0.999  0.998  0.996  0.995  0.996  0.999  0.999  0.998 
EC50  μΜ  73  51  33  68  64  55  10  22  8  63  71  62 
nH    2.68  2.61  2.56  2.73  2.72  2.67  2.56  2.55  2.04  2.74  2.73  2.68 
Lmax(log)    10922  10912  10898  7979  7976  7959  11888  11886  11887  9486  9483  9452 
Free 
parameters    6  5  5  6  5  5  6  5  5  6  5  5 
* k-1 = k-2 = k-3 and k+1 = k+2 = k+3 
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4.1 Stoichiometry of α1β GlyRs in Xenopus oocytes 
The first of the two aims of my work was to identify the stoichiometry of heteromeric ʱ1β 
GlyRs expressed in Xenopus oocytes. For this purpose two different methods were employed, 
which involved either the use of a reporter mutation that alters the receptors‟ sensitivity to 
glycine or the use of a mutation that alters single-channel conductance. Both these techniques 
were proven useful in the past for the identification of the stoichiometry of a given ligand-
gated ion channel.  
 
4.1.1 The 9΄ mutation in oocyte-expressed receptors 
Since the aim was to study heteromeric receptors, it was essential first to test whether co-
injection  of  ʱ1  and  β  subunit  cRNA  into  oocytes  effectively  produces  a  predominantly 
heteromeric population. As a precaution the ʱ:β subunit ratio of 1:40 was chosen because this 
ratio  produces  very  little  contamination  by  ʱ1  homomeric  channels  in  HEK293  cells 
(Burzomato  et  al.,  2003).  My  experiments  with  the  9΄  mutation  involved  obtaining 
macroscopic responses to glycine; hence, at that point, performing single-channel recordings to 
test the validity of the 1:40 ratio in oocytes was not considered (see Burzomato et al., 2003). 
The  only  test  performed  was  that  of  picrotoxin  applied  on  ʱ1+β  injected  oocytes:  if  the 
expressed receptors are heteromers then their sensitivity to the alkaloid should be lower than 
that of homomers (ʱ1-injected cells; Pribilla et al., 1992). For four out of six oocytes injected 
with the ʱ1+β combination the high picrotoxin IC50 confirmed the expression of heteromers, 
but  this  does  not  exclude the presence  of  a small  proportion  of homomers  also.  With the 
glycine  concentration  used  (100  μΜ;  ~EC50  for  homomers)  a  number  of  ʱ1  homomeric 
receptors could be activated too. Indeed, in the remaining two cells the picrotoxin IC50 was as 
low as that of homomers suggesting that in these cells the ʱ1 receptor was predominant. I 
therefore tried to re-fit the four experiments that gave a heteromer-like IC50, this time with two 
components,  to  see  if  I  could  achieve  a  reliable  fit  that  would  describe  the  extent  of 
contamination. Free fits of each curve were poorly defined, probably due to the large number 
of  parameters  fitted.  When  I  repeated  the  fits  with  the  parameters  of  the  first  component 
(representing current from ʱ1 homomers) fixed to the values from ʱ1-injected oocytes and with 
the Hill slopes for both components fixed to 1, fits were again poorly defined. The poor fits to 
two components and the low sensitivity to picrotoxin suggested that the level of contamination 151 
 
was low and that the 1:40 ratio was sufficient for the production of a predominant heteromeric 
population  in  oocytes.  It  was  only  when  cell-attached  single-channel  recordings  were 
performed that the true extent of contamination became evident, and homomers were detected 
in ~50% of patches. The single-channel data therefore confirmed that the PTX experiments 
underestimate the presence of homomers. 
 
Glycine concentration-response curves from the different 9΄ mutant combinations in oocytes 
revealed,  in  most  cases,  small  changes  in  agonist  sensitivity  and  in  Hill  slopes,  which 
confirmed that the mutant subunits were incorporated in the receptors. The only exception was 
the  ʱ1+β
LS  combination,  for  which  glycine  EC50  and  nH  and  picrotoxin  IC50  were  almost 
identical to those of ʱ1 homomers. Thus, introducing the 9΄LS (but not the 9΄LT) mutation on 
the β subunit either prevents its incorporation into heteromers or somehow increases picrotoxin 
sensitivity of ʱ1β
LS receptors while failing to change agonist sensitivity. One way of testing 
this would be to record from ʱ1
LSβ
LS mutants and see whether they differ in glycine sensitivity 
compared with ʱ1
LS homomers. However, it was impossible to record from ʱ1
LSβ
LS mutants 
(or  from  ʱ1
LT  and  ʱ1
LTβ
LT)  due  to  an  increased  death  rate  and  increased  holding  current, 
consistent with the fact that when many 9΄ mutations are incorporated, channels  can open 
spontaneously (Chang and Weiss, 1998, 1999). 
 
In all other combinations the presence of the mutation did change the sensitivity to glycine, but 
these changes were small (less than 2-fold) and similar for receptors in which the ʱ1 subunit is 
mutated and receptors in which the β is mutated. The latter does not give any indication on the 
stoichiometry of the heteromers. My results are in contrast to those from muscle nicotinic 
receptors  (Labarca  et  al.,  1995;  Filatov  and  White,  1995)  and  from  other  pLGIC  family 
members (neuronal nAChRs and GABARs) in which the shift is such that obvious differences 
appear between receptors with mutant ʱ and mutant non-ʱ subunits (for examples see Boorman 
et  al.,  2000;  Chang  et  al.,  1996;  Moroni  et  al.,  2006;  Plazas  et  al.,  2005a,  b;).  More 
importantly,  my  results  from  oocytes  do  not  agree  with  data  from  ʱ1β  glycine  receptors 
expressed in HEK293 cells, in which the same receptor subtype and same subunit constructs 
were studied (Burzomato et al., 2003). In the HEK293 cell study the dose ratios (calculated as 
the horizontal distance between the wild-type and the mutant concentration-response curve) 
were  ~10-fold  when  β  was  mutated  (ʱ1β
LT)  and  ~74-fold  when  ʱ1  was  mutated  (ʱ1
LTβ), 152 
 
suggesting  a  stoichiometry  of  3ʱ:2β  (Burzomato  et  al.,  2003).  The  strongest  effect  of  the 
mutations in oocytes, on the other hand, was only a decrease in the Hill slope and in the 
maximum current produced by glycine. These were more obvious for receptors with a mutated 
ʱ1 subunit (ʱ1
LSβ, ʱ1
LTβ). An effect on the Hill slope coefficient has also been reported for 
GABAA receptors (Chang et al., 1996) and also for HEK293-expressed GlyRs (Burzomato et 
al., 2003); in the latter, the reduction was also proportional to the number of mutations in the 
receptor. Given that 9΄ mutations increase the probability of channel opening, these reductions 
in  the  Hill  slope  of  mutant  receptors  have  been  interpreted  as  an  indication  that  partially 
liganded states of the receptor contribute to the agonist current.  
 
The strong evidence from the Burzomato study and the discrepancy with my data raises some 
questions:  why,  since  the  same  receptors  and  mutations  were  studied,  is  this  discrepancy 
observed? Or, to be more precise, what are the differences between the two expression systems 
that  are  responsible  for  the  dissimilar  results  between  the  two  studies?  Some  ideas  are 
considered below:  
 
A simple explanation for these findings  may be that oocyte-expressed  ʱ1β receptors are a 
mixture of pentamers, some containing two and some containing three copies of the alpha 
subunit. Effectively, the average number of both subunits in each receptor would be the same, 
which would explain why the concentration-response curves for the mutant receptors are so 
similar, irrespective of whether the mutation is in the ʱ1 or the β subunit. In simple words, the 
receptor has on average 2.5 mutations in both cases.  
 
Another thing to be considered is also that the interpretations of the results from 9΄ mutations 
relies  on  the  assumption  that  the  effect  of  the  mutation  is  the  same  irrespective  of  which 
subunit carries it. This holds roughly true for muscle nicotinic receptors (Labarca et al., 1995) 
but not for GABAARs, suggesting that channel asymmetry is much greater in the latter (Chang 
et al., 1996; Chang and Weiss, 1998). It is possible that such an asymmetry also appears in 
oocyte-expressed glycine receptors: it might be that β subunits are produced, or assembled, in 
such a way that they contribute to receptor gating in an asymmetric, non-equivalent manner, 
compared with ʱ1 subunits. If indeed the conformational changes that lead to channel gating 
are asymmetrical and subunit-specific, then a gating mutation such as the 9΄LT would also 153 
 
result in subunit-specific changes to occur in EC50 values (see also Shan et al., 2003). This of 
course does not explain why such „irregularities‟ in receptor symmetry appear only in oocyte-
expressed receptors and not in HEK293 cells.  
 
In addition, there is extensive contamination by homomeric channels in oocytes. In the cRNA 
combinations where the ʱ1 subunit was mutated (i.e. ʱ1
LT+β and ʱ1
LS+β) it is reasonable to 
assume that the contamination by homomers is insignificant because I could detect little, or no, 
current from ʱ1
LS and ʱ1
LT homomers respectively. Therefore, the EC50 obtained from such 
combinations truly represents the glycine sensitivity of a pure population of only ʱ1-mutant 
heteromers. On the other hand, in the combination where the β subunit is mutated (ʱ1+β
LT 
injections), one can argue that the EC50 value I obtained (from one-component fits) is in reality 
the result of a two-component curve, one component corresponding to ʱ1 homomers and the 
other to ʱ1β
LT heteromers. In such a case the EC50 I calculated could be higher than the one 
truly corresponding to ʱ1β
LT heteromers, due to the high EC50 of homomers (~100 μΜ). An 
effort to fit the ʱ1+β
LT data
 with a two-component Hill equation (either with all parameters free 
or with the values of the first component fixed to those from the ʱ1 data) resulted in poor fits, 
indicating that the homomeric component could not be detected. Similar results were obtained 
for two-component fits of ʱ1+β
 data.
 Poor fits, of course, do not exclude the fact that the 
formation  of  homomers  does  indeed  distort  the  values  I  obtained  from  the  heteromeric 
combinations. The contamination however cannot explain why, when the ʱ1 subunit is mutated 
(in ʱ1
LSβ and ʱ1
LTβ channels), I see little effect in the sensitivity to glycine. An additional 
confounding  factor  is  that,  in  oocytes,  agonist  EC50  values  for  glycine  receptors  may  be 
affected by the level of expression. This was reported for 1 homomers by Taleb and Betz 
(1994). 
 
As a last point, the physical differences between oocytes and HEK293 cells should also be 
taken into account. Oocytes are large cells, clearly visible by eye, with a diameter of ~1 mm. 
Though their size makes them ideal for two-electrode voltage clamp it also has a downside, in 
that it increases the thickness of the unstirred layer that the agonist has to diffuse through to 
reach the receptors. This means that the actual time course for the concentration of agonist at 
the receptors is slower than in a HEK293 cell or in a patch. Furthermore, the oocyte membrane 
has extensive invaginations. Because of these, the agonist responses recorded in oocytes are 154 
 
more distorted by desensitization which in turn influences the shape and position of the agonist 
concentration-response curve. The EC50 therefore can be lower in oocytes than in cell lines for 
the same receptor. The problem arises when a mutation is introduced, like a 9΄ mutation which 
has more than one effect: besides reducing the EC50 (by facilitating gating), 9΄ mutations are 
known also to decrease the rate of desensitization (Revah et al., 1991; Yakel et al., 1993). 
Reducing  the impact  of desensitization is  expected to  increase  the  EC50 and in  cells  with 
substantial  agonist  desensitization,  like  oocytes,  this  effect  could  be  large  enough  to 
counterbalance the effect on gating. In other words, the two effects would cancel each other. 
Such  an  effect  was  shown  for  ʱ5-containing  neuronal  nAChRs,  channels  with  fast 
desensitization, in which the effect of 9΄ mutations on the EC50 appeared to be attenuated or 
abolished, reducing their usefulness in determining receptor stoichiometry (Groot-Kormelink et 
al., 2001).  
 
To  summarise,  the  data  from  9΄  mutations  in  oocytes  cannot  provide  any  conclusions 
concerning the stoichiometry of ʱ1β heteromeric GlyRs, unlike what occurs in HEK293 cells 
(Burzomato et al., 2003). We do not know the precise reason for this discrepancy but the 
problem of homomeric receptor contamination is by itself a disadvantage in using oocytes to 
study glycine heteromeric channels. 
 
4.1.2 The use of the conductance mutation 
Because of the inconclusive results of the 9΄ mutation experiments, I tested an alternative way 
to assess stoichiometry. This method was used successfully by Cooper and colleagues (1991) 
for chick ʱ4β2 neuronal nicotinic receptors and by Béhé et al. (1995) for the determination of 
NR1 subunit copies in NMDA receptors expressed in Xenopus oocytes. The method requires 
the use of a mutation that alters the single-channel conductance of glycine receptors and the 
TM2 domain is a good candidate for such a mutation: this region was shown to be the main 
determinant  of  single-channel  conductance  of  both  homomeric  and  heteromeric  glycine 
channels (Bormann et al., 1993; Carland et al., 2009). The task of selecting a single point 
mutation within this region is difficult so I chose the creation of chimeric subunits instead, with 
the β subunit containing the entire TM2 sequence of the ʱ1 subunit and vice versa. Using the β-
chimera (β
Ch) had an advantage: it has already been shown that when β
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ʱ1 in HEK293 cells, it produces channels with a homomer-like conductance (Bormann et al., 
1993).  
 
My cell-attached data from oocytes confirm this, as co-injection of this subunit with ʱ1 in 
oocytes resulted in heteromeric channels with main slope conductance of approximately 70 pS. 
This is close to the conductance of ʱ1 homomers, but the presence of subconductance levels 
and the long duration of clusters distinguish these ʱ1β
Ch channels from ʱ1 homomers. Single-
channel  data  in  oocytes  also  confirmed  that  wild-type  heteromeric  channels  (ʱ1β)  have  a 
conductance  which  is  approximately  half  that  of  the  mutant  ones  (33  pS).  This  mutation 
therefore provides, in principle, a good separation in slope conductance between receptors that 
incorporate only mutant and only wild-type β subunits. For investigating the stoichiometry, this 
~35 pS difference should allow the detection of at least one intermediate conductance (from 
mixed receptors that incorporate both mutant and wild-type β subunits), when both the wild-
type and the mutant subunits are injected in the same cell.  
 
Unfortunately, an intermediate conductance could not be detected in  my cell-attached data 
from either oocytes, or HEK293 cells, transfected with the ʱ1+β+β
Ch combination. In HEK293 
cells  the  slope  conductances  of  the  expressed  receptors  clearly  fall  into  two  groups,  one 
corresponding to wild-type heteromers and the other one to homomer-like channels. In oocytes, 
the low-conductance group of 7 patches has a higher average conductance than wild-type ʱ1β 
channels but this difference is too small (7 pS) to be sure that these channels are truly different 
from ʱ1β. The low expression of this combination did not allow the collection of more data. 
Results from the outside-out experiments in oocytes also point towards the lack of unique 
conductance levels for the ʱ1+β+β
Ch combination. Possible explanations that can account for 
the lack of any intermediate states are discussed below.   
 
First of all, it could be that a mixed receptor containing both mutant and wild-type subunits 
does not assemble or cannot reach the cell membrane. This may also explain the low success 
rate in obtaining cell-attached patches containing channels, using the ʱ1+β+β
Ch combination. 
However, the successful expression of the ʱ1+β
Ch combination suggests that the β
Ch subunit 
preferentially assembles only with ʱ1 but not with wild-type β subunits. One could argue that 
the mutation somehow alters the structure of the subunit, forbidding it to assemble with wild-156 
 
type β subunits. However, this is a completely ad hoc explanation, as there are no indications 
that the TM2 domain is involved in assembly of GlyRs and also there is no reason to assume 
that only the β-β
Ch interactions are affected.  
 
For understanding better the behaviour of the β
Ch subunit we have to take into consideration the 
mutation I have used. In the swapping of the TM2 domain between the two subunits I included 
residue 21΄, in agreement with Bormann and colleagues (1993), who showed that inclusion of 
this residue is essential for the homomer-like behaviour of the β
Ch subunit. This residue, a 
serine (S) for ʱ1 and a glutamate (E) for β, lies immediately after the TM2 and at the beginning 
of the TM2-TM3 loop. Evidence from cationic pLGICs suggest that the TM2-TM3 loop is one 
of  three  regions  involved  in  the  wave  of  conformations  that  lead  from  agonist  binding  to 
channel gating (see for examples Lee and Sine, 2005; Lummis et al., 2005; see Figure 1.6) and 
it is reasonable to assume that TM2-TM3 loop residues of GlyRs (such as residue 21΄) are also 
involved in gating. For the ʱ1 subunit this is demonstrated by the use of alanine and cysteine 
substitution mutants (Lynch et al., 1997, 2001) and also from the fact that mutations in this 
region are linked to hyperekplexia cases with impaired gating (Lewis et al., 1998). This may 
apply only to the ʱ1 subunit, as  there is evidence to suggest that the β subunit TM2-TM3 loop 
is either not involved in gating or that the structure of the loop is quite different from that of ʱ1 
subunits, making it less effective in gating (Shan et al., 2003). The latter might explain the 
appearance of subconductance levels for ʱ1β
Ch heteromers: these channels have a pore of ʱ1 
homomers (due to the presence of five ʱ1-like TM2) but the five TM2-TM3 loops of ʱ1β 
heteromers, and this asymmetry is likely to give rise to abnormal conformations during gating. 
A mixed ʱ1+β+β
Ch receptor, if it does assemble, may be even more asymmetrical, as some of 
the β subunits would have in the 21΄ position either glutamate (wild-type) or serine (chimeras). 
Could that impair the gating of such mixed channels so much that it would explain the failure 
to record any intermediate conductance states?  
 
Another possible explanation for the lack of any intermediate conductance levels in oocytes 
injected with the ʱ1+β+β
Ch combination is that all the expressed ʱ1 subunit is used to form 
homomers. This combination was injected in oocytes in a ratio of 1:40 of ʱ1 over the total β 
subunit, meaning that the expressed ʱ1 will be 40 times less than β and β
Ch, assuming an equal 
efficiency in the production of all subunits. However, two points argue against this hypothesis. 157 
 
First,  even  if  the  expression  of  heteromers  is  low,  the  rate  of  production  of  all-mutant 
heteromers (ʱ1β
Ch) should be the same as that for the production of the mixed combination. 
My data, on the other hand, argue that although the expression of ʱ1β
Ch is successful, that of 
the  mixed  combination  is  not.  Second,  in  HEK293  cells  transfected  with  the  ʱ1+β+β
Ch 
combination,  the  homomeric  contamination  is  minimal  (only  three  patches  contained  a 
homomer-like conductance) and yet I did not observe any intermediate conductances. From the 
above it is evident that the formation of homomers is not sufficient for explaining the lack of 
intermediate conductances but it can justify the low success rate in obtaining patches with 
channels in oocytes.  
 
So far we have considered the possibility that the mixed ʱ1+β+β
Ch receptors are not formed, or 
that they are formed but do not gate. Another possible explanation is that their conductance is 
too close to that of the “control” ʱ1β and ʱ1β
Ch channels and they cannot be recognised as 
mixed channels. This experimental approach assumes that the mixed receptor (containing both 
β and β
Ch) would have a single-channel conductance that is intermediate between the controls. 
Eliminating one-by-one  the  β subunits  in  the channel  (by  replacing  them with  β
Ch) would 
increase the single-channel conductance to an extent proportional to the number of replaced β 
subunits. On the other hand, if the conductance of a mixed channel coincides with the controls, 
it would follow that one, or two, copies of β
Ch subunit(s) together with β is not enough to 
change the conductance, but all the β have to be replaced for this to occur. However, even if 
the two, or three, β subunits in the heteromer are not equivalent (indicative of some asymmetry 
in the channel), it is very unlikely that their substitution would not cause some alteration in 
conductance. This is because the mutation of all β subunits causes a massive increase (~35 pS) 
in the conductance of the channels. One could argue that the slight increase (~7 pS) in the 
conductance of the group of the 7 ʱ1+β+β
Ch patches in oocytes, compared with the wild-type 
ʱ1β, is an indication of the presence of the mutation in these channels. However, none of these 
patches had the features of β
Ch-containing channels (long clusters and subconductance levels). 
Also, this increase was not observed in HEK293 cells. All the above make this explanation 
somewhat unconvincing.  
 
To summarize, I have used two alternative approaches for studying the stoichiometry of ʱ1β 
glycine  receptors  in  Xenopus  oocytes,  in  an  effort  to  shed  some  light  on  the  discrepancy 158 
 
between studies that argue in favour of a 3ʱ:2β or a 2ʱ:3β stoichiometry. Both these techniques 
are reliable and established ways for studying the stoichiometry of a ligand-gated channel. 
However, with the results I obtained it was not possible to reach to a concrete conclusion 
concerning stoichiometry. On the other hand, these data provide indications that the oocyte is 
not a reliable expression system for heteromeric glycine receptors, mainly due to the heavy 
contamination by homomers. The latter is supported by studies showing that the properties of a 
given channel are dependent on the expression system (for examples see Farroni and McCool, 
2004; Lewis et al., 1997), raising a new challenge of establishing which expression system is 
the closest to each native receptor subtype. Therefore, to conclude, oocytes (unlike HEK293 
cells) should not be considered for the study of heteromeric glycine receptors.   
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4.2 Activation mechanism of α2 GlyRs  
 
4.2.1 Maximum likelihood fitting 
The  aim  of  the  last  part  of  my  work  was  to  determine  a  kinetic  mechanism  for  the  ʱ2 
homomeric glycine receptor.  
 
There are different ways to deduce the kinetic mechanism of a given channel. The approach 
followed in the early 80‟s involved fitting mixtures of exponential probability density functions 
to single-channel dwell-time distributions. Counting the number of components needed to fit 
open and shut-time distributions gives a (minimum) number for open and shut states in the 
mechanism,  and  some  information  on  their  connectivity  can  be  extracted  by  analysing 
correlations. Having drawn a putative activation mechanism, the rate constants for the different 
steps have to be estimated from the time constants of the different components. The process is 
somewhat complicated and suffers from several limitations. First of all, as it is the distributions 
of dwell times that are  analysed, the information contained in  the  order  of events  is  lost. 
Secondly,  only  approximate  correction  for  missed  events  is  possible,  given  that  an  exact 
correction is mechanism-dependent and can only be done if a mechanism is postulated (for a 
review  see  Colquhoun,  2006b).  More  recently,  theoretical  advances  led  to  a  more  precise 
method of analysis, which involves analysing the whole of the idealised sequence of events. 
This means that, in principle, all the information contained in a single-channel record is used, 
including relationships between adjacent open and shut times through correlations (Colquhoun 
and Hawkes, 1987; Colquhoun et al., 2003).  In this global fit, rate constants are optimised to 
maximize their likelihood (i.e. to increase the probability of the sequence of events in a single-
channel record). In this way the postulated mechanism is introduced in advance, initial guesses 
are given to the rate constants and their values are changed until a maximum for the likelihood 
is reached. As a mechanism is postulated at the start of the process, it is possible to implement 
an exact correction to missed events (Hawkes et al., 1992). These advantages finally allow the 
calculation of the exact values of the rate constants and more complicated mechanisms can be 
tested (Colquhoun et al., 2003).  
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Figure 4.1  Direct maximum likelihood fitting to idealised single-channel data 
The rate constants of a postulated mechanism are adjusted until the likelihood of the whole 
sequence of events in the experimental single-channel records is maximised. The validity of the 
final calculated rate constants is tested against the experimental observations, usually these 
being the shut times (as in the figure), the open times (or open periods) and the Popen curve. The 
scheme  is  considered  satisfactory  if  the  predicted  distributions  are  in  agreement  with  the 
experimental ones. 
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I used the method of maximum likelihood fitting of kinetic mechanisms to idealised single-
channel data for the ʱ2 glycine receptor, similarly to what was previously performed for other 
pLGICs (see Beato et al., 2004; Burzomato et al., 2004; Hatton et al., 2003; Lape et al., 2008; 
Plested et al., 2007). The procedure is as described in Figure 4.1 (see also Colquhoun et al., 
2003). Briefly: (i) single-channel data are idealised by time course fitting and recordings at 
different agonist concentrations are grouped into sets, (ii) a kinetic mechanism is postulated 
(usually  taking  into  account  exponential  fits  to  experimental  dwell-time  distributions)  and 
initial guesses are given to the rate constants, (iii) appropriate stretches from the idealised 
records,  the  appropriate  resolution  and  the  postulated  mechanism  are  all  input  into  a 
programme (HJCFIT) that can calculate the likelihood of the data given the reaction rates  and 
maximise  it  and  finally,  (iv)  the  validity  of  the  model  and  of  the  final  rate  constants  are 
checked by looking at the experimental data (dwell-time histograms) and the predictions from 
the model superimposed. A good fitting scheme is not necessarily unique. If more than one 
mechanism fit the data equally well, it may not be possible to choose between the two on the 
basis of quality of fit. In such a case the plausibility of each mechanism has to be considered, 
taking also into account the physical interpretations deriving from each scheme (for example 
see Burzomato et al., 2004).     
 
4.2.2 Features of single-channels from α2 receptors 
The  first  kinetic  analysis  on  native  GlyRs,  performed  on  cultures  of  spinal  motoneurons, 
showed  that  the  relative  frequency  of  long  openings  increases  with  agonist  concentration 
(Twyman  and  MacDonald,  1991).  Specifically,  the  analysis  of  open  periods  showed  that, 
although the time constants of the different components were unaffected by the concentration 
of glycine, the area of each component was not (Twyman and MacDonald, 1991). The same 
phenomenon was subsequently shown to occur in recombinant homomeric and heteromeric 
receptors containing the ʱ1 subunit (Beato et al., 2002, 2004; Burzomato et al., 2004; Fucile et 
al., 1999).  
 
A  striking  feature  of  single-channels  from  ʱ2  glycine  receptors  is  that  this  concentration 
dependence is never observed. At all agonist concentrations channel activity occurs in long 
activations, which resemble what in an ʱ1 channel we would consider a cluster of bursts. The 
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openings occur in prolonged group of openings. The number of these groups of openings in 
each patch was usually low and the groups were separated by very long shut times which 
usually  lasted  for  minutes.  In  a  few  patches  initially  more  than  one  channel  could  be 
simultaneously  open  but  the  onset  of  desensitization  finally  allowed  the  separation  of 
individual groups of openings. In general, very few events could be detected in each patch, 
suggesting the presence of a low number of channels. Another thing to be noted is the low 
success rate in obtaining records with any openings at all. It is difficult to be sure whether one 
should classify these groups of openings as bursts, or as clusters (of bursts). The long gaps 
between groups of openings, the low number of these groups and the low number of transitions 
within the groups meant that the number of records that had enough transitions to be used for a 
kinetic analysis was small.  
 
A characteristic of all patches was that the distributions of fitted amplitude histograms could be 
well described with a single Gaussian component. The finding of a single amplitude value (5.9 
±  0.2 pA) differs in  principle from  other single-channel  studies  on  ʱ2 GlyRs  that showed 
multiple conductance states for this subtype, ranging from 20 to 110 pS (Bormann et al., 1993; 
Mangin et al., 2003; Takahashi et al., 1992). These studies agree on a main conductance state 
of  90-110  pS  (which  represents  60-90%  of  the  total  open  time).  This  difference  can  be 
explained by the different patch clamp configuration that was used for recordings. The studies 
mentioned above were performed in the outside-out configuration whereas I was recording in 
the  cell-attached  configuration.  The  same  difference  in  the  number  of  conductance  states 
between cell-attached and outside-out patches was also observed for ʱ1 and ʱ1β channels (see 
Chapter 3.2). The reasons underlying the discrepancy between cell-attached and excised GlyRs 
conductance  is  unclear  although  excision  and  differences  in  ionic  concentrations  in  the 
different  recording  configurations  are  known  to  have  a  variety  of  effects  on  the  channel 
kinetics (Fucile et al., 2000; Pitt et al., 2008).  
 
It is worth noting that the fitted amplitude showed considerable variation between the different 
cell-attached patches (from 4.5 to 9.1 pA). A similar situation was observed for other native or 
recombinant glycine receptors recorded in this configuration (see Beato and Sivilotti, 2007; 
Plested  et  al.,  2007)  although  it  was  shown  that,  despite  the  differences  in  amplitude,  all 
patches had a similar slope conductance (Beato and Sivilotti, 2007). Differences in channel 163 
 
amplitude might be due to differences in the internal chloride concentration, which affects the 
conductance of the channel (Bormann et al., 1987), or in the resting membrane potential which 
determines the driving force for chloride through the channel (together with the pipette holding 
potential which was +100 mV for all patches).  
 
4.2.3 Dwell-time distributions and the Popen 
Open-period  and  shut-time  distributions  for  ʱ2  channels  were  fitted  with  mixtures  of 
exponential probability density functions (the resolution was set at 20 μs for all patches). An 
open period is defined as the duration between two resolvable adjacent shut times, irrespective 
of transitions between different amplitude levels. In theory, at ideal resolution, the number of 
exponential components needed for fitting an open-period, or a shut-time, distribution would 
represent the exact number of open and shut states that the channel can access in a kinetic 
scheme. However, in  real  experiments  one or more components  might be missed, and the 
distributions provide us with a minimum number of shut and open states that might exist in the 
scheme. Other information can also be obtained from the analysis of distributions, such as the 
concentration  dependence  (if  any)  of  the  time  constants,  or  of  the  areas  of  the  different 
exponential components. Nevertheless, information extracted from such empirical fits is only 
descriptive and was not used for determining any of the rate constants of a kinetic model; the 
open-period and shut-time histograms are only used for testing the validity of a fit after a 
model has already been used for fitting the data (Figure 4.1).  
 
The  open-period  distributions  were  best  fitted  with  a  maximum  of  three  exponential 
components,  in  agreement  with  single-channel  data  from  oocytes  and  embryonic  spinal 
neurons (Takahashi et al., 1992). Although the first and second components were not always 
present, the third (slowest) component was observed in all patches and concentrations and was 
always predominant. The differences between my study and that of Takahashi and colleagues 
(who reported slower time constants) is likely to be due to differences in configuration, and 
expression system and to the better resolution of my experiments, which implies that  fewer 
shut  times  are  missed  and  therefore  results  in  shorter  open  periods.  Analysis  of  the  open 
periods  showed  very  little  difference  between  the  time  constants  of  different  glycine 
concentrations. A closer inspection of these components indicates an increase in the mean open 
period (from 12.5 ± 1.8 to 34.4 ± 7.5 ms) as the concentration increases from 20 to 30 μM. 164 
 
This concentration dependence is very mild compared with ʱ1β and ʱ1 channels (Beato et al., 
2004;  Burzomato  et  al.,  2004;  see  also  Twyman  and  MacDonald,  1991).  The  absence  of 
concentration dependence is obvious at higher concentrations (from 30 μΜ to 10 mM) for 
which the time constants of the three components, their areas and also the mean open periods 
are almost identical. The values for the mean open period at concentrations higher than 30 μΜ 
(27-34  ms)  are  similar  to  that  of  ~50  ms  reported  by  Mangin  et  al.,  (2003).  The  small 
difference in this value, compared with my data, and also the fact that the authors only identify 
one component in their distribution can be explained by the different method of analysis and 
the configuration. Note also that their value of ~50 ms was obtained at saturating glycine (30 
mM) and my data from 10 mM identify a small second component (0.012 ms) with an area of 
only 2% which could easily be missed during a „manual‟ idealisation as the one performed by 
Mangin et al., (2003).   
 
Shut-time distributions were fitted with a maximum of four exponential components, similarly 
to data from ʱ1 homomeric receptors (Beato et al., 2004). The time constants of the first three 
components were the most consistent across different patches and concentrations. The majority 
of events belonged to the shortest component (with areas ranging from 88 to 98%) which 
predominated irrespective of concentration, with time constants of 5-10 μs. Note that such time 
constants are faster than the resolution of 20 μs, suggesting that many such gaps would be 
missed,  though  in  an  idealised  record  of  more  than  10000  transitions,  the  number  of  the 
resolved fast shut times is still sufficient for kinetic analysis. 
 
 For an accurate description of the kinetic mechanism it is important to include in the analysis 
only stretches of data that are likely to occur from one channel molecule. For this purpose, a 
critical shut time should be chosen (tcrit) in a way that shut times longer than tcrit could be 
classified  as  between  clusters  (at  high  concentrations)  or  between  bursts  (at  low 
concentrations). In the case of the ʱ2 receptor, for which the discrimination between burst and 
cluster concentrations is not at all obvious, the selection of tcrit from the shut-time distributions 
„by eye‟ was difficult. Having a look at the distributions, one could confidently say that the tcrit 
should be smaller than 10 ms for all concentrations, since events longer than 10 ms are very 
scarce. Additionally, the time constants of the forth component are the most variable across 
concentrations (ranging from 1.1 to 6.1 ms). Despite these two „criteria‟ however, there is a 165 
 
large margin of uncertainty in deciding what the tcrit should be for each concentration and, for 
this reason, different values of tcrit were used during the process of fitting a mechanism. Note 
however that during the idealisation of ʱ2 records I selected stretches of data with consistent 
high Popen (i.e. clusters): at such high channel activity, the lack of double openings increases the 
confidence that the openings occur from only one channel, however ambiguous the choice of 
tcrit was.  
 
The tcrit of 7-10 ms was chosen for calculating the Popen of the clusters at the different glycine 
concentrations. The definition of a cluster is any group of openings that is ended by a gap 
longer than tcrit; the Popen for each cluster was the ratio between the cluster‟s total open time and 
its length, both obtained from the idealised trace. Therefore, the precision of the estimation is 
effectively dependent on the duration of each cluster, with longer clusters resulting in more 
accurate estimates. As mentioned above, the value of 10 ms is the highest possible from the 
shut-time  distributions,  and  it  was  chosen  for  calculating  the  Popen  in  order  to  avoid 
overestimations: a lower tcrit value, if incorrect, would result in breaking up a true cluster into 
several smaller ones, which would lead to overestimation of the Popen (due to a decrease in the 
cluster‟s length). Due to the lack of concentration dependence in the open periods, it was not 
surprising that the calculated Popen was similar for all concentrations and with values close to 1. 
These values provide a rough estimate of the maximum Popen (close to 1) in agreement with 
outside-out  data  from  Mangin  and  colleagues,  who  reported  a  maximum  Popen  of  0.996 
(Mangin et al., 2003), and also suggest that the EC50 for ʱ2 channels should be lower than 20 
μΜ. The high Popen value across all concentrations suggests that the channel can give rise to 
only  one  type  of  activation:  this  would  be  consistent  with  the  channel  opening  only  at 
saturating agonist concentrations or, alternatively, that activations at lower states of ligation 
also have very high Popen.  
 
4.2.4 The kinetic mechanism of α2 GlyRs using maximum likelihood fitting 
For the purpose of characterising the kinetic behaviour of homomeric ʱ2 GlyRs, steady-state 
single-channel data were fitted to 15 different kinetic schemes, most of which are described in 
Chapter 3.3. During this analysis it became evident that to get good fits the mechanisms had to: 
(i) include only one open state, (ii) contain flipped states to improve the quality of the fits to 
shut-time distributions and (iii) be fitted to the data choosing low values of tcrit (0.1-0.3 ms for 166 
 
burst and 1-3 ms for cluster concentrations). Kinetic models with the above characteristics gave 
plausible  estimates  for  the  rate  constant  values  if  the  fits  were  done  with  constraints  for 
identical, non-interacting binding sites. Both model 7A and 7B (with three and two binding 
sites, respectively) gave excellent fits and converged to very similar values for the gating rate 
constants.  
 
i. Introduction of flipped states improves the fits 
From the initial fits with models 1-4 (with direct openings from each liganded state) it was 
obvious that more shut states were needed for a good fit. As in the case of ʱ1-containing 
glycine receptors (Burzomato et al., 2004), extra shut states can be added distal to the open 
states (see Jones and Westbrook, 1995) or, like in the „flip‟ mechanism, between the resting 
and the open states. For ʱ1β glycine receptors both approaches resulted in very good fits to the 
single-channel data (Burzomato et al., 2004). Unlike the first approach, the shut flipped states 
in  the  „flip‟  mechanism  have  an  obvious  plausible  physical  interpretation  (i.e.  the 
conformational changes after the agonist is bound and before the  channel opens).  For this 
reason, the „flip‟ mechanism is more appealing (Burzomato et al., 2004). 
   
Fitting the ʱ2 single-channel data with variations of the „flip‟ mechanism profoundly improved 
the predictions from the shut-time distributions compared with simple sequential mechanisms. 
This observation was evident for all the models that included flipped states (schemes 5-7) 
irrespective of the number of binding sites, or open states in each model. Note that it was not 
the number of shut states in a model that improved the shut-time distribution fits but, rather, the 
presence of flipped state(s): for example, the best-fitting model (7B; with 2 binding sites, 1 
flipped and 1 open state) has a total of 4 shut states, fewer than the sequential models of five, 
or four, binding sites (without flip, models 1 and 2), that could not converge, or could not fit 
well the data.  
 
ii. Number of open states 
Kinetic analysis of homomeric ʱ1 and heteromeric ʱ1β GlyRs suggests that openings can occur 
from any of the liganded shut states, after flipping. Both receptor types are fitted with the „flip‟ 
mechanism, which contains three open states (Burzomato et al., 2004). The „flip‟ model can 
describe the behaviour of the channels over a wide range of agonist concentrations and the 167 
 
openings from any liganded shut state can account for the observation of short bursts at low 
concentrations, or clusters of bursts at higher concentrations. This model is in line with initial 
studies  on  native  and  recombinant  receptors  that  argue  in  favour  of  at  least  three 
distinguishable  open  states  (Beato  et  al.,  2002,  2004;  Lewis  et  al.,  2003,  Twyman  and 
MacDonald, 1991).  
 
Homomeric ʱ2 receptors were different from the ʱ1-containing channels in that they were best 
fitted with a „flip‟ model that contains only one open state (model 7). This was not surprising, 
as there were no apparent monoliganded openings in the single-channel records: it reflects the 
lack of any concentration dependence in the duration of channel openings, as all openings 
occur in groups of high Popen values at all glycine concentrations. The need for fewer open 
states was already obvious when I tried to fit the „flip‟ model of Burzomato and colleagues 
(model  5)  and obtained for monoliganded openings  an efficacy of ~0.  Similarly, fits  with 
model 6 (6A and 6B), with two open states, had very low values of E for the partially liganded 
open state, with ill-defined gating rates across different sets. Model 6 predicts a mean lifetime 
of 16.6 μs for the partially liganded open state (calculated as 1/ʱ2 for model 6A; ʱ2 = 60374 ± 
14272 s
-1, n = 6 sets). Even if these openings truly occurred, most of them would be missed 
with a resolution of 20 μs. For the above reasons I considered it more sensible to remove this 
gating step from the mechanism.  
 
Even though model 7 (with one open state) predicts very accurately the single-channel and 
macroscopic data, there are some drawbacks to be considered. The experimental open-period 
distributions were best fitted with a mixture of at least two exponential components, suggesting 
that the channels can access at least two open states, one of which is not visited frequently (due 
to the very few events that were detected and correspond to the small component in the open-
period distributions). Because of that a second open state should be added to model 6, for a 
more accurate description, but in a manner different to model 7. A recent study on the kinetics 
of nicotinic receptors describes a model of two sequential flipped states (instead of one shown 
in my study), with openings occurring from any of the two flipped states: the first flipped-to-
open transition accounts for the observed brief openings and the second to more prolonged 
openings (Mukhtasimova et al., 2009). It would be interesting to see whether the addition of a 168 
 
second (or more) flipped-to-open transition to model 7 would improve the fits of the ʱ2 data 
further.  
 
iii. Binding sites 
A homomeric pentamer, such as the ʱ2 GlyR, has up to 5 binding sites, but we do not know 
how many of these are functional (i.e. can be occupied by an agonist) and whether the channel 
can open from states that are partially liganded. As seen with model 7, only one open state, 
linked to the fully-liganded shut state after flipping, is sufficient for fitting well the data. Fitting 
this type of model with a different number of binding sites (from one to five) resulted in very 
similar values for the rate constants and therefore identical predictions for the experimental 
distributions. Note that these predictions provide the best fits for the  ʱ2 data but,  as their 
quality is equally high, the fits of the five models are not informative. The only difference in 
the rates between these five different models was a decrease in the binding affinity (increase in 
KR) as the number of binding sites decreased, which is expected since fewer sites are available 
for the agonist to bind. This had a direct effect on the predicted Popen curve, with the EC50 and 
the slope of the curve decreasing as the number of the binding sites decrease. 
 
For ʱ2 GlyRs we do not really have a well-defined experimental Popen curve; all we know is 
that the maximum Popen is nearly 1 and the EC50 is below 20 μΜ, and this information per se is 
not at all useful. Because of that, I had to use macroscopic data for choosing between the 
models.  The  Hill  slopes  from  concentration-response  curves  obtained  from  whole-cell 
recordings and outside-out concentration jumps range between 1.2 and 1.9. These values are 
very close to the Hill slope value predicted from fits with model 7B, which has two binding 
sites. That would make model 7B the best-fitting model from the ones tested.  
 
Scheme 7B (and also 7A) was initially fitted with the constraints of no cooperativity, i.e. that 
the equilibrium dissociation constant (KR) was the same for all binding steps. For both models 
these fits were satisfactory. When the constraints were removed and the fits were performed 
with all parameters free to test for co-operativity in binding, the predicted distributions and 
Popen curves were unchanged, and so were the values of the gating rate constants. When the 
three binding site model (7A) was fitted, affinity decreased (by ~1000-fold) for the second 
binding step and then increased in the third.  These changes were however inconsistent across 169 
 
the four sets fitted. Free fits with model 7B (two binding sites) predicted marked positive 
cooperativity in binding, with a ~13-fold increase in the affinity of the receptor for glycine 
from the first to the second agonist binding step. While the effect on the equilibrium constant 
was clear and consistent, in some sets this effect originated from a change in association rate 
constants and in others from a change in dissociation rate constant. Overall, the results from 
both  models  show  that  the  fits  are  more  reliable  and  consistent  when  the  constraints  are 
included in the models; this does not affect the quality of the predicted fits, even if there are 
fewer free parameters with the constraints.  
 
iv. Fits to macroscopic currents 
Agonist concentration jumps aim to reproduce the fast and brief exposure of the receptors to 
saturating concentrations of neurotransmitter during synaptic transmission (Clements  et al., 
1992). However, these experiments have to be in the outside-out configuration which changes 
the single-channel properties of GlyRs (Fucile et al., 2000; see also Chapter 3.2), so it is not 
surprising that macroscopic glycine currents obtained with concentration jumps usually have a 
deactivation time course  slower than that of  glycinergic  IPSCs  (Singer and Berger, 1999). 
Much of the discrepancy may be due to differences in the intracellular chloride concentration, 
as shown for ʱ1β glycine receptors by Pitt et al. (2008), who found that the deactivation of 
macroscopic currents becomes faster, and resembles the fast decay predicted from cell-attached 
based kinetic models, when the pipette contains low chloride, mimicking more physiological 
chloride concentrations.  
 
In view of the above, I needed to compare the predictions of the cell-attached kinetic models 
with macroscopic outside-out recordings obtained with low intracellular chloride.  I found that 
deactivation after long concentration jumps (1 s) of saturating glycine became 3-fold faster 
when  the  pipette  chloride  is  low.  When  shorter  jumps  (2  ms)  to  three  different  glycine 
concentrations were applied, two different deactivation components were identified. The faster 
component appears to be concentration dependent as it becomes faster and more difficult to 
detect when glycine concentration is reduced from 10 mM to 500 μM. The slow component is 
the main one (area > 95%) at all concentrations and does not show signs of concentration 
dependence. It is this component that defines the deactivation of ʱ2 currents, ~10-fold slower 
than that of ʱ1β channels. Τhis difference may make ʱ2 homomers unsuitable for fast synaptic 170 
 
transmission, as pointed out by Mangin and colleagues (2003). The authors reported an even 
slower  decay  for  ʱ2  currents  but  this  was  probably  because  they  used  high  intracellular 
chloride (Mangin et al., 2003).  
 
Simulations of the relaxation after a brief jump to saturating agonist, using models 7B (and 
7A), predict a somewhat slower deactivation than that observed experimentally in low chloride. 
The presence of 5 or 6 states in these models implies that the decay should have four, or five, 
components, but the small areas of most of these components calculated from our estimates for 
the rate constants mean that only one of these components would be detectable, with a time 
constant of about 200 ms. This is faster than the main time constant from the experiments using 
symmetrical 130 mM chloride (383 ± 70 ms), but is broadly comparable with the main time 
constant of deactivation in low intracellular chloride (112 ± 26 ms).  
 
The desensitization properties of ʱ2 channels are similar to ʱ1-containing receptors with more 
than one components usually being detected (Gentet and Clements, 2002;  Legendre, 1998; 
Legendre et al., 2002; Pitt et al., 2008). Hence, two desensitized states were added to model 7A 
to  account  for  the  presence  of  a  fast  and  a  slow  desensitization  component  detected  in 
responses to long glycine applications. Both states are connected to the single open state in the 
model.  Fast  desensitization  is  only  observed  in  patches  with  high  current  amplitude,  in  a 
manner similar to that described for ʱ1 and ʱ1β GlyRs (Legendre et al., 2002; Pitt et al., 2008). 
The identification of a fast and a slow component for ʱ2 receptors in my study is in contrast 
with concentration jump experiments performed by Mangin and colleagues that identify only 
one slow  desensitization component in  CHO cells  (Mangin  et  al., 2003). Despite this,  the 
authors  proposed  a  model  of  two  desensitized  states,  each  linked  to  a  liganded  shut  state 
(Mangin et al., 2003). It is worth noting that preliminary fits with the model of Mangin et al., 
using  my  ʱ2  single-channel  data,  showed  that  although  the  model  can  predict  well  the 
experimental distributions, it resulted in a very shallow Popen curve with a slope of ~1, much 
lower than what the macroscopic data have shown and what the authors show themselves (nH 
of 1.8; Mangin et al., 2003).  
 
Legendre and colleagues (2002) have shown that the desensitization of  ʱ1 GlyRs was fast 
enough to occur during a brief (1 ms) application of saturating glycine, shaping the decay of 171 
 
the macroscopic current. Specifically, the authors showed that in high-current patches, which 
have  a  prominent  fast  desensitization,  the  deactivation  had  an  additional  exponential 
component which was likely to correspond to desensitization. Is it possible that the second 
component I observed in the deactivation of ʱ2 currents (after a 2 ms application of glycine) 
corresponds  to  desensitization?  Two  points  are  in  favour  of  this  hypothesis:  (i)  the  time 
constant of this deactivation component (6.1 ± 1.4 ms, 10 mM glycine) is similar to the time 
constant of the fast desensitization component (2.5 ± 0.5 ms, 10 mM glycine, 200 ms) and (ii) 
in some patches the onset of the deactivation phase starts prior to the end of the 2 ms pulse of 
glycine  (see  for  example  the  inset  in  Figure  3.31B).  Additionally,  the  small  deactivation 
component appears to be concentration dependent, which would argue in favour of being the 
result  of  desensitization.  This  last  argument  is  not  very  strong  however,  due  to  the  small 
number of patches and the small range of concentrations tested. All the above argue that it is 
likely that fast desensitization can shape the decay of ʱ2 currents, as in the case of ʱ1 GlyRs, 
but more experiments are needed to confirm this.  
 
The model 7A-d, with the desensitized states linked to the open state, could fit very well the 
macroscopic currents from 200 ms jumps to three different glycine concentrations, both from 
high and from low-amplitude patches, though the quality of the fits is slightly better for the 
high amplitude currents. This is in line with the fact that the model is a good candidate for the 
kinetic mechanism of ʱ2 channels. Preliminary fits using model 7B-d (with two instead of 
three binding sites and desensitized states) can also describe equally well the macroscopic 
currents  (data  not  shown).  This  situation  was  expected  since  the  two  models  have  almost 
identical  rate constants.  As previously noted, the mean lifetime of any  of the desensitized 
states, as predicted by the model 7A-d, is longer than the 3 ms limit set by the highest tcrit 
chosen,  meaning  that  desensitization  would  have  been  excluded  from  the  single-channel 
analysis performed with HJCFIT. This confirms that low values of tcrit were necessary for high 
quality analysis of ʱ2 single-channels, not only for improving the fits but also for avoiding 
interference by desensitization.  
 
The rate constant of entry into fast desensitization for high-amplitude patches, predicted by 
model 7A-d (dfast(+) = 337 s
-1), is faster than the closing rate constant (ʱ = 312 s
-1) of fits in 
which the kon was constrained. According to model 7A, when the channel is open (A3R*) it can 172 
 
either  enter  a  short-lived  shut  state  (A3F),  from  which  the  burst  can  terminate  because  of 
dissociation, or enter the longer-lived desensitized state (A3Dfast). The fact that the rate of entry 
into  desensitization  is  comparable  with  the  closing  rate  constant  suggests  that  bursts 
(transitions between open and short-lived shut states) can be terminated also by desensitization. 
That is supported by the fact that the low value of ʱ roughly corresponds to a τdecay value of ~3 
ms though the experimental value is much higher. The latter indicates that deactivation could 
be prolonged due to dwells into desensitization prior to finally entering a resting state. The 
above speculations might explain why we cannot observe any openings at concentrations lower 
than 20 μΜ (i.e. „burst‟ concentrations) and also why the „patch‟ Popen (i.e. the total open 
time/total duration of the recording) is very low for these channels. Other cases in which the 
entry into desensitization appears to contribute to the time course of deactivation have also 
been reported for gain-of-function muscle nAChRs (Elenes et al., 2006) and, as mentioned 
above, for ʱ1 GlyRs (Legendre et al., 2002).  
 
To summarise my findings on recombinant ʱ2 GlyRs, I propose a kinetic scheme that contains 
a single, fully-liganded open state and two, or three, sequential agonist binding steps together 
with  a  pre-opening  conformational  change  (flip).  Additional  data  from  macroscopic 
concentration-response curves favour two rather than three binding steps. Although the model 
can describe adequately the single-channel and macroscopic data I have obtained, there are 
nevertheless  limitations  which  suggest  future  experimental  directions.  For  example,  an 
improvement in recording resolution might help to reveal more exponential components in the 
shut-time and open-period distributions that would allow a more accurate determination of a 
tcrit  value  for  bursts.  In  addition,  a  more  thorough  investigation  of  the  properties  of 
desensitization is needed, in order to clarify its contribution, if any, in shaping deactivation. 
Revisions of the model will have to be done, to account for the more complicated nature of 
these channels. Yet, despite the above considerations, this model is a good starting candidate 
for the kinetics of these channels.  
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